(234433, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0005350', 'increased susceptibility to autoimmune disorder', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(234434, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0001663', 'abnormal digestive system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(234435, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0020924', 'abnormal susceptibility to Hepadnaviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(234436, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0004797', 'increased anti-erythrocyte antigen antibody level', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(234437, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0002148', 'abnormal hypersensitivity reaction', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(234438, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0004829', 'increased anti-chromatin antibody level', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(234439, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0008004', 'abnormal stomach pH', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(234440, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0001664', 'abnormal digestion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(234441, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0008747', 'abnormal T cell anergy', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(234442, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0008555', 'abnormal interferon secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(234443, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0020095', 'abnormal mean heart rate adaptation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(234444, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0011046', 'abnormal lung tissue damping', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(234445, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0004947', 'skin inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(234446, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0008666', 'increased interleukin-12a secretion', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(234447, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0012167', 'abnormal epigenetic regulation of gene expression', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(234448, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0004823', 'increased susceptibility to experimental autoimmune myasthenia gravis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(234449, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0008706', 'decreased interleukin-6 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(234450, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0008690', 'increased interleukin-23 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(234451, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0006323', 'abnormal extraembryonic mesoderm development', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(234452, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0001819', 'abnormal immune cell physiology', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(234453, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0011925', 'abnormal heart echocardiography feature', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(234454, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0008669', 'increased interleukin-12b secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(234455, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0012028', 'abnormal visceral endoderm physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(234456, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0004212', 'abnormal salty taste sensitivity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(234457, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0003303', 'peritoneal inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(234458, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0030988', 'dysosmia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(234459, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0031110', 'meningitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(234460, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0020163', 'increased susceptibility to virus induced diabetes', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(234461, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0004036', 'abnormal muscle relaxation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(234462, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0004771', 'increased anti-single stranded DNA antibody level', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(234463, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0014048', 'abnormal Peyers patch physiology', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(234464, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0013636', 'abnormal bone stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(234465, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0020920', 'decreased susceptibility to Ortervirales infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(234466, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0004085', 'abnormal heartbeat', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(234467, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0031221', 'abnormal CXCL10 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(234468, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0003746', 'stomatitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(234469, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0008694', 'decreased interleukin-23a secretion', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(234470, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0008655', 'decreased interleukin-1 alpha secretion', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(234471, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0003077', 'abnormal cell cycle', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(234472, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0004804', 'decreased susceptibility to autoimmune diabetes', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(234473, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0020912', 'abnormal susceptibility to Riboviria infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(234474, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0008557', 'abnormal interferon-alpha secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(234475, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0008671', 'abnormal interleukin-13 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(234476, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0006080', 'brain ischemia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(234477, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0020001', 'decreased response to antigen', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(234478, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0001533', 'abnormal skeleton physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(234479, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0008687', 'increased interleukin-2 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(234480, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0008707', 'abnormal interleukin-7 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(234481, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0008544', 'impaired olfaction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(234482, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0005088', 'increased acute inflammation', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(234483, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0004800', 'decreased susceptibility to experimental autoimmune encephalomyelitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(234484, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0020412', 'abnormal amnion physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(234485, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0008709', 'decreased interleukin-7 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(234486, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0010223', 'abnormal immunoglobulin transcytosis', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(234487, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0003137', 'abnormal impulse conducting system conduction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(234488, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0000350', 'abnormal cell proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(234489, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0005042', 'abnormal level of surface class II molecules', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(234490, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0001872', 'sinus inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(234491, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0002869', 'increased anti-insulin autoantibody level', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(234492, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0008560', 'increased tumor necrosis factor secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(234493, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0020916', 'increased susceptibility to Herpesvirales infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(234494, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0012186', 'abnormal muscle precursor cell physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(234495, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0020098', 'abnormal susceptibility to diet-induced aortic fatty streak lesions', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(234496, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0004821', 'increased susceptibility to experimental autoimmune uveoretinitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(234497, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0004795', 'decreased anti-nuclear antigen antibody level', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(234498, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0001861', 'lung inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(234499, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0008668', 'abnormal interleukin-12b secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(234500, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0002410', 'decreased susceptibility to viral infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(234501, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0008746', 'abnormal peripheral B cell anergy', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(234502, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0013136', 'genital discharge', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(234503, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0021014', 'abnormal tau protein phosphorylation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(234504, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0020155', 'enhanced humoral immune response', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(234505, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0011398', 'abnormal endoneurial fluid pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(234506, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0008673', 'decreased interleukin-13 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(234507, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0008683', 'abnormal interleukin-18 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(234508, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0011082', 'abnormal gastrointestinal motility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(234509, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0020183', 'abnormal susceptibility to fungal infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(234510, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0002406', 'increased susceptibility to infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(234511, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0010368', 'abnormal lymphatic system physiology', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(234512, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0008932', 'abnormal embryonic tissue physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(234513, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0008695', 'abnormal interleukin-3 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(234514, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0008670', 'decreased interleukin-12b secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(234515, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0001866', 'nasal inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(234516, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0005190', 'osteomyelitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(234517, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0005026', 'decreased susceptibility to parasitic infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(234518, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0003880', 'abnormal central pattern generator function', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(234519, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0005004', 'abnormal lymphocyte anergy', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(234520, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0008682', 'decreased interleukin-17 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(234521, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0008699', 'increased interleukin-4 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(234522, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0001835', 'abnormal antigen presentation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(234523, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0011717', 'increased interleukin-8 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(234524, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0004802', 'decreased susceptibility to systemic lupus erythematosus', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(234525, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0010680', 'abnormal skin adnexa physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(234526, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0002471', 'abnormal complement pathway', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(234527, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0002418', 'increased susceptibility to viral infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(234528, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0030990', 'nerve inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(234529, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0008710', 'abnormal interleukin-9 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(234530, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0005044', 'sepsis', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(234531, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0020922', 'increased susceptibility to Parvoviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(234532, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0008702', 'increased interleukin-5 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(234533, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0020933', 'abnormal susceptibility to Retroviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(234534, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0020936', 'abnormal susceptibility to Picornaviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(234535, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0013559', 'abnormal exocrine gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(234536, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0005399', 'increased susceptibility to fungal infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(234537, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0008656', 'abnormal interleukin-1 beta secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(234538, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0008679', 'decreased interleukin-16 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(234539, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0005000', 'abnormal immune tolerance', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(234540, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0009062', 'impaired lectin complement pathway', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(234541, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0001864', 'vascular inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(234542, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0003566', 'abnormal cell adhesion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(234543, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0006082', 'CNS inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(234544, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0020929', 'decreased susceptibility to Poxviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(234545, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0020921', 'abnormal susceptibility to Parvoviridae infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(234546, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0020092', 'abnormal susceptibility to aortic cartilaginous metaplasia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(234547, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0001545', 'abnormal hematopoietic system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(234548, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0002419', 'abnormal innate immunity', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(234549, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0012554', 'increased serum complement activity', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(234550, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0002161', 'abnormal fertility/fecundity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(234551, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0003767', 'palate inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(234552, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0011716', 'abnormal interleukin-8 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(234553, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0002531', 'abnormal type I hypersensitivity reaction', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(234554, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0002534', 'abnormal type IV hypersensitivity reaction', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(234555, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0005027', 'increased susceptibility to parasitic infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(234556, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0008860', 'abnormal hair cycle telogen phase', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(234557, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0020931', 'increased susceptibility to Adenoviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(234558, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0008660', 'increased interleukin-10 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(234559, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0008662', 'abnormal interleukin-12 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(234560, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0004210', 'abnormal bitter taste sensitivity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(234561, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0001836', 'abnormal antigen presentation via MHC class I', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(234562, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0008650', 'abnormal interleukin-1 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(234563, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0008688', 'decreased interleukin-2 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(234564, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0003925', 'abnormal cellular glucose uptake', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(234565, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0002500', 'granulomatous inflammation', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(234566, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0008561', 'decreased tumor necrosis factor secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(234567, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0008704', 'abnormal interleukin-6 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(234568, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0008564', 'increased interferon-beta secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(234569, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0002998', 'abnormal bone remodeling', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(234570, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0010950', 'abnormal lung hysteresivity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(234571, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0001837', 'defective assembly of class I molecules', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(234572, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0004803', 'increased susceptibility to autoimmune diabetes', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(234573, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0008563', 'decreased interferon-alpha secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(234574, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0008686', 'abnormal interleukin-2 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(234575, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0011762', 'renal/urinary system inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(234576, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0005672', 'increased susceptibility to graft versus host disease', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(234577, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0005363', 'decreased susceptibility to prion infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(234578, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0005501', 'abnormal skin physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(234579, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0008197', 'abnormal follicular dendritic cell physiology', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(234580, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0020185', 'abnormal susceptibility to viral infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(234581, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0008562', 'increased interferon-alpha secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(234582, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0005671', 'abnormal response to transplant', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(234583, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0008698', 'abnormal interleukin-4 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(234584, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0001873', 'stomach inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(234585, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0001542', 'abnormal bone strength', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(234586, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0003298', 'choking', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(234587, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0008711', 'increased interleukin-9 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(234588, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0003725', 'increased autoantibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(234589, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0001876', 'decreased inflammatory response', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(234590, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0004558', 'delayed allantois development', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(234591, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0002106', 'abnormal muscle physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(234592, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0008676', 'decreased interleukin-15 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(234593, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0008735', 'increased susceptibility to endotoxin shock', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(234594, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0008689', 'abnormal interleukin-23 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(234595, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0009697', 'abnormal copulation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(234596, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0030153', 'dental pulp inflammation', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(234597, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0012685', 'abnormal primitive streak elongation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(234598, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0008708', 'increased interleukin-7 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(234599, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0004076', 'abnormal vitelline vascular remodeling', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(234600, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0003875', 'abnormal hair follicle regression', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(234601, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0001724', 'abnormal extraembryonic endoderm formation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(234602, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0008685', 'decreased interleukin-18 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(234603, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0031092', 'dysgeusia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(234604, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0001943', 'abnormal respiration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(234605, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0008556', 'abnormal tumor necrosis factor secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(234606, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0012704', 'abnormal embryonic neuroepithelial cell proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(234607, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0020162', 'decreased susceptibility to virus induced diabetes', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(234608, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0001845', 'abnormal inflammatory response', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(234609, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0020928', 'increased susceptibility to Poxviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(234610, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0001838', 'defective intracellular transport of class I molecules', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(234611, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0002634', 'abnormal sensorimotor gating', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(234612, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0005076', 'abnormal cell differentiation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(234613, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0030987', 'spinal cord inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(234614, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0020915', 'abnormal susceptibility to Herpesvirales infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(234615, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0000313', 'abnormal cell death', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(234616, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0004822', 'decreased susceptibility to experimental autoimmune uveoretinitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(234617, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0008749', 'abnormal peripheral T cell anergy', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(234618, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0031302', 'syncope', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(234619, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0008697', 'decreased interleukin-3 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(234620, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0020000', 'abnormal response to antigen', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(234621, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0020002', 'increased response to antigen', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(234622, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0008566', 'increased interferon-gamma secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(234623, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0009785', 'abnormal susceptibility to infection induced morbidity/mortality', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(234624, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0004213', 'abnormal umami taste sensitivity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(234625, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0004824', 'decreased susceptibility to experimental autoimmune myasthenia gravis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(234626, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0020932', 'decreased susceptibility to Adenoviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(234627, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0000427', 'abnormal hair cycle', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(234628, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0012567', 'increased susceptibility to experimental autoimmune orchitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(234629, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0001919', 'abnormal reproductive system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(234630, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0008678', 'increased interleukin-16 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(234631, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0011764', 'ureteritis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(234632, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0008705', 'increased interleukin-6 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(234633, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0004751', 'increased length of allograft survival', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(234634, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0010822', 'pneumothorax', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(234635, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0008691', 'decreased interleukin-23 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(234636, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0005043', 'defective assembly of class II molecules', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(234637, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0020386', 'adipose tissue inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(234638, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0008674', 'abnormal interleukin-15 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(234639, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0013806', 'encephalopathy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(234640, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0002420', 'abnormal adaptive immunity', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(234641, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0004211', 'abnormal sour taste sensitivity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(234642, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0020913', 'increased susceptibility to Riboviria infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(234643, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0004825', 'increased susceptibility to experimental autoimmune thyroiditis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(234644, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0008568', 'abnormal interleukin secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(234645, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0013498', 'trachea inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(234646, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0002272', 'abnormal nervous system electrophysiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(234647, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0004145', 'abnormal muscle electrophysiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(234648, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0008565', 'decreased interferon-beta secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(234649, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0003278', 'esophageal inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(234650, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0004801', 'increased susceptibility to systemic lupus erythematosus', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(234651, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0004510', 'myositis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(234652, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0008651', 'increased interleukin-1 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(234653, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0000751', 'myopathy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(234654, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0008703', 'decreased interleukin-5 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(234655, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0002425', 'abnormal susceptibility to autoimmune disorder', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(234656, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0009046', 'muscle twitch', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(234657, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0009562', 'abnormal odor adaptation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(234658, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0020948', 'abnormal susceptibility to Coronaviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(234659, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0031111', 'meningoencephalitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(234660, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0008775', 'abnormal heart ventricle pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(234661, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0011763', 'urethritis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(234662, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0020187', 'abnormal susceptibility to prion infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(234663, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0008667', 'decreased interleukin-12a secretion', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(234664, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0008681', 'increased interleukin-17 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(234665, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0002409', 'decreased susceptibility to infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(234666, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0030132', 'periodontium inflammation', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(234667, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0005364', 'increased susceptibility to prion infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(234668, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0002533', 'abnormal type III hypersensitivity reaction', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(234669, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0008271', 'abnormal bone ossification', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(234670, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0008559', 'abnormal interferon-gamma secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(234671, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0001947', 'abnormal mucociliary clearance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(234672, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0001847', 'brain inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(234673, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0004752', 'decreased length of allograft survival', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(234674, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0005001', 'abnormal clonal deletion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(234675, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0003865', 'lymph node inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(234676, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0009057', 'increased interleukin-21 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(234677, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0001844', 'autoimmune response', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(234678, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0005398', 'decreased susceptibility to fungal infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(234679, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0001544', 'abnormal cardiovascular system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(234680, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0002473', 'impaired complement classical pathway', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(234681, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0012382', 'abnormal blood cell physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(234682, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0020846', 'abnormal cell motility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(234683, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0020154', 'impaired humoral immune response', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(234684, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0020951', 'abnormal susceptibility to Paramyxoviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(234685, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0020184', 'abnormal susceptibility to parasitic infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(234686, 'HP:0003729', 'Enteroviral dermatomyositis syndrome', 'MP:0009786', 'decreased susceptibility to infection induced morbidity/mortality', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(234687, 'HP:0025400', 'Nodular-random pattern on pulmonary HRCT', 'MP:0002313', 'abnormal tidal volume', 0.46511627906976744, 9.915985363358194, 2.1475768241242124, 'UPHENO:0019970', 'abnormal lung morphology'),
(234688, 'HP:0025400', 'Nodular-random pattern on pulmonary HRCT', 'MP:0002309', 'abnormal vital capacity', 0.46511627906976744, 9.915985363358194, 2.1475768241242124, 'UPHENO:0019970', 'abnormal lung morphology'),
(234689, 'HP:0025400', 'Nodular-random pattern on pulmonary HRCT', 'MP:0002306', 'abnormal functional residual capacity', 0.46511627906976744, 9.915985363358194, 2.1475768241242124, 'UPHENO:0019970', 'abnormal lung morphology'),
(234690, 'HP:0025400', 'Nodular-random pattern on pulmonary HRCT', 'MP:0002337', 'abnormal whole-body plethysmography', 0.46511627906976744, 9.915985363358194, 2.1475768241242124, 'UPHENO:0019970', 'abnormal lung morphology'),
(234691, 'HP:0025400', 'Nodular-random pattern on pulmonary HRCT', 'MP:0005585', 'increased tidal volume', 0.45454545454545453, 9.915985363358194, 2.123032282904272, 'UPHENO:0019970', 'abnormal lung morphology'),
(234692, 'HP:0025400', 'Nodular-random pattern on pulmonary HRCT', 'MP:0005586', 'decreased tidal volume', 0.45454545454545453, 9.915985363358194, 2.123032282904272, 'UPHENO:0019970', 'abnormal lung morphology'),
(234693, 'HP:0025400', 'Nodular-random pattern on pulmonary HRCT', 'MP:0002308', 'abnormal residual volume', 0.46511627906976744, 9.915985363358194, 2.1475768241242124, 'UPHENO:0019970', 'abnormal lung morphology'),
(234694, 'HP:0025400', 'Nodular-random pattern on pulmonary HRCT', 'MP:0010937', 'increased total lung capacity', 0.4444444444444444, 9.915985363358194, 2.099310507270655, 'UPHENO:0019970', 'abnormal lung morphology'),
(234695, 'HP:0025400', 'Nodular-random pattern on pulmonary HRCT', 'MP:0010857', 'pulmonary necrosis', 0.4222222222222222, 9.915985363358194, 2.046154778026366, 'UPHENO:0019970', 'abnormal lung morphology'),
(234696, 'HP:0025400', 'Nodular-random pattern on pulmonary HRCT', 'MP:0006050', 'pulmonary fibrosis', 0.4358974358974359, 9.915985363358194, 2.079026838278992, 'UPHENO:0019970', 'abnormal lung morphology'),
(234697, 'HP:0025400', 'Nodular-random pattern on pulmonary HRCT', 'MP:0010938', 'decreased total lung capacity', 0.4444444444444444, 9.915985363358194, 2.099310507270655, 'UPHENO:0019970', 'abnormal lung morphology'),
(234698, 'HP:0025400', 'Nodular-random pattern on pulmonary HRCT', 'MP:0002311', 'abnormal inspiratory capacity', 0.46511627906976744, 9.915985363358194, 2.1475768241242124, 'UPHENO:0019970', 'abnormal lung morphology'),
(234699, 'HP:0025400', 'Nodular-random pattern on pulmonary HRCT', 'MP:0004881', 'abnormal lung size', 0.4358974358974359, 9.915985363358194, 2.079026838278992, 'UPHENO:0019970', 'abnormal lung morphology'),
(234700, 'HP:0025400', 'Nodular-random pattern on pulmonary HRCT', 'MP:0002304', 'abnormal total lung capacity', 0.45454545454545453, 9.915985363358194, 2.123032282904272, 'UPHENO:0019970', 'abnormal lung morphology'),
(234701, 'HP:0025400', 'Nodular-random pattern on pulmonary HRCT', 'MP:0001942', 'abnormal lung volume', 0.47619047619047616, 9.915985363358194, 2.172992819149509, 'UPHENO:0019970', 'abnormal lung morphology'),
(234702, 'HP:0025400', 'Nodular-random pattern on pulmonary HRCT', 'MP:0002312', 'abnormal inspiratory reserve volume', 0.46511627906976744, 9.915985363358194, 2.1475768241242124, 'UPHENO:0019970', 'abnormal lung morphology'),
(234703, 'HP:0025400', 'Nodular-random pattern on pulmonary HRCT', 'MP:0005629', 'abnormal lung weight', 0.40476190476190477, 9.915985363358194, 2.00340039015271, 'UPHENO:0019970', 'abnormal lung morphology'),
(234704, 'HP:0001608', 'Abnormality of the voice', 'MP:0009046', 'muscle twitch', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234705, 'HP:0001608', 'Abnormality of the voice', 'MP:0005652', 'sex reversal', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234706, 'HP:0001608', 'Abnormality of the voice', 'MP:0004512', 'anosmia', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234707, 'HP:0001608', 'Abnormality of the voice', 'MP:0030486', 'abnormal osteocyte canaliculus morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234708, 'HP:0001608', 'Abnormality of the voice', 'MP:0002838', 'decreased susceptibility to dystrophic cardiac calcinosis', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234709, 'HP:0001608', 'Abnormality of the voice', 'MP:0011475', 'abnormal glycosaminoglycan level', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(234710, 'HP:0001608', 'Abnormality of the voice', 'MP:0000350', 'abnormal cell proliferation', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234711, 'HP:0001608', 'Abnormality of the voice', 'MP:0005000', 'abnormal immune tolerance', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234712, 'HP:0001608', 'Abnormality of the voice', 'MP:0001542', 'abnormal bone strength', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234713, 'HP:0001608', 'Abnormality of the voice', 'MP:0003298', 'choking', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234714, 'HP:0001608', 'Abnormality of the voice', 'MP:0005620', 'abnormal muscle contractility', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234715, 'HP:0001608', 'Abnormality of the voice', 'MP:0000516', 'abnormal renal/urinary system morphology', 0.47368421052631576, 1.7901636446558942, 0.9208540887305324, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234716, 'HP:0001608', 'Abnormality of the voice', 'MP:0020846', 'abnormal cell motility', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234717, 'HP:0001608', 'Abnormality of the voice', 'MP:0011685', 'abnormal limb paddle morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234718, 'HP:0001608', 'Abnormality of the voice', 'MP:0031090', 'ageusia', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234719, 'HP:0001608', 'Abnormality of the voice', 'MP:0000285', 'abnormal heart valve morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234720, 'HP:0001608', 'Abnormality of the voice', 'MP:0011200', 'abnormal extraembryonic coelom morphology', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234721, 'HP:0001608', 'Abnormality of the voice', 'MP:0021014', 'abnormal tau protein phosphorylation', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234722, 'HP:0001608', 'Abnormality of the voice', 'MP:0012496', 'abnormal pleuropericardial membrane morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234723, 'HP:0001608', 'Abnormality of the voice', 'MP:0004209', 'abnormal sweet taste sensitivity', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234724, 'HP:0001608', 'Abnormality of the voice', 'MP:0013177', 'abnormal tail tip morphology', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234725, 'HP:0001608', 'Abnormality of the voice', 'MP:0014064', 'argyrophilic inclusion bodies', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234726, 'HP:0001608', 'Abnormality of the voice', 'MP:0008546', 'abnormal vesicle-mediated transport', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234727, 'HP:0001608', 'Abnormality of the voice', 'MP:0020130', 'abnormal total fat pad weight', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234728, 'HP:0001608', 'Abnormality of the voice', 'MP:0005499', 'abnormal olfactory system morphology', 0.5, 1.7901636446558942, 0.9460876398769551, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234729, 'HP:0001608', 'Abnormality of the voice', 'MP:0002420', 'abnormal adaptive immunity', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234730, 'HP:0001608', 'Abnormality of the voice', 'MP:0004076', 'abnormal vitelline vascular remodeling', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234731, 'HP:0001608', 'Abnormality of the voice', 'MP:0014065', 'Lewy bodies', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234732, 'HP:0001608', 'Abnormality of the voice', 'MP:0011511', 'biventricular, ambiguous atrioventricular connection', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234733, 'HP:0001608', 'Abnormality of the voice', 'MP:0004998', 'decreased CNS synapse formation', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234734, 'HP:0001608', 'Abnormality of the voice', 'MP:0011186', 'abnormal visceral endoderm morphology', 0.5, 1.7901636446558942, 0.9460876398769551, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234735, 'HP:0001608', 'Abnormality of the voice', 'MP:0030222', 'hyperostosis', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234736, 'HP:0001608', 'Abnormality of the voice', 'MP:0014066', 'Rosenthal fibers', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234737, 'HP:0001608', 'Abnormality of the voice', 'MP:0010478', 'intracranial aneurysm', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234738, 'HP:0001608', 'Abnormality of the voice', 'MP:0012500', 'abnormal angioblastic cord morphology', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234739, 'HP:0001608', 'Abnormality of the voice', 'MP:0003209', 'abnormal pulmonary elastic fiber morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234740, 'HP:0001608', 'Abnormality of the voice', 'MP:0012058', 'abnormal morula morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234741, 'HP:0001608', 'Abnormality of the voice', 'MP:0000566', 'synostosis', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234742, 'HP:0001608', 'Abnormality of the voice', 'MP:0002138', 'abnormal hepatobiliary system morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234743, 'HP:0001608', 'Abnormality of the voice', 'MP:0001944', 'abnormal pancreas morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234744, 'HP:0001608', 'Abnormality of the voice', 'MP:0006280', 'abnormal digit development', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234745, 'HP:0001608', 'Abnormality of the voice', 'MP:0005422', 'osteosclerosis', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234746, 'HP:0001608', 'Abnormality of the voice', 'MP:0003257', 'abnormal abdominal wall morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234747, 'HP:0001608', 'Abnormality of the voice', 'MP:0011398', 'abnormal endoneurial fluid pressure', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234748, 'HP:0001608', 'Abnormality of the voice', 'MP:0010971', 'abnormal periosteum morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234749, 'HP:0001608', 'Abnormality of the voice', 'MP:0012684', 'abnormal pleural cavity morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234750, 'HP:0001608', 'Abnormality of the voice', 'MP:0001664', 'abnormal digestion', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234751, 'HP:0001608', 'Abnormality of the voice', 'MP:0001688', 'abnormal somite development', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234752, 'HP:0001608', 'Abnormality of the voice', 'MP:0013055', 'genital wound', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234753, 'HP:0001608', 'Abnormality of the voice', 'MP:0013806', 'encephalopathy', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234754, 'HP:0001608', 'Abnormality of the voice', 'MP:0011925', 'abnormal heart echocardiography feature', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234755, 'HP:0001608', 'Abnormality of the voice', 'MP:0002787', 'pseudohermaphroditism', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234756, 'HP:0001608', 'Abnormality of the voice', 'MP:0002396', 'abnormal hematopoietic system morphology/development', 0.47368421052631576, 1.7901636446558942, 0.9208540887305324, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234757, 'HP:0001608', 'Abnormality of the voice', 'MP:0003942', 'abnormal urinary system development', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234758, 'HP:0001608', 'Abnormality of the voice', 'MP:0013800', 'abnormal pericardial fat pad morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234759, 'HP:0001608', 'Abnormality of the voice', 'MP:0003941', 'abnormal skin development', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234760, 'HP:0001608', 'Abnormality of the voice', 'MP:0013113', 'greasy tail', 0.47368421052631576, 1.7901636446558942, 0.9208540887305324, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234761, 'HP:0001608', 'Abnormality of the voice', 'MP:0010545', 'abnormal heart layer morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234762, 'HP:0001608', 'Abnormality of the voice', 'MP:0013125', 'thorax swellings', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234763, 'HP:0001608', 'Abnormality of the voice', 'MP:0002212', 'abnormal secondary sex determination', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234764, 'HP:0001608', 'Abnormality of the voice', 'MP:0002421', 'abnormal cell-mediated immunity', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234765, 'HP:0001608', 'Abnormality of the voice', 'MP:0001983', 'abnormal olfactory system physiology', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234766, 'HP:0001608', 'Abnormality of the voice', 'MP:0010123', 'increased bone mineral content', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234767, 'HP:0001608', 'Abnormality of the voice', 'MP:0000733', 'abnormal muscle development', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234768, 'HP:0001608', 'Abnormality of the voice', 'MP:0012072', 'decreased susceptibility to osteoporosis', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234769, 'HP:0001608', 'Abnormality of the voice', 'MP:0012531', 'delayed limb development', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234770, 'HP:0001608', 'Abnormality of the voice', 'MP:0006279', 'abnormal limb development', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234771, 'HP:0001608', 'Abnormality of the voice', 'MP:0013636', 'abnormal bone stiffness', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234772, 'HP:0001608', 'Abnormality of the voice', 'MP:0014062', 'nervous system inclusion bodies', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234773, 'HP:0001608', 'Abnormality of the voice', 'MP:0005457', 'abnormal percent body fat/body weight', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234774, 'HP:0001608', 'Abnormality of the voice', 'MP:0031113', 'pulmonary parenchymal consolidation', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234775, 'HP:0001608', 'Abnormality of the voice', 'MP:0001119', 'abnormal female reproductive system morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234776, 'HP:0001608', 'Abnormality of the voice', 'MP:0002160', 'abnormal reproductive system morphology', 0.47368421052631576, 1.7901636446558942, 0.9208540887305324, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234777, 'HP:0001608', 'Abnormality of the voice', 'MP:0008932', 'abnormal embryonic tissue physiology', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234778, 'HP:0001608', 'Abnormality of the voice', 'MP:0002998', 'abnormal bone remodeling', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234779, 'HP:0001608', 'Abnormality of the voice', 'MP:0002152', 'abnormal brain morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234780, 'HP:0001608', 'Abnormality of the voice', 'MP:0009705', 'abnormal midgut morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234781, 'HP:0001608', 'Abnormality of the voice', 'MP:0031100', 'hemoptysis', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234782, 'HP:0001608', 'Abnormality of the voice', 'MP:0003085', 'abnormal egg cylinder morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234783, 'HP:0001608', 'Abnormality of the voice', 'MP:0006113', 'abnormal heart septum morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234784, 'HP:0001608', 'Abnormality of the voice', 'MP:0000358', 'abnormal cell morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234785, 'HP:0001608', 'Abnormality of the voice', 'MP:0010874', 'abnormal bone volume', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234786, 'HP:0001608', 'Abnormality of the voice', 'MP:0005502', 'abnormal renal/urinary system physiology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234787, 'HP:0001608', 'Abnormality of the voice', 'MP:0013258', 'abnormal extracellular matrix morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234788, 'HP:0001608', 'Abnormality of the voice', 'MP:0031377', 'ambiguous external genitalia', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234789, 'HP:0001608', 'Abnormality of the voice', 'MP:0002210', 'abnormal sex determination', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234790, 'HP:0001608', 'Abnormality of the voice', 'MP:0002161', 'abnormal fertility/fecundity', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234791, 'HP:0001608', 'Abnormality of the voice', 'MP:0010695', 'abnormal blood pressure regulation', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234792, 'HP:0001608', 'Abnormality of the voice', 'MP:0011258', 'abnormal tail fold morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234793, 'HP:0001608', 'Abnormality of the voice', 'MP:0012186', 'abnormal muscle precursor cell physiology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234794, 'HP:0001608', 'Abnormality of the voice', 'MP:0000767', 'abnormal smooth muscle morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234795, 'HP:0001608', 'Abnormality of the voice', 'MP:0010425', 'abnormal heart and great vessel attachment', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234796, 'HP:0001608', 'Abnormality of the voice', 'MP:0002111', 'abnormal tail morphology', 0.5, 1.7901636446558942, 0.9460876398769551, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234797, 'HP:0001608', 'Abnormality of the voice', 'MP:0021145', 'abnormal amino acid derivative level', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(234798, 'HP:0001608', 'Abnormality of the voice', 'MP:0010950', 'abnormal lung hysteresivity', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234799, 'HP:0001608', 'Abnormality of the voice', 'MP:0001919', 'abnormal reproductive system physiology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234800, 'HP:0001608', 'Abnormality of the voice', 'MP:0004547', 'esophageal ulcer', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234801, 'HP:0001608', 'Abnormality of the voice', 'MP:0013941', 'abnormal enthesis morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234802, 'HP:0001608', 'Abnormality of the voice', 'MP:0002837', 'dystrophic cardiac calcinosis', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234803, 'HP:0001608', 'Abnormality of the voice', 'MP:0000428', 'abnormal craniofacial morphology', 0.47368421052631576, 1.7901636446558942, 0.9208540887305324, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234804, 'HP:0001608', 'Abnormality of the voice', 'MP:0011642', 'abnormal bone collagen fibril morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234805, 'HP:0001608', 'Abnormality of the voice', 'MP:0013119', 'abdomen swellings', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234806, 'HP:0001608', 'Abnormality of the voice', 'MP:0020973', 'abnormal gland development', 0.47368421052631576, 1.7901636446558942, 0.9208540887305324, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234807, 'HP:0001608', 'Abnormality of the voice', 'MP:0002128', 'abnormal blood circulation', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234808, 'HP:0001608', 'Abnormality of the voice', 'MP:0013554', 'abnormal apocrine gland morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234809, 'HP:0001608', 'Abnormality of the voice', 'MP:0010433', 'double inlet heart left ventricle', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234810, 'HP:0001608', 'Abnormality of the voice', 'MP:0003077', 'abnormal cell cycle', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234811, 'HP:0001608', 'Abnormality of the voice', 'MP:0000578', 'ulcerated paws', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234812, 'HP:0001608', 'Abnormality of the voice', 'MP:0011510', 'biventricular, discordant atrioventricular connection', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234813, 'HP:0001608', 'Abnormality of the voice', 'MP:0002127', 'abnormal cardiovascular system morphology', 0.5, 1.7901636446558942, 0.9460876398769551, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234814, 'HP:0001608', 'Abnormality of the voice', 'MP:0002114', 'abnormal axial skeleton morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234815, 'HP:0001608', 'Abnormality of the voice', 'MP:0031277', 'pectus carinatum', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234816, 'HP:0001608', 'Abnormality of the voice', 'MP:0001726', 'abnormal allantois morphology', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234817, 'HP:0001608', 'Abnormality of the voice', 'MP:0003875', 'abnormal hair follicle regression', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234818, 'HP:0001608', 'Abnormality of the voice', 'MP:0013801', 'abnormal subscapular fat pad morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234819, 'HP:0001608', 'Abnormality of the voice', 'MP:0003894', 'abnormal Purkinje cell innervation', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234820, 'HP:0001608', 'Abnormality of the voice', 'MP:0002109', 'abnormal limb morphology', 0.47368421052631576, 1.7901636446558942, 0.9208540887305324, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234821, 'HP:0001608', 'Abnormality of the voice', 'MP:0002106', 'abnormal muscle physiology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234822, 'HP:0001608', 'Abnormality of the voice', 'MP:0020982', 'abnormal skin adnexa development', 0.47368421052631576, 1.7901636446558942, 0.9208540887305324, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234823, 'HP:0001608', 'Abnormality of the voice', 'MP:0031088', 'coughing', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234824, 'HP:0001608', 'Abnormality of the voice', 'MP:0006080', 'brain ischemia', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234825, 'HP:0001608', 'Abnormality of the voice', 'MP:0011488', 'abnormal ureterovesical junction morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234826, 'HP:0001608', 'Abnormality of the voice', 'MP:0008923', 'thoracoschisis', 0.47368421052631576, 1.7901636446558942, 0.9208540887305324, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234827, 'HP:0001608', 'Abnormality of the voice', 'MP:0004557', 'dilated allantois', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234828, 'HP:0001608', 'Abnormality of the voice', 'MP:0020000', 'abnormal response to antigen', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234829, 'HP:0001608', 'Abnormality of the voice', 'MP:3000001', 'abnormal gastrula morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234830, 'HP:0001608', 'Abnormality of the voice', 'MP:0005459', 'decreased percent body fat/body weight', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234831, 'HP:0001608', 'Abnormality of the voice', 'MP:0010887', 'pale lung', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234832, 'HP:0001608', 'Abnormality of the voice', 'MP:0031349', 'monostotic fibrous dysplasia', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234833, 'HP:0001608', 'Abnormality of the voice', 'MP:0013283', 'failure of ventral body wall closure', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234834, 'HP:0001608', 'Abnormality of the voice', 'MP:0020502', 'abnormal physiological umbilical hernia morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234835, 'HP:0001608', 'Abnormality of the voice', 'MP:0004817', 'abnormal skeletal muscle mass', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234836, 'HP:0001608', 'Abnormality of the voice', 'MP:0014149', 'abnormal lacrimal gland innervation pattern', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234837, 'HP:0001608', 'Abnormality of the voice', 'MP:0004210', 'abnormal bitter taste sensitivity', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234838, 'HP:0001608', 'Abnormality of the voice', 'MP:0012070', 'abnormal susceptibility to osteoporosis', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234839, 'HP:0001608', 'Abnormality of the voice', 'MP:0002132', 'abnormal respiratory system morphology', 0.47368421052631576, 1.7901636446558942, 0.9208540887305324, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234840, 'HP:0001608', 'Abnormality of the voice', 'MP:0004179', 'transmission ratio distortion', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234841, 'HP:0001608', 'Abnormality of the voice', 'MP:0001544', 'abnormal cardiovascular system physiology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234842, 'HP:0001608', 'Abnormality of the voice', 'MP:0003105', 'abnormal heart atrium morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234843, 'HP:0001608', 'Abnormality of the voice', 'MP:0001175', 'abnormal lung morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234844, 'HP:0001608', 'Abnormality of the voice', 'MP:0020520', 'whitened brown adipose tissue morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234845, 'HP:0001608', 'Abnormality of the voice', 'MP:0000751', 'myopathy', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234846, 'HP:0001608', 'Abnormality of the voice', 'MP:0003795', 'abnormal bone structure', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234847, 'HP:0001608', 'Abnormality of the voice', 'MP:0020521', 'browned white adipose tissue morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234848, 'HP:0001608', 'Abnormality of the voice', 'MP:0003137', 'abnormal impulse conducting system conduction', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234849, 'HP:0001608', 'Abnormality of the voice', 'MP:0011018', 'pulmonary hyaline membrane formation', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234850, 'HP:0001608', 'Abnormality of the voice', 'MP:0009931', 'abnormal skin appearance', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234851, 'HP:0001608', 'Abnormality of the voice', 'MP:0031102', 'rhinorrhea', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234852, 'HP:0001608', 'Abnormality of the voice', 'MP:0001890', 'anencephaly', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234853, 'HP:0001608', 'Abnormality of the voice', 'MP:0005504', 'abnormal ligament morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234854, 'HP:0001608', 'Abnormality of the voice', 'MP:0003673', 'abnormal inguinal canal morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234855, 'HP:0001608', 'Abnormality of the voice', 'MP:0001724', 'abnormal extraembryonic endoderm formation', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234856, 'HP:0001608', 'Abnormality of the voice', 'MP:0002164', 'abnormal gland physiology', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234857, 'HP:0001608', 'Abnormality of the voice', 'MP:0001790', 'abnormal immune system physiology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234858, 'HP:0001608', 'Abnormality of the voice', 'MP:0001943', 'abnormal respiration', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234859, 'HP:0001608', 'Abnormality of the voice', 'MP:0001845', 'abnormal inflammatory response', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234860, 'HP:0001608', 'Abnormality of the voice', 'MP:0010853', 'abnormal lung position or orientation', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234861, 'HP:0001608', 'Abnormality of the voice', 'MP:0003936', 'abnormal reproductive system development', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234862, 'HP:0001608', 'Abnormality of the voice', 'MP:0013124', 'mouth swellings', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234863, 'HP:0001608', 'Abnormality of the voice', 'MP:0002971', 'abnormal brown adipose tissue morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234864, 'HP:0001608', 'Abnormality of the voice', 'MP:0002184', 'abnormal innervation', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234865, 'HP:0001608', 'Abnormality of the voice', 'MP:0020517', 'abnormal visceral yolk sac physiology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234866, 'HP:0001608', 'Abnormality of the voice', 'MP:0031089', 'sneezing', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234867, 'HP:0001608', 'Abnormality of the voice', 'MP:0000423', 'delayed hair regrowth', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234868, 'HP:0001608', 'Abnormality of the voice', 'MP:0020098', 'abnormal susceptibility to diet-induced aortic fatty streak lesions', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234869, 'HP:0001608', 'Abnormality of the voice', 'MP:0003279', 'aneurysm', 0.47368421052631576, 1.7901636446558942, 0.9208540887305324, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234870, 'HP:0001608', 'Abnormality of the voice', 'MP:0005500', 'abnormal gustatory system morphology', 0.5, 1.7901636446558942, 0.9460876398769551, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234871, 'HP:0001608', 'Abnormality of the voice', 'MP:0014032', 'abnormal mucous gland morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234872, 'HP:0001608', 'Abnormality of the voice', 'MP:0000001', 'mammalian phenotype', 0.42857142857142855, 1.5524157786304194, 0.8156721449114622, 'UPHENO:0001003', 'phenotype by ontology source'),
(234873, 'HP:0001608', 'Abnormality of the voice', 'MP:0014067', 'Hirano bodies', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234874, 'HP:0001608', 'Abnormality of the voice', 'MP:0001725', 'abnormal umbilical cord morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234875, 'HP:0001608', 'Abnormality of the voice', 'MP:0008860', 'abnormal hair cycle telogen phase', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234876, 'HP:0001608', 'Abnormality of the voice', 'MP:0031291', 'pes valgus', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234877, 'HP:0001608', 'Abnormality of the voice', 'MP:0013332', 'peliosis', 0.47368421052631576, 1.7901636446558942, 0.9208540887305324, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234878, 'HP:0001608', 'Abnormality of the voice', 'MP:0009697', 'abnormal copulation', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234879, 'HP:0001608', 'Abnormality of the voice', 'MP:0010352', 'gastrointestinal tract polyps', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234880, 'HP:0001608', 'Abnormality of the voice', 'MP:0002163', 'abnormal gland morphology', 0.5, 1.7901636446558942, 0.9460876398769551, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234881, 'HP:0001608', 'Abnormality of the voice', 'MP:0013543', 'abnormal holocrine gland morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234882, 'HP:0001608', 'Abnormality of the voice', 'MP:0001937', 'abnormal sexual maturation', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234883, 'HP:0001608', 'Abnormality of the voice', 'MP:0003119', 'abnormal digestive system development', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234884, 'HP:0001608', 'Abnormality of the voice', 'MP:0012167', 'abnormal epigenetic regulation of gene expression', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234885, 'HP:0001608', 'Abnormality of the voice', 'MP:0002133', 'abnormal respiratory system physiology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234886, 'HP:0001608', 'Abnormality of the voice', 'MP:0011187', 'abnormal parietal endoderm morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234887, 'HP:0001608', 'Abnormality of the voice', 'MP:0014063', 'Lafora bodies', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234888, 'HP:0001608', 'Abnormality of the voice', 'MP:0013083', 'tail wound', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234889, 'HP:0001608', 'Abnormality of the voice', 'MP:0005508', 'abnormal skeleton morphology', 0.47368421052631576, 1.7901636446558942, 0.9208540887305324, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234890, 'HP:0001608', 'Abnormality of the voice', 'MP:0002108', 'abnormal muscle morphology', 0.47368421052631576, 1.7901636446558942, 0.9208540887305324, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234891, 'HP:0001608', 'Abnormality of the voice', 'MP:0031091', 'hypogeusia', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234892, 'HP:0001608', 'Abnormality of the voice', 'MP:0000731', 'increased collagen deposition in the muscles', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234893, 'HP:0001608', 'Abnormality of the voice', 'MP:0030988', 'dysosmia', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234894, 'HP:0001608', 'Abnormality of the voice', 'MP:0013304', 'osteophytes', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234895, 'HP:0001608', 'Abnormality of the voice', 'MP:0002970', 'abnormal white adipose tissue morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234896, 'HP:0001608', 'Abnormality of the voice', 'MP:0002932', 'abnormal joint morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234897, 'HP:0001608', 'Abnormality of the voice', 'MP:0013544', 'abnormal merocrine gland morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234898, 'HP:0001608', 'Abnormality of the voice', 'MP:0003880', 'abnormal central pattern generator function', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234899, 'HP:0001608', 'Abnormality of the voice', 'MP:0003385', 'abnormal body wall morphology', 0.5, 1.7901636446558942, 0.9460876398769551, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234900, 'HP:0001608', 'Abnormality of the voice', 'MP:0011199', 'abnormal amniotic cavity morphology', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234901, 'HP:0001608', 'Abnormality of the voice', 'MP:0012515', 'abnormal heart apex morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234902, 'HP:0001608', 'Abnormality of the voice', 'MP:0002778', 'meroanencephaly', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234903, 'HP:0001608', 'Abnormality of the voice', 'MP:0012514', 'pectus excavatum', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234904, 'HP:0001608', 'Abnormality of the voice', 'MP:0010126', 'abnormal distal visceral endoderm morphology', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234905, 'HP:0001608', 'Abnormality of the voice', 'MP:0010678', 'abnormal skin adnexa morphology', 0.5, 1.7901636446558942, 0.9460876398769551, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234906, 'HP:0001608', 'Abnormality of the voice', 'MP:0021122', 'abnormal trimethylamine N-oxide level', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(234907, 'HP:0001608', 'Abnormality of the voice', 'MP:0002839', 'increased susceptibility to dystrophic cardiac calcinosis', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234908, 'HP:0001608', 'Abnormality of the voice', 'MP:0002148', 'abnormal hypersensitivity reaction', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234909, 'HP:0001608', 'Abnormality of the voice', 'MP:0004997', 'increased CNS synapse formation', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234910, 'HP:0001608', 'Abnormality of the voice', 'MP:0013558', 'abnormal exocrine gland morphology', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234911, 'HP:0001608', 'Abnormality of the voice', 'MP:0031099', 'abnormal sputum morphology', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234912, 'HP:0001608', 'Abnormality of the voice', 'MP:0001156', 'abnormal spermatogenesis', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234913, 'HP:0001608', 'Abnormality of the voice', 'MP:0011257', 'abnormal head fold morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234914, 'HP:0001608', 'Abnormality of the voice', 'MP:0031273', 'decreased susceptibility to induced aneurysm formation', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234915, 'HP:0001608', 'Abnormality of the voice', 'MP:0011989', 'abnormal porphyrin level', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(234916, 'HP:0001608', 'Abnormality of the voice', 'MP:0010994', 'aerophagia', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234917, 'HP:0001608', 'Abnormality of the voice', 'MP:0001835', 'abnormal antigen presentation', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234918, 'HP:0001608', 'Abnormality of the voice', 'MP:0003705', 'abnormal hypodermis morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234919, 'HP:0001608', 'Abnormality of the voice', 'MP:0002139', 'abnormal hepatobiliary system physiology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234920, 'HP:0001608', 'Abnormality of the voice', 'MP:0031119', 'pulmonary cavitation', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234921, 'HP:0001608', 'Abnormality of the voice', 'MP:0011046', 'abnormal lung tissue damping', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234922, 'HP:0001608', 'Abnormality of the voice', 'MP:0012071', 'increased susceptibility to osteoporosis', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234923, 'HP:0001608', 'Abnormality of the voice', 'MP:0031112', 'rhabdomyolysis', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234924, 'HP:0001608', 'Abnormality of the voice', 'MP:0002211', 'abnormal primary sex determination', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234925, 'HP:0001608', 'Abnormality of the voice', 'MP:0020981', 'abnormal immune system development', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234926, 'HP:0001608', 'Abnormality of the voice', 'MP:0000467', 'abnormal esophagus morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234927, 'HP:0001608', 'Abnormality of the voice', 'MP:0004996', 'abnormal CNS synapse formation', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234928, 'HP:0001608', 'Abnormality of the voice', 'MP:0013120', 'urogenital swellings', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234929, 'HP:0001608', 'Abnormality of the voice', 'MP:0002399', 'abnormal pluripotent precursor cell morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234930, 'HP:0001608', 'Abnormality of the voice', 'MP:0004134', 'abnormal chest morphology', 0.47368421052631576, 1.7901636446558942, 0.9208540887305324, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234931, 'HP:0001608', 'Abnormality of the voice', 'MP:0002653', 'abnormal ependyma morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234932, 'HP:0001608', 'Abnormality of the voice', 'MP:0012187', 'abnormal intraembryonic coelom morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234933, 'HP:0001608', 'Abnormality of the voice', 'MP:0003632', 'abnormal nervous system morphology', 0.47368421052631576, 1.7901636446558942, 0.9208540887305324, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234934, 'HP:0001608', 'Abnormality of the voice', 'MP:0008926', 'abnormal anterior definitive endoderm morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234935, 'HP:0001608', 'Abnormality of the voice', 'MP:0013560', 'abnormal endocrine gland morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234936, 'HP:0001608', 'Abnormality of the voice', 'MP:0001191', 'abnormal skin condition', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234937, 'HP:0001608', 'Abnormality of the voice', 'MP:0003925', 'abnormal cellular glucose uptake', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234938, 'HP:0001608', 'Abnormality of the voice', 'MP:0004145', 'abnormal muscle electrophysiology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234939, 'HP:0001608', 'Abnormality of the voice', 'MP:0000462', 'abnormal digestive system morphology', 0.47368421052631576, 1.7901636446558942, 0.9208540887305324, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234940, 'HP:0001608', 'Abnormality of the voice', 'MP:0009877', 'exostosis', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234941, 'HP:0001608', 'Abnormality of the voice', 'MP:0014134', 'abnormal embryo morphology', 0.5, 1.7901636446558942, 0.9460876398769551, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234942, 'HP:0001608', 'Abnormality of the voice', 'MP:0000550', 'abnormal forelimb morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234943, 'HP:0001608', 'Abnormality of the voice', 'MP:0020452', 'abnormal axon radial sorting', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234944, 'HP:0001608', 'Abnormality of the voice', 'MP:0020370', 'abnormal glymphatic system morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234945, 'HP:0001608', 'Abnormality of the voice', 'MP:0005334', 'abnormal fat pad morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234946, 'HP:0001608', 'Abnormality of the voice', 'MP:0021138', 'abnormal multifidus muscle morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234947, 'HP:0001608', 'Abnormality of the voice', 'MP:0000752', 'dystrophic muscle', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234948, 'HP:0001608', 'Abnormality of the voice', 'MP:0006323', 'abnormal extraembryonic mesoderm development', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234949, 'HP:0001608', 'Abnormality of the voice', 'MP:0002113', 'abnormal skeleton development', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234950, 'HP:0001608', 'Abnormality of the voice', 'MP:0020092', 'abnormal susceptibility to aortic cartilaginous metaplasia', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234951, 'HP:0001608', 'Abnormality of the voice', 'MP:0010377', 'abnormal gut flora balance', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234952, 'HP:0001608', 'Abnormality of the voice', 'MP:0005458', 'increased percent body fat/body weight', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234953, 'HP:0001608', 'Abnormality of the voice', 'MP:0003890', 'abnormal embryonic-extraembryonic boundary morphology', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234954, 'HP:0001608', 'Abnormality of the voice', 'MP:0031106', 'abnormal susceptibility to pulmonary hyaline membrane formation', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234955, 'HP:0001608', 'Abnormality of the voice', 'MP:0002249', 'abnormal larynx morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234956, 'HP:0001608', 'Abnormality of the voice', 'MP:0005501', 'abnormal skin physiology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234957, 'HP:0001608', 'Abnormality of the voice', 'MP:0011082', 'abnormal gastrointestinal motility', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234958, 'HP:0001608', 'Abnormality of the voice', 'MP:0031279', 'abnormal susceptibility to aneurysm induced morbidity/mortality', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234959, 'HP:0001608', 'Abnormality of the voice', 'MP:0003384', 'abnormal ventral body wall morphology', 0.47368421052631576, 1.7901636446558942, 0.9208540887305324, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234960, 'HP:0001608', 'Abnormality of the voice', 'MP:0001545', 'abnormal hematopoietic system physiology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234961, 'HP:0001608', 'Abnormality of the voice', 'MP:0010736', 'abnormal extraembryonic ectoderm morphology', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234962, 'HP:0001608', 'Abnormality of the voice', 'MP:0002634', 'abnormal sensorimotor gating', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234963, 'HP:0001608', 'Abnormality of the voice', 'MP:0013069', 'limb wound', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234964, 'HP:0001608', 'Abnormality of the voice', 'MP:0010440', 'anomalous pulmonary venous connection', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234965, 'HP:0001608', 'Abnormality of the voice', 'MP:0020412', 'abnormal amnion physiology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234966, 'HP:0001608', 'Abnormality of the voice', 'MP:0004211', 'abnormal sour taste sensitivity', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234967, 'HP:0001608', 'Abnormality of the voice', 'MP:0011487', 'abnormal ureteropelvic junction morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234968, 'HP:0001608', 'Abnormality of the voice', 'MP:0013136', 'genital discharge', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234969, 'HP:0001608', 'Abnormality of the voice', 'MP:0010434', 'double inlet heart right ventricle', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234970, 'HP:0001608', 'Abnormality of the voice', 'MP:0013221', 'pancreatic acinar-to-ductal metaplasia', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234971, 'HP:0001608', 'Abnormality of the voice', 'MP:0011479', 'abnormal catecholamine level', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(234972, 'HP:0001608', 'Abnormality of the voice', 'MP:0005360', 'urolithiasis', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234973, 'HP:0001608', 'Abnormality of the voice', 'MP:0001985', 'abnormal gustatory system physiology', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234974, 'HP:0001608', 'Abnormality of the voice', 'MP:0020095', 'abnormal mean heart rate adaptation', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234975, 'HP:0001608', 'Abnormality of the voice', 'MP:0001722', 'pale yolk sac', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234976, 'HP:0001608', 'Abnormality of the voice', 'MP:0011203', 'abnormal parietal yolk sac morphology', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234977, 'HP:0001608', 'Abnormality of the voice', 'MP:0002924', 'delayed CNS synapse formation', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234978, 'HP:0001608', 'Abnormality of the voice', 'MP:0031272', 'abnormal susceptibility to induced aneurysm formation', 0.47368421052631576, 1.7901636446558942, 0.9208540887305324, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234979, 'HP:0001608', 'Abnormality of the voice', 'MP:0012028', 'abnormal visceral endoderm physiology', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234980, 'HP:0001608', 'Abnormality of the voice', 'MP:0001533', 'abnormal skeleton physiology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234981, 'HP:0001608', 'Abnormality of the voice', 'MP:0008052', 'abnormal serous gland morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234982, 'HP:0001608', 'Abnormality of the voice', 'MP:0008533', 'abnormal anterior visceral endoderm morphology', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234983, 'HP:0001608', 'Abnormality of the voice', 'MP:0013118', 'swellings', 0.47368421052631576, 1.7901636446558942, 0.9208540887305324, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234984, 'HP:0001608', 'Abnormality of the voice', 'MP:0031274', 'increased susceptibility to induced aneurysm formation', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234985, 'HP:0001608', 'Abnormality of the voice', 'MP:0008493', 'alpha-synuclein inclusion body', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234986, 'HP:0001608', 'Abnormality of the voice', 'MP:0005076', 'abnormal cell differentiation', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234987, 'HP:0001608', 'Abnormality of the voice', 'MP:0000736', 'delayed muscle development', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234988, 'HP:0001608', 'Abnormality of the voice', 'MP:0008004', 'abnormal stomach pH', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234989, 'HP:0001608', 'Abnormality of the voice', 'MP:0002723', 'abnormal immune serum protein physiology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234990, 'HP:0001608', 'Abnormality of the voice', 'MP:0012685', 'abnormal primitive streak elongation', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234991, 'HP:0001608', 'Abnormality of the voice', 'MP:0000474', 'abnormal foregut morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234992, 'HP:0001608', 'Abnormality of the voice', 'MP:0001614', 'abnormal blood vessel morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234993, 'HP:0001608', 'Abnormality of the voice', 'MP:0014138', 'abnormal germ layer morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234994, 'HP:0001608', 'Abnormality of the voice', 'MP:0002086', 'abnormal extraembryonic tissue morphology', 0.5, 1.7901636446558942, 0.9460876398769551, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234995, 'HP:0001608', 'Abnormality of the voice', 'MP:0010820', 'abnormal pleura morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234996, 'HP:0001608', 'Abnormality of the voice', 'MP:0005671', 'abnormal response to transplant', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234997, 'HP:0001608', 'Abnormality of the voice', 'MP:0003566', 'abnormal cell adhesion', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234998, 'HP:0001608', 'Abnormality of the voice', 'MP:0008786', 'abnormal hindgut morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(234999, 'HP:0001608', 'Abnormality of the voice', 'MP:0010223', 'abnormal immunoglobulin transcytosis', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(235000, 'HP:0001608', 'Abnormality of the voice', 'MP:0001984', 'abnormal olfaction', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(235001, 'HP:0001608', 'Abnormality of the voice', 'MP:0010551', 'abnormal coronary vessel morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(235002, 'HP:0001608', 'Abnormality of the voice', 'MP:0000266', 'abnormal heart morphology', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(235003, 'HP:0001608', 'Abnormality of the voice', 'MP:0005294', 'abnormal heart ventricle morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(235004, 'HP:0001608', 'Abnormality of the voice', 'MP:0000427', 'abnormal hair cycle', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(235005, 'HP:0001608', 'Abnormality of the voice', 'MP:0003115', 'abnormal respiratory system development', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(235006, 'HP:0001608', 'Abnormality of the voice', 'MP:0004957', 'abnormal blastocyst morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(235007, 'HP:0001608', 'Abnormality of the voice', 'MP:0005621', 'abnormal cell physiology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(235008, 'HP:0001608', 'Abnormality of the voice', 'MP:0009563', 'dyskeratosis', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(235009, 'HP:0001608', 'Abnormality of the voice', 'MP:0001986', 'abnormal taste sensitivity', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(235010, 'HP:0001608', 'Abnormality of the voice', 'MP:0013559', 'abnormal exocrine gland physiology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(235011, 'HP:0001608', 'Abnormality of the voice', 'MP:0031098', 'abnormal sputum production', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(235012, 'HP:0001608', 'Abnormality of the voice', 'MP:0013122', 'tail swellings', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(235013, 'HP:0001608', 'Abnormality of the voice', 'MP:0031348', 'bone fibrous dysplasia', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(235014, 'HP:0001608', 'Abnormality of the voice', 'MP:0004036', 'abnormal muscle relaxation', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(235015, 'HP:0001608', 'Abnormality of the voice', 'MP:0011197', 'abnormal proamniotic cavity morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(235016, 'HP:0001608', 'Abnormality of the voice', 'MP:0014137', 'abnormal preimplantation embryo morphology', 0.47368421052631576, 1.7901636446558942, 0.9208540887305324, 'UPHENO:0002536', 'abnormal anatomical entity'),
(235017, 'HP:0001608', 'Abnormality of the voice', 'MP:0031350', 'polyostotic fibrous dysplasia', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(235018, 'HP:0001608', 'Abnormality of the voice', 'MP:0004558', 'delayed allantois development', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(235019, 'HP:0001608', 'Abnormality of the voice', 'MP:0003861', 'abnormal nervous system development', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(235020, 'HP:0001608', 'Abnormality of the voice', 'MP:0008775', 'abnormal heart ventricle pressure', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(235021, 'HP:0001608', 'Abnormality of the voice', 'MP:0002419', 'abnormal innate immunity', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(235022, 'HP:0001608', 'Abnormality of the voice', 'MP:0013133', 'pale limbs', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(235023, 'HP:0001608', 'Abnormality of the voice', 'MP:0004264', 'abnormal extraembryonic tissue physiology', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(235024, 'HP:0001608', 'Abnormality of the voice', 'MP:0020516', 'abnormal visceral yolk sac mesenchyme morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(235025, 'HP:0001608', 'Abnormality of the voice', 'MP:0008861', 'abnormal hair shedding', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(235026, 'HP:0001608', 'Abnormality of the voice', 'MP:0011201', 'abnormal visceral yolk sac cavity morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(235027, 'HP:0001608', 'Abnormality of the voice', 'MP:0013121', 'testicular swellings', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(235028, 'HP:0001608', 'Abnormality of the voice', 'MP:0031092', 'dysgeusia', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(235029, 'HP:0001608', 'Abnormality of the voice', 'MP:0030485', 'abnormal osteocyte lacunocanalicular system morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(235030, 'HP:0001608', 'Abnormality of the voice', 'MP:0000163', 'abnormal cartilage morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(235031, 'HP:0001608', 'Abnormality of the voice', 'MP:0008909', 'supination', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(235032, 'HP:0001608', 'Abnormality of the voice', 'MP:0005623', 'abnormal meninges morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(235033, 'HP:0001608', 'Abnormality of the voice', 'MP:0010435', 'abnormal heart atrium and ventricle connection', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(235034, 'HP:0001608', 'Abnormality of the voice', 'MP:0006281', 'abnormal tail development', 0.47368421052631576, 1.7901636446558942, 0.9208540887305324, 'UPHENO:0002536', 'abnormal anatomical entity'),
(235035, 'HP:0001608', 'Abnormality of the voice', 'MP:0000572', 'abnormal autopod morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(235036, 'HP:0001608', 'Abnormality of the voice', 'MP:0004213', 'abnormal umami taste sensitivity', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(235037, 'HP:0001608', 'Abnormality of the voice', 'MP:0010124', 'decreased bone mineral content', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(235038, 'HP:0001608', 'Abnormality of the voice', 'MP:0030572', 'abnormal pilosebaceous unit morphology', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(235039, 'HP:0001608', 'Abnormality of the voice', 'MP:0001947', 'abnormal mucociliary clearance', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(235040, 'HP:0001608', 'Abnormality of the voice', 'MP:0002272', 'abnormal nervous system electrophysiology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(235041, 'HP:0001608', 'Abnormality of the voice', 'MP:0000955', 'abnormal spinal cord morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(235042, 'HP:0001608', 'Abnormality of the voice', 'MP:0009407', 'increased skeletal muscle fiber density', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(235043, 'HP:0001608', 'Abnormality of the voice', 'MP:0000288', 'abnormal pericardium morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(235044, 'HP:0001608', 'Abnormality of the voice', 'MP:0003868', 'abnormal feces composition', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(235045, 'HP:0001608', 'Abnormality of the voice', 'MP:0003630', 'abnormal urothelium morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(235046, 'HP:0001608', 'Abnormality of the voice', 'MP:0006301', 'abnormal mesenchyme morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(235047, 'HP:0001608', 'Abnormality of the voice', 'MP:0011167', 'abnormal adipose tissue development', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(235048, 'HP:0001608', 'Abnormality of the voice', 'MP:0012704', 'abnormal embryonic neuroepithelial cell proliferation', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(235049, 'HP:0001608', 'Abnormality of the voice', 'MP:0002925', 'abnormal cardiovascular development', 0.47368421052631576, 1.7901636446558942, 0.9208540887305324, 'UPHENO:0002536', 'abnormal anatomical entity'),
(235050, 'HP:0001608', 'Abnormality of the voice', 'MP:0008469', 'abnormal protein level', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(235051, 'HP:0001608', 'Abnormality of the voice', 'MP:0010680', 'abnormal skin adnexa physiology', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(235052, 'HP:0001608', 'Abnormality of the voice', 'MP:0003939', 'abnormal myotome morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(235053, 'HP:0001608', 'Abnormality of the voice', 'MP:0003633', 'abnormal nervous system physiology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(235054, 'HP:0001608', 'Abnormality of the voice', 'MP:0005666', 'abnormal adipose tissue physiology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(235055, 'HP:0001608', 'Abnormality of the voice', 'MP:0000313', 'abnormal cell death', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(235056, 'HP:0001608', 'Abnormality of the voice', 'MP:0001052', 'abnormal innervation pattern to muscle', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(235057, 'HP:0001608', 'Abnormality of the voice', 'MP:0011239', 'abnormal skin coloration', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(235058, 'HP:0001608', 'Abnormality of the voice', 'MP:0000778', 'abnormal nervous system tract morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(235059, 'HP:0001608', 'Abnormality of the voice', 'MP:0001145', 'abnormal male reproductive system morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(235060, 'HP:0001608', 'Abnormality of the voice', 'MP:0004142', 'abnormal muscle tone', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(235061, 'HP:0001608', 'Abnormality of the voice', 'MP:0008271', 'abnormal bone ossification', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(235062, 'HP:0001608', 'Abnormality of the voice', 'MP:0012260', 'encephalomeningocele', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(235063, 'HP:0001608', 'Abnormality of the voice', 'MP:0004212', 'abnormal salty taste sensitivity', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(235064, 'HP:0001608', 'Abnormality of the voice', 'MP:0011174', 'lipodystrophy', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(235065, 'HP:0001608', 'Abnormality of the voice', 'MP:0010122', 'abnormal bone mineral content', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(235066, 'HP:0001608', 'Abnormality of the voice', 'MP:0000003', 'abnormal adipose tissue morphology', 0.47368421052631576, 1.7901636446558942, 0.9208540887305324, 'UPHENO:0002536', 'abnormal anatomical entity'),
(235067, 'HP:0001608', 'Abnormality of the voice', 'MP:0008544', 'impaired olfaction', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(235068, 'HP:0001608', 'Abnormality of the voice', 'MP:0003300', 'gastrointestinal ulcer', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(235069, 'HP:0001608', 'Abnormality of the voice', 'MP:0000759', 'abnormal skeletal muscle morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(235070, 'HP:0001608', 'Abnormality of the voice', 'MP:0002213', 'true hermaphroditism', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(235071, 'HP:0001608', 'Abnormality of the voice', 'MP:0002060', 'abnormal skin morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(235072, 'HP:0001608', 'Abnormality of the voice', 'MP:0001800', 'abnormal humoral immune response', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(235073, 'HP:0001608', 'Abnormality of the voice', 'MP:0004733', 'abnormal thoracic cavity morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(235074, 'HP:0001608', 'Abnormality of the voice', 'MP:0010822', 'pneumothorax', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(235075, 'HP:0001608', 'Abnormality of the voice', 'MP:0009250', 'abnormal appendicular skeleton morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(235076, 'HP:0001608', 'Abnormality of the voice', 'MP:0012320', 'abnormal body fat mass', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(235077, 'HP:0001608', 'Abnormality of the voice', 'MP:0031310', 'abnormal cyst', 0.47368421052631576, 1.7901636446558942, 0.9208540887305324, 'UPHENO:0002536', 'abnormal anatomical entity'),
(235078, 'HP:0001608', 'Abnormality of the voice', 'MP:0012123', 'abnormal bronchoconstrictive response', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(235079, 'HP:0001608', 'Abnormality of the voice', 'MP:0014136', 'abnormal extraembryonic endoderm morphology', 0.47368421052631576, 1.7901636446558942, 0.9208540887305324, 'UPHENO:0002536', 'abnormal anatomical entity'),
(235080, 'HP:0001608', 'Abnormality of the voice', 'MP:0003935', 'abnormal craniofacial development', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(235081, 'HP:0001608', 'Abnormality of the voice', 'MP:0001929', 'abnormal gametogenesis', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(235082, 'HP:0001608', 'Abnormality of the voice', 'MP:0003301', 'peptic ulcer', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(235083, 'HP:0001608', 'Abnormality of the voice', 'MP:0005410', 'abnormal fertilization', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(235084, 'HP:0001608', 'Abnormality of the voice', 'MP:0012103', 'abnormal bilaminar embryonic disk morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(235085, 'HP:0001608', 'Abnormality of the voice', 'MP:0030484', 'abnormal osteocyte lacuna morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(235086, 'HP:0001608', 'Abnormality of the voice', 'MP:0013126', 'teat swellings', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(235087, 'HP:0001608', 'Abnormality of the voice', 'MP:0003186', 'abnormal redox activity', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(235088, 'HP:0001608', 'Abnormality of the voice', 'MP:0031402', 'decreased muscle fatigability', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(235089, 'HP:0001608', 'Abnormality of the voice', 'MP:0010426', 'abnormal heart and great artery attachment', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(235090, 'HP:0001608', 'Abnormality of the voice', 'MP:0002231', 'abnormal primitive streak morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(235091, 'HP:0001608', 'Abnormality of the voice', 'MP:0010233', 'hairless tail', 0.47368421052631576, 1.7901636446558942, 0.9208540887305324, 'UPHENO:0002536', 'abnormal anatomical entity'),
(235092, 'HP:0001608', 'Abnormality of the voice', 'MP:0005332', 'abnormal amino acid level', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(235093, 'HP:0001608', 'Abnormality of the voice', 'MP:0009408', 'decreased skeletal muscle fiber density', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(235094, 'HP:0001608', 'Abnormality of the voice', 'MP:0005029', 'abnormal amnion morphology', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(235095, 'HP:0001608', 'Abnormality of the voice', 'MP:0001718', 'abnormal visceral yolk sac morphology', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(235096, 'HP:0001608', 'Abnormality of the voice', 'MP:0000685', 'abnormal immune system morphology', 0.47368421052631576, 1.7901636446558942, 0.9208540887305324, 'UPHENO:0002536', 'abnormal anatomical entity'),
(235097, 'HP:0001608', 'Abnormality of the voice', 'MP:0002836', 'abnormal chorion morphology', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(235098, 'HP:0001608', 'Abnormality of the voice', 'MP:0011043', 'abnormal lung elastance', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(235099, 'HP:0001608', 'Abnormality of the voice', 'MP:0010942', 'abnormal respiratory epithelium morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(235100, 'HP:0001608', 'Abnormality of the voice', 'MP:0001756', 'abnormal urination', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(235101, 'HP:0001608', 'Abnormality of the voice', 'MP:0004085', 'abnormal heartbeat', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(235102, 'HP:0001608', 'Abnormality of the voice', 'MP:0013123', 'head/neck swellings', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(235103, 'HP:0001608', 'Abnormality of the voice', 'MP:0002085', 'abnormal embryonic tissue morphology', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(235104, 'HP:0001608', 'Abnormality of the voice', 'MP:0001663', 'abnormal digestive system physiology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(235105, 'HP:0001608', 'Abnormality of the voice', 'MP:0000556', 'abnormal hindlimb morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(235106, 'HP:0001608', 'Abnormality of the voice', 'MP:0002098', 'abnormal vibrissa morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(235107, 'HP:0001608', 'Abnormality of the voice', 'MP:0020515', 'abnormal visceral yolk sac endoderm morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(235108, 'HP:0001608', 'Abnormality of the voice', 'MP:0012204', 'abnormal neuronal stem cell physiology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(235109, 'HP:0001608', 'Abnormality of the voice', 'MP:0009562', 'abnormal odor adaptation', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(235110, 'HP:0001608', 'Abnormality of the voice', 'MP:0031302', 'syncope', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(235111, 'HP:0001608', 'Abnormality of the voice', 'MP:0012382', 'abnormal blood cell physiology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(235112, 'HP:0001608', 'Abnormality of the voice', 'MP:0000267', 'abnormal heart development', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(235113, 'HP:0000523', 'Subcapsular cataract', 'MP:0002840', 'abnormal lens fiber morphology', 0.40384615384615385, 10.410750055107773, 2.0504490650608487, 'UPHENO:0087578', 'abnormal lens of camera-type eye morphology'),
(235114, 'HP:0000523', 'Subcapsular cataract', 'MP:0003847', 'disorganized lens bow', 0.4117647058823529, 10.410750055107773, 2.070453919906488, 'UPHENO:0087578', 'abnormal lens of camera-type eye morphology'),
(235115, 'HP:0000523', 'Subcapsular cataract', 'MP:0010254', 'nuclear cataract', 0.46153846153846156, 12.214829845132515, 2.3743659731971705, 'UPHENO:0084816', 'opaque lens of camera-type eye'),
(235116, 'HP:0000523', 'Subcapsular cataract', 'MP:0005193', 'abnormal anterior eye segment morphology', 0.40816326530612246, 8.423925443855504, 1.854275307460947, 'UPHENO:0087597', 'abnormal anterior segment of eyeball morphology'),
(235117, 'HP:0000523', 'Subcapsular cataract', 'MP:0008841', 'ruptured lens capsule', 0.43636363636363634, 10.410750055107773, 2.1314015931587726, 'UPHENO:0087578', 'abnormal lens of camera-type eye morphology'),
(235118, 'HP:0000523', 'Subcapsular cataract', 'MP:0001306', 'small lens', 0.43636363636363634, 10.410750055107773, 2.1314015931587726, 'UPHENO:0087578', 'abnormal lens of camera-type eye morphology'),
(235119, 'HP:0000523', 'Subcapsular cataract', 'MP:0010263', 'total cataract', 0.46153846153846156, 12.214829845132515, 2.3743659731971705, 'UPHENO:0084816', 'opaque lens of camera-type eye'),
(235120, 'HP:0000523', 'Subcapsular cataract', 'MP:0002697', 'abnormal eye size', 0.43137254901960786, 8.581084971325078, 1.9239658254330683, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(235121, 'HP:0000523', 'Subcapsular cataract', 'MP:0009829', 'enlarged eye anterior chamber', 0.40350877192982454, 8.423925443855504, 1.8436723707531488, 'UPHENO:0087597', 'abnormal anterior segment of eyeball morphology'),
(235122, 'HP:0000523', 'Subcapsular cataract', 'MP:0010262', 'lamellar cataract', 0.46153846153846156, 12.214829845132515, 2.3743659731971705, 'UPHENO:0084816', 'opaque lens of camera-type eye'),
(235123, 'HP:0000523', 'Subcapsular cataract', 'MP:0001303', 'abnormal lens morphology', 0.42, 10.410750055107773, 2.0910559588746698, 'UPHENO:0087578', 'abnormal lens of camera-type eye morphology'),
(235124, 'HP:0000523', 'Subcapsular cataract', 'MP:0013732', 'mature cataract', 0.46153846153846156, 12.214829845132515, 2.3743659731971705, 'UPHENO:0084816', 'opaque lens of camera-type eye'),
(235125, 'HP:0000523', 'Subcapsular cataract', 'MP:0006225', 'ocular rupture', 0.43137254901960786, 8.581084971325078, 1.9239658254330683, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(235126, 'HP:0000523', 'Subcapsular cataract', 'MP:0001305', 'enlarged lens', 0.43636363636363634, 10.410750055107773, 2.1314015931587726, 'UPHENO:0087578', 'abnormal lens of camera-type eye morphology'),
(235127, 'HP:0000523', 'Subcapsular cataract', 'MP:0013731', 'immature cataract', 0.46153846153846156, 12.214829845132515, 2.3743659731971705, 'UPHENO:0084816', 'opaque lens of camera-type eye'),
(235128, 'HP:0000523', 'Subcapsular cataract', 'MP:0005176', 'eyelids fail to open', 0.4074074074074074, 8.581084971325078, 1.8697586959044252, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(235129, 'HP:0000523', 'Subcapsular cataract', 'MP:0010255', 'cortical cataract', 0.46153846153846156, 12.214829845132515, 2.3743659731971705, 'UPHENO:0084816', 'opaque lens of camera-type eye'),
(235130, 'HP:0000523', 'Subcapsular cataract', 'MP:0010256', 'anterior cortical cataract', 0.4528301886792453, 12.214829845132515, 2.351859626647865, 'UPHENO:0084816', 'opaque lens of camera-type eye'),
(235131, 'HP:0000523', 'Subcapsular cataract', 'MP:0006209', 'calcified intraocular region', 0.43137254901960786, 8.581084971325078, 1.9239658254330683, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(235132, 'HP:0000523', 'Subcapsular cataract', 'MP:0031345', 'developmental cataract', 0.46153846153846156, 12.214829845132515, 2.3743659731971705, 'UPHENO:0084816', 'opaque lens of camera-type eye'),
(235133, 'HP:0000523', 'Subcapsular cataract', 'MP:0010253', 'posterior subcapsular cataract', 0.4528301886792453, 12.214829845132515, 2.351859626647865, 'UPHENO:0084816', 'opaque lens of camera-type eye'),
(235134, 'HP:0000523', 'Subcapsular cataract', 'MP:0010260', 'posterior polar cataract', 0.4528301886792453, 12.214829845132515, 2.351859626647865, 'UPHENO:0084816', 'opaque lens of camera-type eye'),
(235135, 'HP:0000523', 'Subcapsular cataract', 'MP:0031317', 'spherophakia', 0.42857142857142855, 10.410750055107773, 2.1122854976583105, 'UPHENO:0087578', 'abnormal lens of camera-type eye morphology'),
(235136, 'HP:0000523', 'Subcapsular cataract', 'MP:0031316', 'lentiglobus', 0.4117647058823529, 10.410750055107773, 2.070453919906488, 'UPHENO:0087578', 'abnormal lens of camera-type eye morphology'),
(235137, 'HP:0000523', 'Subcapsular cataract', 'MP:0001304', 'cataract', 0.47058823529411764, 12.214829845132515, 2.3975310678360002, 'UPHENO:0084816', 'opaque lens of camera-type eye'),
(235138, 'HP:0000523', 'Subcapsular cataract', 'MP:0003236', 'abnormal lens capsule morphology', 0.40384615384615385, 10.410750055107773, 2.0504490650608487, 'UPHENO:0087578', 'abnormal lens of camera-type eye morphology'),
(235139, 'HP:0000523', 'Subcapsular cataract', 'MP:0005545', 'abnormal lens development', 0.40384615384615385, 10.410750055107773, 2.0504490650608487, 'UPHENO:0087578', 'abnormal lens of camera-type eye morphology'),
(235140, 'HP:0000523', 'Subcapsular cataract', 'MP:0031432', 'cornea perforation', 0.40350877192982454, 8.423925443855504, 1.8436723707531488, 'UPHENO:0087597', 'abnormal anterior segment of eyeball morphology'),
(235141, 'HP:0000523', 'Subcapsular cataract', 'MP:0010257', 'posterior cortical cataract', 0.4528301886792453, 12.214829845132515, 2.351859626647865, 'UPHENO:0084816', 'opaque lens of camera-type eye'),
(235142, 'HP:0000523', 'Subcapsular cataract', 'MP:0010259', 'anterior polar cataract', 0.4528301886792453, 12.214829845132515, 2.351859626647865, 'UPHENO:0084816', 'opaque lens of camera-type eye'),
(235143, 'HP:0000523', 'Subcapsular cataract', 'MP:0010261', 'sutural cataract', 0.4528301886792453, 12.214829845132515, 2.351859626647865, 'UPHENO:0084816', 'opaque lens of camera-type eye'),
(235144, 'HP:0000523', 'Subcapsular cataract', 'MP:0020486', 'abnormal lens topology', 0.4074074074074074, 10.410750055107773, 2.059470001995169, 'UPHENO:0087578', 'abnormal lens of camera-type eye morphology'),
(235145, 'HP:0000523', 'Subcapsular cataract', 'MP:0010258', 'polar cataract', 0.46153846153846156, 12.214829845132515, 2.3743659731971705, 'UPHENO:0084816', 'opaque lens of camera-type eye'),
(235146, 'HP:0000523', 'Subcapsular cataract', 'MP:0010251', 'subcapsular cataract', 0.46153846153846156, 12.214829845132515, 2.3743659731971705, 'UPHENO:0084816', 'opaque lens of camera-type eye'),
(235147, 'HP:0000523', 'Subcapsular cataract', 'MP:0002794', 'lenticonus', 0.40384615384615385, 10.410750055107773, 2.0504490650608487, 'UPHENO:0087578', 'abnormal lens of camera-type eye morphology'),
(235148, 'HP:0000523', 'Subcapsular cataract', 'MP:0031498', 'abnormal cornea size', 0.40350877192982454, 8.423925443855504, 1.8436723707531488, 'UPHENO:0087597', 'abnormal anterior segment of eyeball morphology'),
(235149, 'HP:0000523', 'Subcapsular cataract', 'MP:0003237', 'abnormal lens epithelium morphology', 0.40384615384615385, 10.410750055107773, 2.0504490650608487, 'UPHENO:0087578', 'abnormal lens of camera-type eye morphology'),
(235150, 'HP:0000523', 'Subcapsular cataract', 'MP:0010252', 'anterior subcapsular cataract', 0.4528301886792453, 12.214829845132515, 2.351859626647865, 'UPHENO:0084816', 'opaque lens of camera-type eye'),
(235151, 'HP:0033272', 'Abnormal glomerular endothelial cell morphology', 'MP:0011377', 'renal glomerulus fibrosis', 0.4423076923076923, 9.804092483287297, 2.082408586578051, 'UPHENO:0076738', 'abnormal renal glomerulus morphology'),
(235152, 'HP:0033272', 'Abnormal glomerular endothelial cell morphology', 'MP:0020518', 'renal glomerular protein deposits', 0.4166666666666667, 9.804092483287297, 2.021147826039214, 'UPHENO:0076738', 'abnormal renal glomerulus morphology'),
(235153, 'HP:0033272', 'Abnormal glomerular endothelial cell morphology', 'MP:0011506', 'glomerular crescent', 0.4166666666666667, 9.804092483287297, 2.021147826039214, 'UPHENO:0076738', 'abnormal renal glomerulus morphology'),
(235154, 'HP:0033272', 'Abnormal glomerular endothelial cell morphology', 'MP:0011483', 'renal glomerular synechia', 0.4166666666666667, 9.804092483287297, 2.021147826039214, 'UPHENO:0076738', 'abnormal renal glomerulus morphology'),
(235155, 'HP:0033272', 'Abnormal glomerular endothelial cell morphology', 'MP:0000523', 'cortical renal glomerulopathies', 0.4166666666666667, 9.804092483287297, 2.021147826039214, 'UPHENO:0076738', 'abnormal renal glomerulus morphology'),
(235156, 'HP:0033272', 'Abnormal glomerular endothelial cell morphology', 'MP:0021200', 'decreased susceptibility to glomerulonephritis', 0.40816326530612246, 9.804092483287297, 2.0004175567470295, 'UPHENO:0076738', 'abnormal renal glomerulus morphology'),
(235157, 'HP:0033272', 'Abnormal glomerular endothelial cell morphology', 'MP:0021199', 'abnormal susceptibility to glomerulonephritis', 0.4166666666666667, 9.804092483287297, 2.021147826039214, 'UPHENO:0076738', 'abnormal renal glomerulus morphology'),
(235158, 'HP:0033272', 'Abnormal glomerular endothelial cell morphology', 'MP:0020519', 'renal glomerular immunoglobulin deposits', 0.40816326530612246, 9.804092483287297, 2.0004175567470295, 'UPHENO:0076738', 'abnormal renal glomerulus morphology'),
(235159, 'HP:0033272', 'Abnormal glomerular endothelial cell morphology', 'MP:0021201', 'increased susceptibility to glomerulonephritis', 0.40816326530612246, 9.804092483287297, 2.0004175567470295, 'UPHENO:0076738', 'abnormal renal glomerulus morphology'),
(235160, 'HP:0033272', 'Abnormal glomerular endothelial cell morphology', 'MP:0002827', 'abnormal renal corpuscle morphology', 0.41304347826086957, 9.692263881549227, 2.000831423648002, 'UPHENO:0086675', 'abnormal renal corpuscle morphology'),
(235161, 'HP:0033272', 'Abnormal glomerular endothelial cell morphology', 'MP:0003670', 'dilated renal glomerular capsule', 0.4074074074074074, 9.692263881549227, 1.987133639162305, 'UPHENO:0086675', 'abnormal renal corpuscle morphology'),
(235162, 'HP:0033272', 'Abnormal glomerular endothelial cell morphology', 'MP:0011855', 'abnormal glomerular filtration barrier morphology', 0.4166666666666667, 9.804092483287297, 2.021147826039214, 'UPHENO:0076738', 'abnormal renal glomerulus morphology'),
(235163, 'HP:0033272', 'Abnormal glomerular endothelial cell morphology', 'MP:0005325', 'abnormal renal glomerulus morphology', 0.425531914893617, 9.804092483287297, 2.042536229350011, 'UPHENO:0076738', 'abnormal renal glomerulus morphology'),
(235164, 'HP:0033272', 'Abnormal glomerular endothelial cell morphology', 'MP:0011349', 'abnormal renal glomerulus basement membrane thickness', 0.4339622641509434, 9.804092483287297, 2.0626696710798362, 'UPHENO:0076738', 'abnormal renal glomerulus morphology'),
(235165, 'HP:0033272', 'Abnormal glomerular endothelial cell morphology', 'MP:0011561', 'renal glomerulus lipidosis', 0.4166666666666667, 9.804092483287297, 2.021147826039214, 'UPHENO:0076738', 'abnormal renal glomerulus morphology'),
(235166, 'HP:0033272', 'Abnormal glomerular endothelial cell morphology', 'MP:0011294', 'renal glomerulus hypertrophy', 0.41818181818181815, 9.804092483287297, 2.0248193055884713, 'UPHENO:0076738', 'abnormal renal glomerulus morphology'),
(235167, 'HP:0033272', 'Abnormal glomerular endothelial cell morphology', 'MP:0011567', 'increased renal glomerulus lobularity', 0.4166666666666667, 9.804092483287297, 2.021147826039214, 'UPHENO:0076738', 'abnormal renal glomerulus morphology'),
(235168, 'HP:0033272', 'Abnormal glomerular endothelial cell morphology', 'MP:0011348', 'abnormal renal glomerulus basement membrane morphology', 0.40816326530612246, 9.804092483287297, 2.0004175567470295, 'UPHENO:0076738', 'abnormal renal glomerulus morphology'),
(235169, 'HP:0031019', 'Pyknotic bone marrow neutrophils', 'MP:0008250', 'abnormal myeloid leukocyte morphology', 0.42592592592592593, 10.541058077453503, 2.1188935607713626, 'UPHENO:0085076', 'abnormal myeloid leukocyte morphology'),
(235170, 'HP:0031019', 'Pyknotic bone marrow neutrophils', 'MP:0008246', 'abnormal leukocyte morphology', 0.40384615384615385, 8.546451336223722, 1.8578082519913814, 'UPHENO:0085042', 'abnormal leukocyte morphology'),
(235171, 'HP:0031019', 'Pyknotic bone marrow neutrophils', 'MP:0005065', 'abnormal neutrophil morphology', 0.40625, 13.607147267911277, 2.3511494162619604, 'UPHENO:0088175', 'abnormal neutrophil morphology'),
(235172, 'HP:0031019', 'Pyknotic bone marrow neutrophils', 'MP:0008251', 'abnormal phagocyte morphology', 0.4107142857142857, 10.541058077453503, 2.0807121710977032, 'UPHENO:0085076', 'abnormal myeloid leukocyte morphology'),
(235173, 'HP:0031738', 'Mechanical entropion', 'MP:0001343', 'pronounced eyelids', 0.425531914893617, 10.404207209241001, 2.104120295206122, 'UPHENO:0076761', 'abnormal eyelid morphology'),
(235174, 'HP:0031738', 'Mechanical entropion', 'MP:0004874', 'abnormal timing of postnatal eyelid opening', 0.4222222222222222, 10.404207209241001, 2.095921632205317, 'UPHENO:0076761', 'abnormal eyelid morphology'),
(235175, 'HP:0031738', 'Mechanical entropion', 'MP:0006225', 'ocular rupture', 0.44680851063829785, 6.679863125803252, 1.727605190576781, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(235176, 'HP:0031738', 'Mechanical entropion', 'MP:0009651', 'abnormal eyelid development', 0.41304347826086957, 10.404207209241001, 2.073014697066019, 'UPHENO:0076761', 'abnormal eyelid morphology'),
(235177, 'HP:0031738', 'Mechanical entropion', 'MP:0006209', 'calcified intraocular region', 0.44680851063829785, 6.679863125803252, 1.727605190576781, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(235178, 'HP:0031738', 'Mechanical entropion', 'MP:0005287', 'narrow eye opening', 0.4074074074074074, 10.404207209241001, 2.05882274255127, 'UPHENO:0076761', 'abnormal eyelid morphology'),
(235179, 'HP:0031738', 'Mechanical entropion', 'MP:0009274', 'buphthalmos', 0.40384615384615385, 6.679863125803252, 1.6424484867338733, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(235180, 'HP:0031738', 'Mechanical entropion', 'MP:0030166', 'increased inner canthal distance', 0.4074074074074074, 10.404207209241001, 2.05882274255127, 'UPHENO:0076761', 'abnormal eyelid morphology'),
(235181, 'HP:0031738', 'Mechanical entropion', 'MP:0006248', 'lagophthalmos', 0.40384615384615385, 6.679863125803252, 1.6424484867338733, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(235182, 'HP:0031738', 'Mechanical entropion', 'MP:0030163', 'abnormal canthus morphology', 0.41304347826086957, 10.404207209241001, 2.073014697066019, 'UPHENO:0076761', 'abnormal eyelid morphology'),
(235183, 'HP:0031738', 'Mechanical entropion', 'MP:0009263', 'abnormal eyelid fusion', 0.40425531914893614, 10.404207209241001, 2.05084277941128, 'UPHENO:0076761', 'abnormal eyelid morphology'),
(235184, 'HP:0031738', 'Mechanical entropion', 'MP:0001302', 'eyelids open at birth', 0.4222222222222222, 10.404207209241001, 2.095921632205317, 'UPHENO:0076761', 'abnormal eyelid morphology'),
(235185, 'HP:0031738', 'Mechanical entropion', 'MP:0001286', 'abnormal eye development', 0.4090909090909091, 6.679863125803252, 1.6530793322577395, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(235186, 'HP:0031738', 'Mechanical entropion', 'MP:0006165', 'entropion', 0.4222222222222222, 10.404207209241001, 2.095921632205317, 'UPHENO:0076761', 'abnormal eyelid morphology'),
(235187, 'HP:0031738', 'Mechanical entropion', 'MP:0010081', 'posterior microphthalmia', 0.40384615384615385, 6.679863125803252, 1.6424484867338733, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(235188, 'HP:0031738', 'Mechanical entropion', 'MP:0001290', 'delayed eyelid opening', 0.41304347826086957, 10.404207209241001, 2.073014697066019, 'UPHENO:0076761', 'abnormal eyelid morphology'),
(235189, 'HP:0031738', 'Mechanical entropion', 'MP:0002697', 'abnormal eye size', 0.44680851063829785, 6.679863125803252, 1.727605190576781, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(235190, 'HP:0031738', 'Mechanical entropion', 'MP:0031289', 'unilateral microphthalmia', 0.40384615384615385, 6.679863125803252, 1.6424484867338733, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(235191, 'HP:0031738', 'Mechanical entropion', 'MP:0003153', 'early eyelid opening', 0.41304347826086957, 10.404207209241001, 2.073014697066019, 'UPHENO:0076761', 'abnormal eyelid morphology'),
(235192, 'HP:0031738', 'Mechanical entropion', 'MP:0006162', 'thick eyelids', 0.4230769230769231, 10.404207209241001, 2.0980419378888553, 'UPHENO:0076761', 'abnormal eyelid morphology'),
(235193, 'HP:0031738', 'Mechanical entropion', 'MP:0030063', 'abnormal face size', 0.4222222222222222, 5.913369942082322, 1.5801127167920936, 'UPHENO:0087472', 'abnormal face morphology'),
(235194, 'HP:0031738', 'Mechanical entropion', 'MP:0013396', 'eyelid hyperplasia', 0.44, 10.404207209241001, 2.139591356326259, 'UPHENO:0076761', 'abnormal eyelid morphology'),
(235195, 'HP:0031738', 'Mechanical entropion', 'MP:0013395', 'eyelid hypoplasia', 0.41509433962264153, 10.404207209241001, 2.078154835621499, 'UPHENO:0076761', 'abnormal eyelid morphology'),
(235196, 'HP:0031738', 'Mechanical entropion', 'MP:0013745', 'abnormal eyelid margin morphology', 0.41304347826086957, 10.404207209241001, 2.073014697066019, 'UPHENO:0076761', 'abnormal eyelid morphology'),
(235197, 'HP:0031738', 'Mechanical entropion', 'MP:0003671', 'abnormal eyelid aperture', 0.4583333333333333, 10.404207209241001, 2.1837112837786328, 'UPHENO:0076761', 'abnormal eyelid morphology'),
(235198, 'HP:0031738', 'Mechanical entropion', 'MP:0013146', 'eye lesions', 0.4090909090909091, 6.679863125803252, 1.6530793322577395, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(235199, 'HP:0031738', 'Mechanical entropion', 'MP:0001297', 'microphthalmia', 0.4117647058823529, 6.679863125803252, 1.6584727538704853, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(235200, 'HP:0031738', 'Mechanical entropion', 'MP:0030167', 'decreased inner canthal distance', 0.4074074074074074, 10.404207209241001, 2.05882274255127, 'UPHENO:0076761', 'abnormal eyelid morphology'),
(235201, 'HP:0031738', 'Mechanical entropion', 'MP:0001340', 'abnormal eyelid morphology', 0.4318181818181818, 10.404207209241001, 2.119605114249838, 'UPHENO:0076761', 'abnormal eyelid morphology'),
(235202, 'HP:0031738', 'Mechanical entropion', 'MP:0005176', 'eyelids fail to open', 0.4489795918367347, 10.404207209241001, 2.1613136528948864, 'UPHENO:0076761', 'abnormal eyelid morphology'),
(235203, 'HP:0031738', 'Mechanical entropion', 'MP:0006168', 'epicanthus inversus', 0.4222222222222222, 10.404207209241001, 2.095921632205317, 'UPHENO:0076761', 'abnormal eyelid morphology'),
(235204, 'HP:0031738', 'Mechanical entropion', 'MP:0006163', 'ankyloblepharon filiform', 0.4222222222222222, 10.404207209241001, 2.095921632205317, 'UPHENO:0076761', 'abnormal eyelid morphology'),
(235205, 'HP:0031738', 'Mechanical entropion', 'MP:0030041', 'abnormal forehead size', 0.40425531914893614, 5.913369942082322, 1.5461278256283388, 'UPHENO:0087472', 'abnormal face morphology'),
(235206, 'HP:0031738', 'Mechanical entropion', 'MP:0031290', 'bilateral microphthalmia', 0.40384615384615385, 6.679863125803252, 1.6424484867338733, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(235207, 'HP:0031738', 'Mechanical entropion', 'MP:0001296', 'macrophthalmia', 0.4117647058823529, 6.679863125803252, 1.6584727538704853, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(235208, 'HP:0031738', 'Mechanical entropion', 'MP:0006166', 'eyelid retraction', 0.4489795918367347, 10.404207209241001, 2.1613136528948864, 'UPHENO:0076761', 'abnormal eyelid morphology'),
(235209, 'HP:0031738', 'Mechanical entropion', 'MP:0006164', 'ectropion', 0.4583333333333333, 10.404207209241001, 2.1837112837786328, 'UPHENO:0076761', 'abnormal eyelid morphology'),
(235210, 'HP:0031738', 'Mechanical entropion', 'MP:0006249', 'phthisis bulbi', 0.40384615384615385, 6.679863125803252, 1.6424484867338733, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(235211, 'HP:0031738', 'Mechanical entropion', 'MP:0001299', 'abnormal eye distance/ position', 0.40425531914893614, 6.679863125803252, 1.6432803168640473, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(235212, 'HP:0031738', 'Mechanical entropion', 'MP:0008968', 'abnormal lacrimal apparatus morphology', 0.40425531914893614, 9.175301480945878, 1.9259191126492001, 'UPHENO:0075878', 'abnormal ocular adnexa'),
(235213, 'HP:0031738', 'Mechanical entropion', 'MP:0009859', 'eye opacity', 0.4090909090909091, 6.679863125803252, 1.6530793322577395, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(235214, 'HP:0031738', 'Mechanical entropion', 'MP:0013451', 'nasolacrimal duct obstruction', 0.4074074074074074, 9.175301480945878, 1.9334129896464194, 'UPHENO:0075878', 'abnormal ocular adnexa'),
(235215, 'HP:0031738', 'Mechanical entropion', 'MP:0001344', 'blepharoptosis', 0.4222222222222222, 10.404207209241001, 2.095921632205317, 'UPHENO:0076761', 'abnormal eyelid morphology'),
(235216, 'HP:0031738', 'Mechanical entropion', 'MP:0002092', 'abnormal eye morphology', 0.4186046511627907, 6.679863125803252, 1.6721907108915715, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(235217, 'HP:0032904', 'Focal verbal automatism seizure', 'MP:0003219', 'increased spike-wave discharge type II', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(235218, 'HP:0032904', 'Focal verbal automatism seizure', 'MP:0008814', 'decreased nerve conduction velocity', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(235219, 'HP:0032904', 'Focal verbal automatism seizure', 'MP:0021001', 'impaired neuron physiology', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(235220, 'HP:0032904', 'Focal verbal automatism seizure', 'MP:0005423', 'abnormal somatic nervous system physiology', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(235221, 'HP:0032904', 'Focal verbal automatism seizure', 'MP:0006058', 'decreased cerebral infarct size', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(235222, 'HP:0032904', 'Focal verbal automatism seizure', 'MP:0011397', 'endoneurial edema', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(235223, 'HP:0032904', 'Focal verbal automatism seizure', 'MP:0003088', 'abnormal prepulse inhibition', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(235224, 'HP:0032904', 'Focal verbal automatism seizure', 'MP:0012685', 'abnormal primitive streak elongation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235225, 'HP:0032904', 'Focal verbal automatism seizure', 'MP:0000948', 'nonconvulsive seizures', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(235226, 'HP:0032904', 'Focal verbal automatism seizure', 'MP:0012028', 'abnormal visceral endoderm physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235227, 'HP:0032904', 'Focal verbal automatism seizure', 'MP:0004807', 'abnormal paired-pulse inhibition', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(235228, 'HP:0032904', 'Focal verbal automatism seizure', 'MP:0003482', 'increased nerve fiber response threshold', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(235229, 'HP:0032904', 'Focal verbal automatism seizure', 'MP:0013907', 'abnormal cerebrospinal fluid flow', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(235230, 'HP:0032904', 'Focal verbal automatism seizure', 'MP:0003463', 'abnormal single cell response', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(235231, 'HP:0032904', 'Focal verbal automatism seizure', 'MP:0021024', 'abnormal cerebrospinal fluid physiology', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(235232, 'HP:0032904', 'Focal verbal automatism seizure', 'MP:0005446', 'abnormal synaptic epinephrine release', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(235233, 'HP:0032904', 'Focal verbal automatism seizure', 'MP:0002921', 'abnormal post-tetanic potentiation', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(235234, 'HP:0032904', 'Focal verbal automatism seizure', 'MP:0014120', 'focal seizures', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(235235, 'HP:0032904', 'Focal verbal automatism seizure', 'MP:0002913', 'abnormal PNS synaptic transmission', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(235236, 'HP:0032904', 'Focal verbal automatism seizure', 'MP:0011399', 'increased endoneurial fluid pressure', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(235237, 'HP:0032904', 'Focal verbal automatism seizure', 'MP:0005666', 'abnormal adipose tissue physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235238, 'HP:0032904', 'Focal verbal automatism seizure', 'MP:0003465', 'increased single cell response threshold', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(235239, 'HP:0032904', 'Focal verbal automatism seizure', 'MP:0009244', 'abnormal acid-activated cation-mediated receptor currents', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(235240, 'HP:0032904', 'Focal verbal automatism seizure', 'MP:0005645', 'abnormal hypothalamus physiology', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(235241, 'HP:0032904', 'Focal verbal automatism seizure', 'MP:0002920', 'decreased paired-pulse facilitation', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(235242, 'HP:0032904', 'Focal verbal automatism seizure', 'MP:0003996', 'clonic seizures', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(235243, 'HP:0032904', 'Focal verbal automatism seizure', 'MP:0003480', 'increased nerve fiber response intensity', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(235244, 'HP:0032904', 'Focal verbal automatism seizure', 'MP:0001900', 'impaired synaptic plasticity', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(235245, 'HP:0032904', 'Focal verbal automatism seizure', 'MP:0006080', 'brain ischemia', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(235246, 'HP:0032904', 'Focal verbal automatism seizure', 'MP:0003484', 'abnormal channel response', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(235247, 'HP:0032904', 'Focal verbal automatism seizure', 'MP:0014255', 'increased paired-pulse inhibition', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(235248, 'HP:0032904', 'Focal verbal automatism seizure', 'MP:0014254', 'increased paired-pulse ratio', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(235249, 'HP:0032904', 'Focal verbal automatism seizure', 'MP:0003477', 'abnormal nerve fiber response', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(235250, 'HP:0032904', 'Focal verbal automatism seizure', 'MP:0003474', 'abnormal summary potential intensity', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(235251, 'HP:0032904', 'Focal verbal automatism seizure', 'MP:0009435', 'abnormal miniature inhibitory postsynaptic currents', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(235252, 'HP:0032904', 'Focal verbal automatism seizure', 'MP:0001911', 'abnormal cerebrospinal fluid production', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(235253, 'HP:0032904', 'Focal verbal automatism seizure', 'MP:0006323', 'abnormal extraembryonic mesoderm development', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235254, 'HP:0032904', 'Focal verbal automatism seizure', 'MP:0031092', 'dysgeusia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235255, 'HP:0032904', 'Focal verbal automatism seizure', 'MP:0012704', 'abnormal embryonic neuroepithelial cell proliferation', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(235256, 'HP:0032904', 'Focal verbal automatism seizure', 'MP:0002886', 'abnormal glutamate-mediated receptor currents', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(235257, 'HP:0032904', 'Focal verbal automatism seizure', 'MP:0003486', 'abnormal channel response intensity', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(235258, 'HP:0032904', 'Focal verbal automatism seizure', 'MP:0002912', 'abnormal excitatory postsynaptic potential', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(235259, 'HP:0032904', 'Focal verbal automatism seizure', 'MP:0003467', 'abnormal single cell response intensity', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(235260, 'HP:0032904', 'Focal verbal automatism seizure', 'MP:0003469', 'decreased single cell response intensity', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(235261, 'HP:0032904', 'Focal verbal automatism seizure', 'MP:0008921', 'increased neurotransmitter release', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(235262, 'HP:0032904', 'Focal verbal automatism seizure', 'MP:0003889', 'enhanced sensorimotor gating', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(235263, 'HP:0032904', 'Focal verbal automatism seizure', 'MP:0001908', 'abnormal somatosensory cortex physiology', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(235264, 'HP:0032904', 'Focal verbal automatism seizure', 'MP:0004811', 'abnormal neuron physiology', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(235265, 'HP:0032904', 'Focal verbal automatism seizure', 'MP:0006277', 'abnormal parasympathetic nervous system physiology', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(235266, 'HP:0032904', 'Focal verbal automatism seizure', 'MP:0001533', 'abnormal skeleton physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235267, 'HP:0032904', 'Focal verbal automatism seizure', 'MP:0002918', 'abnormal paired-pulse facilitation', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(235268, 'HP:0032904', 'Focal verbal automatism seizure', 'MP:0006059', 'decreased susceptibility to ischemic brain injury', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(235269, 'HP:0032904', 'Focal verbal automatism seizure', 'MP:0002206', 'abnormal CNS synaptic transmission', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(235270, 'HP:0032904', 'Focal verbal automatism seizure', 'MP:0002915', 'abnormal synaptic depression', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(235271, 'HP:0032904', 'Focal verbal automatism seizure', 'MP:0003476', 'decreased summary potential intensity', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(235272, 'HP:0032904', 'Focal verbal automatism seizure', 'MP:0000427', 'abnormal hair cycle', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235273, 'HP:0032904', 'Focal verbal automatism seizure', 'MP:0001544', 'abnormal cardiovascular system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235274, 'HP:0032904', 'Focal verbal automatism seizure', 'MP:0012705', 'increased embryonic neuroepithelial cell proliferation', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(235275, 'HP:0032904', 'Focal verbal automatism seizure', 'MP:0021010', 'impaired synaptic physiology', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(235276, 'HP:0032904', 'Focal verbal automatism seizure', 'MP:0004835', 'abnormal miniature endplate potential', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(235277, 'HP:0032904', 'Focal verbal automatism seizure', 'MP:0003466', 'decreased single cell response threshold', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(235278, 'HP:0032904', 'Focal verbal automatism seizure', 'MP:0001500', 'decreased kindling response', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(235279, 'HP:0032904', 'Focal verbal automatism seizure', 'MP:0001496', 'audiogenic seizures', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(235280, 'HP:0032904', 'Focal verbal automatism seizure', 'MP:0003475', 'increased summary potential intensity', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(235281, 'HP:0032904', 'Focal verbal automatism seizure', 'MP:0003478', 'abnormal nerve fiber response threshold', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(235282, 'HP:0032904', 'Focal verbal automatism seizure', 'MP:0009358', 'environmentally induced seizures', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(235283, 'HP:0032904', 'Focal verbal automatism seizure', 'MP:0002194', 'maximal tonic hindlimb extension seizures', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(235284, 'HP:0032904', 'Focal verbal automatism seizure', 'MP:0012204', 'abnormal neuronal stem cell physiology', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(235285, 'HP:0032904', 'Focal verbal automatism seizure', 'MP:0012706', 'decreased embryonic neuroepithelial cell proliferation', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(235286, 'HP:0032904', 'Focal verbal automatism seizure', 'MP:0003880', 'abnormal central pattern generator function', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(235287, 'HP:0032904', 'Focal verbal automatism seizure', 'MP:0004994', 'abnormal brain wave pattern', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(235288, 'HP:0032904', 'Focal verbal automatism seizure', 'MP:0002207', 'abnormal long-term potentiation', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(235289, 'HP:0032904', 'Focal verbal automatism seizure', 'MP:0004183', 'abnormal sympathetic nervous system physiology', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(235290, 'HP:0032904', 'Focal verbal automatism seizure', 'MP:0003481', 'decreased nerve fiber response intensity', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(235291, 'HP:0032904', 'Focal verbal automatism seizure', 'MP:0001912', 'increased cerebrospinal fluid production', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(235292, 'HP:0032904', 'Focal verbal automatism seizure', 'MP:0003997', 'tonic-clonic seizures', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(235293, 'HP:0032904', 'Focal verbal automatism seizure', 'MP:0001663', 'abnormal digestive system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235294, 'HP:0032904', 'Focal verbal automatism seizure', 'MP:0002910', 'abnormal excitatory postsynaptic currents', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(235295, 'HP:0032904', 'Focal verbal automatism seizure', 'MP:0003216', 'absence seizures', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(235296, 'HP:0032904', 'Focal verbal automatism seizure', 'MP:0011398', 'abnormal endoneurial fluid pressure', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(235297, 'HP:0032904', 'Focal verbal automatism seizure', 'MP:0012006', 'abnormal hippocampus physiology', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(235298, 'HP:0032904', 'Focal verbal automatism seizure', 'MP:0001983', 'abnormal olfactory system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235299, 'HP:0032904', 'Focal verbal automatism seizure', 'MP:0003635', 'abnormal synaptic transmission', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(235300, 'HP:0032904', 'Focal verbal automatism seizure', 'MP:0000920', 'abnormal myelination', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(235301, 'HP:0032904', 'Focal verbal automatism seizure', 'MP:0010680', 'abnormal skin adnexa physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235302, 'HP:0032904', 'Focal verbal automatism seizure', 'MP:0002164', 'abnormal gland physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235303, 'HP:0032904', 'Focal verbal automatism seizure', 'MP:0004768', 'abnormal axonal transport', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(235304, 'HP:0032904', 'Focal verbal automatism seizure', 'MP:0021009', 'abnormal synaptic physiology', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(235305, 'HP:0032904', 'Focal verbal automatism seizure', 'MP:0020371', 'abnormal glymphatic system physiology', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(235306, 'HP:0032904', 'Focal verbal automatism seizure', 'MP:0003464', 'abnormal single cell response threshold', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(235307, 'HP:0032904', 'Focal verbal automatism seizure', 'MP:0003220', 'decreased spike-wave discharge type II', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(235308, 'HP:0032904', 'Focal verbal automatism seizure', 'MP:0009357', 'abnormal seizure response to inducing agent', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(235309, 'HP:0032904', 'Focal verbal automatism seizure', 'MP:0002919', 'enhanced paired-pulse facilitation', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(235310, 'HP:0032904', 'Focal verbal automatism seizure', 'MP:0010149', 'abnormal synaptic dopamine release', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(235311, 'HP:0032904', 'Focal verbal automatism seizure', 'MP:0020424', 'increased kindling response', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(235312, 'HP:0032904', 'Focal verbal automatism seizure', 'MP:0003218', 'decreased spike-wave discharge type I', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(235313, 'HP:0032904', 'Focal verbal automatism seizure', 'MP:0004753', 'abnormal miniature excitatory postsynaptic currents', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(235314, 'HP:0032904', 'Focal verbal automatism seizure', 'MP:0002139', 'abnormal hepatobiliary system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235315, 'HP:0032904', 'Focal verbal automatism seizure', 'MP:0004513', 'avnosmia', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(235316, 'HP:0032904', 'Focal verbal automatism seizure', 'MP:0012348', 'decreased susceptibility to induction of seizure by inducing agent', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(235317, 'HP:0032904', 'Focal verbal automatism seizure', 'MP:0001919', 'abnormal reproductive system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235318, 'HP:0032904', 'Focal verbal automatism seizure', 'MP:0021015', 'increased tau protein phosphorylation', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(235319, 'HP:0032904', 'Focal verbal automatism seizure', 'MP:0000921', 'demyelination', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(235320, 'HP:0032904', 'Focal verbal automatism seizure', 'MP:0003990', 'decreased neurotransmitter release', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(235321, 'HP:0032904', 'Focal verbal automatism seizure', 'MP:0014256', 'decreased paired-pulse inhibition', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(235322, 'HP:0032904', 'Focal verbal automatism seizure', 'MP:0012207', 'decreased neuronal stem cell self-renewal', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(235323, 'HP:0032904', 'Focal verbal automatism seizure', 'MP:0001985', 'abnormal gustatory system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235324, 'HP:0032904', 'Focal verbal automatism seizure', 'MP:0002193', 'minimal clonic seizures', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(235325, 'HP:0032904', 'Focal verbal automatism seizure', 'MP:0002578', 'impaired ability to fire action potentials', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(235326, 'HP:0032904', 'Focal verbal automatism seizure', 'MP:0005447', 'abnormal synaptic norepinephrine release', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(235327, 'HP:0032904', 'Focal verbal automatism seizure', 'MP:0002272', 'abnormal nervous system electrophysiology', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(235328, 'HP:0032904', 'Focal verbal automatism seizure', 'MP:0003485', 'abnormal channel response threshold', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(235329, 'HP:0032904', 'Focal verbal automatism seizure', 'MP:0006276', 'abnormal autonomic nervous system physiology', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(235330, 'HP:0032904', 'Focal verbal automatism seizure', 'MP:0008932', 'abnormal embryonic tissue physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235331, 'HP:0032904', 'Focal verbal automatism seizure', 'MP:0004558', 'delayed allantois development', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235332, 'HP:0032904', 'Focal verbal automatism seizure', 'MP:0003470', 'abnormal summary potential', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(235333, 'HP:0032904', 'Focal verbal automatism seizure', 'MP:0004859', 'abnormal synaptic plasticity', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(235334, 'HP:0032904', 'Focal verbal automatism seizure', 'MP:0014252', 'abnormal paired-pulse ratio', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(235335, 'HP:0032904', 'Focal verbal automatism seizure', 'MP:0002204', 'abnormal synaptic neurotransmitter level', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(235336, 'HP:0032904', 'Focal verbal automatism seizure', 'MP:0001913', 'decreased cerebrospinal fluid production', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(235337, 'HP:0032904', 'Focal verbal automatism seizure', 'MP:0003468', 'increased single cell response intensity', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(235338, 'HP:0032904', 'Focal verbal automatism seizure', 'MP:0003412', 'abnormal afterhyperpolarization', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(235339, 'HP:0032904', 'Focal verbal automatism seizure', 'MP:0000947', 'convulsive seizures', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(235340, 'HP:0032904', 'Focal verbal automatism seizure', 'MP:0003075', 'abnormal response to CNS ischemic injury', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(235341, 'HP:0032904', 'Focal verbal automatism seizure', 'MP:0003471', 'abnormal summary potential threshold', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(235342, 'HP:0032904', 'Focal verbal automatism seizure', 'MP:0008840', 'abnormal spike wave discharge', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(235343, 'HP:0032904', 'Focal verbal automatism seizure', 'MP:0010050', 'hypermyelination', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(235344, 'HP:0032904', 'Focal verbal automatism seizure', 'MP:0021014', 'abnormal tau protein phosphorylation', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(235345, 'HP:0032904', 'Focal verbal automatism seizure', 'MP:0005502', 'abnormal renal/urinary system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235346, 'HP:0032904', 'Focal verbal automatism seizure', 'MP:0003444', 'abnormal neurotransmitter uptake', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(235347, 'HP:0032904', 'Focal verbal automatism seizure', 'MP:0002064', 'seizures', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(235348, 'HP:0032904', 'Focal verbal automatism seizure', 'MP:0012205', 'abnormal neuronal stem cell self-renewal', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(235349, 'HP:0032904', 'Focal verbal automatism seizure', 'MP:0001545', 'abnormal hematopoietic system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235350, 'HP:0032904', 'Focal verbal automatism seizure', 'MP:0002133', 'abnormal respiratory system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235351, 'HP:0032904', 'Focal verbal automatism seizure', 'MP:0002826', 'tonic seizures', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(235352, 'HP:0032904', 'Focal verbal automatism seizure', 'MP:0003479', 'abnormal nerve fiber response intensity', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(235353, 'HP:0032904', 'Focal verbal automatism seizure', 'MP:0005402', 'abnormal action potential', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(235354, 'HP:0032904', 'Focal verbal automatism seizure', 'MP:0006060', 'increased cerebral infarct size', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(235355, 'HP:0032904', 'Focal verbal automatism seizure', 'MP:0003483', 'decreased nerve fiber response threshold', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(235356, 'HP:0032904', 'Focal verbal automatism seizure', 'MP:0002635', 'reduced sensorimotor gating', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(235357, 'HP:0032904', 'Focal verbal automatism seizure', 'MP:0000951', 'sporadic seizures', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(235358, 'HP:0032904', 'Focal verbal automatism seizure', 'MP:0002106', 'abnormal muscle physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235359, 'HP:0032904', 'Focal verbal automatism seizure', 'MP:0011994', 'increased nerve conduction velocity', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(235360, 'HP:0032904', 'Focal verbal automatism seizure', 'MP:0003472', 'increased summary potential threshold', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(235361, 'HP:0032904', 'Focal verbal automatism seizure', 'MP:0006082', 'CNS inflammation', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(235362, 'HP:0032904', 'Focal verbal automatism seizure', 'MP:0014253', 'decreased paired-pulse ratio', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(235363, 'HP:0032904', 'Focal verbal automatism seizure', 'MP:0004836', 'abnormal synaptic acetylcholine release', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(235364, 'HP:0032904', 'Focal verbal automatism seizure', 'MP:0002914', 'abnormal endplate potential', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(235365, 'HP:0032904', 'Focal verbal automatism seizure', 'MP:0002911', 'abnormal inhibitory postsynaptic potential', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(235366, 'HP:0032904', 'Focal verbal automatism seizure', 'MP:0012206', 'increased neuronal stem cell self-renewal', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(235367, 'HP:0032904', 'Focal verbal automatism seizure', 'MP:0004076', 'abnormal vitelline vascular remodeling', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235368, 'HP:0032904', 'Focal verbal automatism seizure', 'MP:0000950', 'abnormal seizure response to pharmacological agent', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(235369, 'HP:0032904', 'Focal verbal automatism seizure', 'MP:0004008', 'abnormal GABA-mediated receptor currents', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(235370, 'HP:0032904', 'Focal verbal automatism seizure', 'MP:0009475', 'abnormal nicotine-mediated receptor currents', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(235371, 'HP:0032904', 'Focal verbal automatism seizure', 'MP:0001499', 'abnormal kindling response', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(235372, 'HP:0032904', 'Focal verbal automatism seizure', 'MP:0001984', 'abnormal olfaction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235373, 'HP:0032904', 'Focal verbal automatism seizure', 'MP:0004264', 'abnormal extraembryonic tissue physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235374, 'HP:0032904', 'Focal verbal automatism seizure', 'MP:0005445', 'abnormal neurotransmitter secretion', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(235375, 'HP:0032904', 'Focal verbal automatism seizure', 'MP:0011987', 'abnormal GABAergic neuron physiology', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(235376, 'HP:0032904', 'Focal verbal automatism seizure', 'MP:0005403', 'abnormal nerve conduction', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(235377, 'HP:0032904', 'Focal verbal automatism seizure', 'MP:0013806', 'encephalopathy', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(235378, 'HP:0032904', 'Focal verbal automatism seizure', 'MP:0003633', 'abnormal nervous system physiology', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(235379, 'HP:0032904', 'Focal verbal automatism seizure', 'MP:0002945', 'abnormal inhibitory postsynaptic currents', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(235380, 'HP:0032904', 'Focal verbal automatism seizure', 'MP:0003473', 'decreased summary potential threshold', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(235381, 'HP:0032904', 'Focal verbal automatism seizure', 'MP:0001752', 'abnormal hypothalamus secretion', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(235382, 'HP:0032904', 'Focal verbal automatism seizure', 'MP:0003076', 'increased susceptibility to ischemic brain injury', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(235383, 'HP:0032904', 'Focal verbal automatism seizure', 'MP:0004770', 'abnormal synaptic vesicle recycling', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(235384, 'HP:0032904', 'Focal verbal automatism seizure', 'MP:0013438', 'dysmyelination', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(235385, 'HP:0032904', 'Focal verbal automatism seizure', 'MP:0012349', 'increased susceptibility to induction of seizure by inducing agent', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(235386, 'HP:0032904', 'Focal verbal automatism seizure', 'MP:0001724', 'abnormal extraembryonic endoderm formation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235387, 'HP:0032904', 'Focal verbal automatism seizure', 'MP:0012011', 'febrile seizures', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(235388, 'HP:0032904', 'Focal verbal automatism seizure', 'MP:0030990', 'nerve inflammation', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(235389, 'HP:0032904', 'Focal verbal automatism seizure', 'MP:0002634', 'abnormal sensorimotor gating', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(235390, 'HP:0032904', 'Focal verbal automatism seizure', 'MP:0001986', 'abnormal taste sensitivity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235391, 'HP:0032904', 'Focal verbal automatism seizure', 'MP:0003217', 'increased spike-wave discharge type I', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(235392, 'HP:0032904', 'Focal verbal automatism seizure', 'MP:0001650', 'abnormal seizure response to electrical stimulation', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(235393, 'HP:0032904', 'Focal verbal automatism seizure', 'MP:0021016', 'decreased tau protein phosphorylation', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(235394, 'HP:0032904', 'Focal verbal automatism seizure', 'MP:0004494', 'abnormal synaptic glutamate release', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(235395, 'HP:0032904', 'Focal verbal automatism seizure', 'MP:0001790', 'abnormal immune system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235396, 'HP:0032904', 'Focal verbal automatism seizure', 'MP:0002195', 'psychomotor seizures', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(235397, 'HP:0032904', 'Focal verbal automatism seizure', 'MP:0005621', 'abnormal cell physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235398, 'HP:0002301', 'Hemiplegia', 'MP:0004770', 'abnormal synaptic vesicle recycling', 0.4358974358974359, 11.437222266468964, 2.23281344042508, 'UPHENO:0085565', 'abnormality of neuron physiology'),
(235399, 'HP:0002301', 'Hemiplegia', 'MP:0009967', 'abnormal neuron proliferation', 0.425, 11.437222266468964, 2.2047266187101995, 'UPHENO:0085565', 'abnormality of neuron physiology'),
(235400, 'HP:0002301', 'Hemiplegia', 'MP:0010653', 'abnormal Wallerian degeneration', 0.4146341463414634, 11.437222266468964, 2.177673733821239, 'UPHENO:0085565', 'abnormality of neuron physiology'),
(235401, 'HP:0002301', 'Hemiplegia', 'MP:0021001', 'impaired neuron physiology', 0.4358974358974359, 11.437222266468964, 2.23281344042508, 'UPHENO:0085565', 'abnormality of neuron physiology'),
(235402, 'HP:0002301', 'Hemiplegia', 'MP:0010654', 'slow Wallerian degeneration', 0.40476190476190477, 11.437222266468964, 2.151592868030857, 'UPHENO:0085565', 'abnormality of neuron physiology'),
(235403, 'HP:0002301', 'Hemiplegia', 'MP:0004811', 'abnormal neuron physiology', 0.4473684210526316, 11.437222266468964, 2.2620017830625647, 'UPHENO:0085565', 'abnormality of neuron physiology'),
(235404, 'HP:0002301', 'Hemiplegia', 'MP:0003202', 'abnormal neuron apoptosis', 0.4146341463414634, 11.437222266468964, 2.177673733821239, 'UPHENO:0085565', 'abnormality of neuron physiology'),
(235405, 'HP:0002301', 'Hemiplegia', 'MP:0004768', 'abnormal axonal transport', 0.4358974358974359, 11.437222266468964, 2.23281344042508, 'UPHENO:0085565', 'abnormality of neuron physiology'),
(235406, 'HP:0002301', 'Hemiplegia', 'MP:0011987', 'abnormal GABAergic neuron physiology', 0.4358974358974359, 11.437222266468964, 2.23281344042508, 'UPHENO:0085565', 'abnormality of neuron physiology'),
(235407, 'HP:0010493', 'Long metacarpals', 'MP:0004639', 'fused metacarpal bones', 0.41975308641975306, 10.629867344411359, 2.1123256439406335, 'UPHENO:0076755', 'abnormal metacarpal bone morphology'),
(235408, 'HP:0010493', 'Long metacarpals', 'MP:0030885', 'increased radius size', 0.42105263157894735, 7.313292484018204, 1.754788034465246, 'UPHENO:0079872', 'abnormal anatomical entity morphology in the skeleton of pectoral complex'),
(235409, 'HP:0010493', 'Long metacarpals', 'MP:0004637', 'metacarpal bone hypoplasia', 0.43209876543209874, 10.629867344411359, 2.143164145889701, 'UPHENO:0076755', 'abnormal metacarpal bone morphology'),
(235410, 'HP:0010493', 'Long metacarpals', 'MP:0008161', 'increased diameter of radius', 0.41025641025641024, 7.313292484018204, 1.7321446595618086, 'UPHENO:0079872', 'abnormal anatomical entity morphology in the skeleton of pectoral complex'),
(235411, 'HP:0010493', 'Long metacarpals', 'MP:0004370', 'long ulna', 0.45, 13.062826751687464, 2.4245148047102867, 'UPHENO:0072241', 'increased length of the long bone'),
(235412, 'HP:0010493', 'Long metacarpals', 'MP:0004634', 'short metacarpal bones', 0.45, 10.629867344411359, 2.1871077488283723, 'UPHENO:0076755', 'abnormal metacarpal bone morphology'),
(235413, 'HP:0010493', 'Long metacarpals', 'MP:0008951', 'long radius', 0.45569620253164556, 13.062826751687464, 2.4398115798300424, 'UPHENO:0072241', 'increased length of the long bone'),
(235414, 'HP:0010493', 'Long metacarpals', 'MP:0004350', 'long humerus', 0.45, 13.062826751687464, 2.4245148047102867, 'UPHENO:0072241', 'increased length of the long bone'),
(235415, 'HP:0010493', 'Long metacarpals', 'MP:0030901', 'increased ulna size', 0.4155844155844156, 7.313292484018204, 1.7433560688994674, 'UPHENO:0079872', 'abnormal anatomical entity morphology in the skeleton of pectoral complex'),
(235416, 'HP:0010493', 'Long metacarpals', 'MP:0004638', 'elongated metacarpal bones', 0.5753424657534246, 15.87018167374507, 3.021719619045966, 'UPHENO:0072242', 'increased length of the metacarpal bone'),
(235417, 'HP:0010493', 'Long metacarpals', 'MP:0008163', 'increased diameter of ulna', 0.4050632911392405, 7.313292484018204, 1.7211468044999196, 'UPHENO:0079872', 'abnormal anatomical entity morphology in the skeleton of pectoral complex'),
(235418, 'HP:0003146', 'Hypocholesterolemia', 'MP:0000180', 'abnormal circulating cholesterol level', 0.4166666666666667, 13.607147267911277, 2.38110157174427, 'UPHENO:0051722', 'abnormal blood cholesterol level'),
(235419, 'HP:0003146', 'Hypocholesterolemia', 'MP:0005185', 'decreased circulating progesterone level', 0.42028985507246375, 11.92532322793753, 2.238770281016378, 'UPHENO:0034466', 'decreased level of lipid in blood'),
(235420, 'HP:0003146', 'Hypocholesterolemia', 'MP:0020151', 'abnormal circulating non-HDL cholesterol level', 0.4098360655737705, 13.607147267911277, 2.361503694674992, 'UPHENO:0051722', 'abnormal blood cholesterol level'),
(235421, 'HP:0003146', 'Hypocholesterolemia', 'MP:0000186', 'decreased circulating HDL cholesterol level', 0.4523809523809524, 15.192109768632433, 2.621568440039266, 'UPHENO:0034263', 'decreased level of cholesterol in blood'),
(235422, 'HP:0003146', 'Hypocholesterolemia', 'MP:0003510', 'decreased circulating dihydrotestosterone level', 0.4027777777777778, 11.92532322793753, 2.191632995971359, 'UPHENO:0034466', 'decreased level of lipid in blood'),
(235423, 'HP:0003146', 'Hypocholesterolemia', 'MP:0005179', 'decreased circulating cholesterol level', 0.6031746031746031, 15.192109768632433, 3.027126489111395, 'UPHENO:0034263', 'decreased level of cholesterol in blood'),
(235424, 'HP:0003146', 'Hypocholesterolemia', 'MP:0003368', 'decreased circulating glucocorticoid level', 0.417910447761194, 11.92532322793753, 2.232424056913099, 'UPHENO:0034466', 'decreased level of lipid in blood'),
(235425, 'HP:0003146', 'Hypocholesterolemia', 'MP:0000183', 'decreased circulating LDL cholesterol level', 0.4470588235294118, 15.192109768632433, 2.606101824582934, 'UPHENO:0034263', 'decreased level of cholesterol in blood'),
(235426, 'HP:0003146', 'Hypocholesterolemia', 'MP:0003458', 'decreased circulating ketone body level', 0.46774193548387094, 11.92532322793753, 2.361773437039689, 'UPHENO:0034466', 'decreased level of lipid in blood'),
(235427, 'HP:0003146', 'Hypocholesterolemia', 'MP:0003374', 'decreased circulating mineralocorticoid level', 0.417910447761194, 11.92532322793753, 2.232424056913099, 'UPHENO:0034466', 'decreased level of lipid in blood'),
(235428, 'HP:0003146', 'Hypocholesterolemia', 'MP:0005146', 'decreased circulating VLDL cholesterol level', 0.4470588235294118, 15.192109768632433, 2.606101824582934, 'UPHENO:0034263', 'decreased level of cholesterol in blood'),
(235429, 'HP:0003146', 'Hypocholesterolemia', 'MP:0005181', 'decreased circulating estradiol level', 0.4084507042253521, 11.92532322793753, 2.2070130653365045, 'UPHENO:0034466', 'decreased level of lipid in blood'),
(235430, 'HP:0005293', 'Venous insufficiency', 'MP:0003070', 'increased vascular permeability', 0.4375, 11.410750055107773, 2.2343238684464817, 'UPHENO:0002343', 'abnormality of blood vessel physiology'),
(235431, 'HP:0005293', 'Venous insufficiency', 'MP:0001619', 'abnormal vascular permeability', 0.44680851063829785, 11.410750055107773, 2.2579681657163766, 'UPHENO:0002343', 'abnormality of blood vessel physiology'),
(235432, 'HP:0005293', 'Venous insufficiency', 'MP:0003071', 'decreased vascular permeability', 0.4375, 11.410750055107773, 2.2343238684464817, 'UPHENO:0002343', 'abnormality of blood vessel physiology'),
(235433, 'HP:0005293', 'Venous insufficiency', 'MP:0003711', 'pathological neovascularization', 0.4117647058823529, 11.410750055107773, 2.167612543869059, 'UPHENO:0002343', 'abnormality of blood vessel physiology'),
(235434, 'HP:0003288', 'Mitochondrial propionyl-CoA carboxylase defect', 'MP:0013258', 'abnormal extracellular matrix morphology', 0.4230769230769231, 6.910179741676988, 1.7098355426815723, 'UPHENO:0006889', 'abnormal cellular_component'),
(235435, 'HP:0034664', 'Elevated urine 2-hydroxy-3-methylvaleric acid level', 'MP:0011654', 'histidinuria', 0.4444444444444444, 10.47786425096631, 2.157968617933316, 'UPHENO:0068491', 'increased level of carboxylic acid in urine'),
(235436, 'HP:0034664', 'Elevated urine 2-hydroxy-3-methylvaleric acid level', 'MP:0030617', 'hyperglutaminuria', 0.4266666666666667, 10.47786425096631, 2.1143687979502594, 'UPHENO:0068491', 'increased level of carboxylic acid in urine'),
(235437, 'HP:0034664', 'Elevated urine 2-hydroxy-3-methylvaleric acid level', 'MP:0020406', 'hyperthreoninuria', 0.4266666666666667, 10.47786425096631, 2.1143687979502594, 'UPHENO:0068491', 'increased level of carboxylic acid in urine'),
(235438, 'HP:0034664', 'Elevated urine 2-hydroxy-3-methylvaleric acid level', 'MP:0020401', 'argininuria', 0.4266666666666667, 10.47786425096631, 2.1143687979502594, 'UPHENO:0068491', 'increased level of carboxylic acid in urine'),
(235439, 'HP:0034664', 'Elevated urine 2-hydroxy-3-methylvaleric acid level', 'MP:0011516', 'aspartylglucosaminuria', 0.47761194029850745, 10.47786425096631, 2.237041142913645, 'UPHENO:0068491', 'increased level of carboxylic acid in urine'),
(235440, 'HP:0034664', 'Elevated urine 2-hydroxy-3-methylvaleric acid level', 'MP:0030615', 'ethylmalonic aciduria', 0.47058823529411764, 10.47786425096631, 2.2205313885449938, 'UPHENO:0068491', 'increased level of carboxylic acid in urine'),
(235441, 'HP:0034664', 'Elevated urine 2-hydroxy-3-methylvaleric acid level', 'MP:0020403', 'lysinuria', 0.4155844155844156, 10.47786425096631, 2.086728801572134, 'UPHENO:0068491', 'increased level of carboxylic acid in urine'),
(235442, 'HP:0034664', 'Elevated urine 2-hydroxy-3-methylvaleric acid level', 'MP:0013730', 'glutathionuria', 0.41025641025641024, 10.47786425096631, 2.0733091845538643, 'UPHENO:0068491', 'increased level of carboxylic acid in urine'),
(235443, 'HP:0034664', 'Elevated urine 2-hydroxy-3-methylvaleric acid level', 'MP:0011470', 'increased urine creatinine level', 0.40298507462686567, 9.50911518495075, 1.9575575323455603, 'UPHENO:0068110', 'increased level of chemical entity in urine'),
(235444, 'HP:0034664', 'Elevated urine 2-hydroxy-3-methylvaleric acid level', 'MP:0020400', 'cystinuria', 0.4444444444444444, 10.47786425096631, 2.157968617933316, 'UPHENO:0068491', 'increased level of carboxylic acid in urine'),
(235445, 'HP:0034664', 'Elevated urine 2-hydroxy-3-methylvaleric acid level', 'MP:0030682', 'hydroxyprolinuria', 0.4155844155844156, 10.47786425096631, 2.086728801572134, 'UPHENO:0068491', 'increased level of carboxylic acid in urine'),
(235446, 'HP:0034664', 'Elevated urine 2-hydroxy-3-methylvaleric acid level', 'MP:0030620', 'valinuria', 0.4155844155844156, 10.47786425096631, 2.086728801572134, 'UPHENO:0068491', 'increased level of carboxylic acid in urine'),
(235447, 'HP:0034664', 'Elevated urine 2-hydroxy-3-methylvaleric acid level', 'MP:0030616', 'hyperglycinuria', 0.41025641025641024, 10.47786425096631, 2.0733091845538643, 'UPHENO:0068491', 'increased level of carboxylic acid in urine'),
(235448, 'HP:0034664', 'Elevated urine 2-hydroxy-3-methylvaleric acid level', 'MP:0020402', 'ornithinuria', 0.42105263157894735, 10.47786425096631, 2.1004124157403803, 'UPHENO:0068491', 'increased level of carboxylic acid in urine'),
(235449, 'HP:0034664', 'Elevated urine 2-hydroxy-3-methylvaleric acid level', 'MP:0030689', 'cystathioninuria', 0.42105263157894735, 10.47786425096631, 2.1004124157403803, 'UPHENO:0068491', 'increased level of carboxylic acid in urine'),
(235450, 'HP:0034664', 'Elevated urine 2-hydroxy-3-methylvaleric acid level', 'MP:0030618', 'tryptophanuria', 0.4444444444444444, 10.47786425096631, 2.157968617933316, 'UPHENO:0068491', 'increased level of carboxylic acid in urine'),
(235451, 'HP:0034664', 'Elevated urine 2-hydroxy-3-methylvaleric acid level', 'MP:0030734', 'increased urine gamma-aminobutyric acid level', 0.42105263157894735, 10.47786425096631, 2.1004124157403803, 'UPHENO:0068491', 'increased level of carboxylic acid in urine'),
(235452, 'HP:0034664', 'Elevated urine 2-hydroxy-3-methylvaleric acid level', 'MP:0002931', 'glutaricadicuria', 0.47058823529411764, 10.47786425096631, 2.2205313885449938, 'UPHENO:0068491', 'increased level of carboxylic acid in urine'),
(235453, 'HP:0034664', 'Elevated urine 2-hydroxy-3-methylvaleric acid level', 'MP:0030612', 'organic aciduria', 0.43636363636363634, 10.430558536187952, 2.133428333025214, 'UPHENO:0068144', 'increased level of organic acid in urine'),
(235454, 'HP:0034664', 'Elevated urine 2-hydroxy-3-methylvaleric acid level', 'MP:0011517', 'hyperoxaluria', 0.49230769230769234, 10.47786425096631, 2.271196418125586, 'UPHENO:0068491', 'increased level of carboxylic acid in urine'),
(235455, 'HP:0034664', 'Elevated urine 2-hydroxy-3-methylvaleric acid level', 'MP:0020405', 'taurinuria', 0.4266666666666667, 10.47786425096631, 2.1143687979502594, 'UPHENO:0068491', 'increased level of carboxylic acid in urine'),
(235456, 'HP:0034664', 'Elevated urine 2-hydroxy-3-methylvaleric acid level', 'MP:0011765', 'oroticaciduria', 0.5245901639344263, 10.47786425096631, 2.344479585131225, 'UPHENO:0068491', 'increased level of carboxylic acid in urine'),
(235457, 'HP:0034664', 'Elevated urine 2-hydroxy-3-methylvaleric acid level', 'MP:0003311', 'aminoaciduria', 0.48484848484848486, 10.47786425096631, 2.253924711814731, 'UPHENO:0068491', 'increased level of carboxylic acid in urine'),
(235458, 'HP:0034664', 'Elevated urine 2-hydroxy-3-methylvaleric acid level', 'MP:0020404', 'prolinuria', 0.4266666666666667, 10.47786425096631, 2.1143687979502594, 'UPHENO:0068491', 'increased level of carboxylic acid in urine'),
(235459, 'HP:0034664', 'Elevated urine 2-hydroxy-3-methylvaleric acid level', 'MP:0030613', 'dicarboxylic aciduria', 0.5517241379310345, 10.47786425096631, 2.404348273695554, 'UPHENO:0068491', 'increased level of carboxylic acid in urine'),
(235460, 'HP:0034664', 'Elevated urine 2-hydroxy-3-methylvaleric acid level', 'MP:0030614', 'methylmalonic aciduria', 0.47761194029850745, 10.47786425096631, 2.237041142913645, 'UPHENO:0068491', 'increased level of carboxylic acid in urine'),
(235461, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0003746', 'stomatitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235462, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0004209', 'abnormal sweet taste sensitivity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235463, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0011763', 'urethritis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235464, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0013806', 'encephalopathy', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235465, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0004085', 'abnormal heartbeat', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235466, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0012705', 'increased embryonic neuroepithelial cell proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235467, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0020002', 'increased response to antigen', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235468, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0008674', 'abnormal interleukin-15 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235469, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0005041', 'abnormal antigen presentation via MHC class II', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235470, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0012196', 'abnormal myofibroblast differentiation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235471, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0004213', 'abnormal umami taste sensitivity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235472, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0003259', 'nausea', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235473, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0031111', 'meningoencephalitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235474, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0005350', 'increased susceptibility to autoimmune disorder', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235475, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0008700', 'decreased interleukin-4 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235476, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0030129', 'tongue inflammation', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235477, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0004824', 'decreased susceptibility to experimental autoimmune myasthenia gravis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235478, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0006141', 'abnormal atrioventricular node conduction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235479, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0031170', 'abnormal vasculature physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235480, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0008671', 'abnormal interleukin-13 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235481, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0004945', 'abnormal bone resorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235482, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0001947', 'abnormal mucociliary clearance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235483, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0011044', 'increased lung elastance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235484, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0011566', 'abnormal complement protein level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235485, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0004076', 'abnormal vitelline vascular remodeling', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235486, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0001847', 'brain inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235487, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0008667', 'decreased interleukin-12a secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235488, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0014048', 'abnormal Peyers patch physiology', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235489, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0001194', 'dermatitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235490, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0012006', 'abnormal hippocampus physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235491, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0003137', 'abnormal impulse conducting system conduction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235492, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0008712', 'decreased interleukin-9 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235493, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0004751', 'increased length of allograft survival', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235494, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0005399', 'increased susceptibility to fungal infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235495, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0011046', 'abnormal lung tissue damping', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235496, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0002327', 'abnormal respiratory function', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235497, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0012566', 'decreased susceptibility to experimental autoimmune orchitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235498, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0005597', 'decreased susceptibility to type I hypersensitivity reaction', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235499, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0002723', 'abnormal immune serum protein physiology', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235500, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0005502', 'abnormal renal/urinary system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235501, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0003726', 'decreased autoantibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235502, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0031055', 'bronchitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235503, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0001924', 'infertility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235504, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0005617', 'increased susceptibility to type IV hypersensitivity reaction', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235505, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0020948', 'abnormal susceptibility to Coronaviridae infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235506, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0003298', 'choking', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235507, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0008748', 'abnormal central T cell anergy', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235508, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0008860', 'abnormal hair cycle telogen phase', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235509, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0003463', 'abnormal single cell response', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235510, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0006138', 'congestive heart failure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235511, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0001545', 'abnormal hematopoietic system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235512, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0004212', 'abnormal salty taste sensitivity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235513, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0011043', 'abnormal lung elastance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235514, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0013296', 'abnormal susceptibility to induced colitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235515, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0008721', 'abnormal chemokine level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235516, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0001862', 'interstitial pneumonia', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235517, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0003777', 'lip inflammation', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235518, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0031222', 'decreased CXCL10 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235519, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0014200', 'abnormal respiratory epithelium physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235520, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0012706', 'decreased embryonic neuroepithelial cell proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235521, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0031013', 'abnormal egg activation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235522, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0012704', 'abnormal embryonic neuroepithelial cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235523, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0010755', 'abnormal heart right ventricle pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235524, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0003477', 'abnormal nerve fiber response', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235525, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0030132', 'periodontium inflammation', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235526, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0008709', 'decreased interleukin-7 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235527, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0010071', 'abnormal pruritus', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235528, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0008558', 'abnormal interferon-beta secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235529, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0002533', 'abnormal type III hypersensitivity reaction', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235530, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0008687', 'increased interleukin-2 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235531, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0003412', 'abnormal afterhyperpolarization', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235532, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0001840', 'increased level of surface class I molecules', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235533, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0020919', 'increased susceptibility to Ortervirales infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235534, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0005190', 'osteomyelitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235535, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0008005', 'decreased stomach pH', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235536, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0004045', 'abnormal cell cycle checkpoint function', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235537, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0002106', 'abnormal muscle physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235538, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0020094', 'increased susceptibility to aortic cartilaginous metaplasia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235539, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0004149', 'increased bone strength', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235540, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0001914', 'hemorrhage', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235541, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0013475', 'delayed reproductive senescence', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235542, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0008650', 'abnormal interleukin-1 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235543, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0001835', 'abnormal antigen presentation', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235544, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0008660', 'increased interleukin-10 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235545, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0008703', 'decreased interleukin-5 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235546, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0008707', 'abnormal interleukin-7 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235547, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0005027', 'increased susceptibility to parasitic infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235548, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0004782', 'abnormal surfactant physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235549, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0003157', 'impaired muscle relaxation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235550, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0020095', 'abnormal mean heart rate adaptation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235551, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0000501', 'abnormal digestive secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235552, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0002534', 'abnormal type IV hypersensitivity reaction', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235553, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0010211', 'abnormal acute phase protein level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235554, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0001724', 'abnormal extraembryonic endoderm formation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235555, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0020914', 'decreased susceptibility to Riboviria infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235556, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0008670', 'decreased interleukin-12b secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235557, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0008694', 'decreased interleukin-23a secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235558, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0002405', 'respiratory system inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235559, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0004046', 'abnormal mitosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235560, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0001872', 'sinus inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235561, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0001636', 'irregular heartbeat', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235562, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0005671', 'abnormal response to transplant', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235563, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0001950', 'abnormal respiratory sounds', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235564, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0030988', 'dysosmia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235565, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0008696', 'increased interleukin-3 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235566, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0002418', 'increased susceptibility to viral infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235567, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0008665', 'abnormal interleukin-12a secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235568, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0006323', 'abnormal extraembryonic mesoderm development', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235569, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0001663', 'abnormal digestive system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235570, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0004823', 'increased susceptibility to experimental autoimmune myasthenia gravis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235571, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0005001', 'abnormal clonal deletion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235572, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0002471', 'abnormal complement pathway', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235573, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0020186', 'abnormal susceptibility to bacterial infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235574, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0002133', 'abnormal respiratory system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235575, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0031125', 'aspiration pneumonia', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235576, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0020929', 'decreased susceptibility to Poxviridae infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235577, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0008932', 'abnormal embryonic tissue physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235578, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0011698', 'abnormal brown adipose tissue physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235579, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0020912', 'abnormal susceptibility to Riboviria infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235580, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0031092', 'dysgeusia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235581, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0008669', 'increased interleukin-12b secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235582, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0011431', 'increased urine flow rate', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235583, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0008198', 'abnormal follicular dendritic cell antigen presentation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235584, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0002693', 'abnormal pancreas physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235585, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0003925', 'abnormal cellular glucose uptake', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235586, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0020923', 'decreased susceptibility to Parvoviridae infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235587, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0008565', 'decreased interferon-beta secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235588, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0008702', 'increased interleukin-5 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235589, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0020163', 'increased susceptibility to virus induced diabetes', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235590, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0004797', 'increased anti-erythrocyte antigen antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235591, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0008561', 'decreased tumor necrosis factor secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235592, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0005364', 'increased susceptibility to prion infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235593, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0012028', 'abnormal visceral endoderm physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235594, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0001844', 'autoimmune response', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235595, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0001836', 'abnormal antigen presentation via MHC class I', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235596, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0005087', 'decreased acute inflammation', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235597, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0005620', 'abnormal muscle contractility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235598, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0003009', 'abnormal cytokine secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235599, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0005044', 'sepsis', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235600, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0005614', 'decreased susceptibility to type III hypersensitivity reaction', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235601, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0011762', 'renal/urinary system inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235602, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0012685', 'abnormal primitive streak elongation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235603, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0004036', 'abnormal muscle relaxation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235604, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0005398', 'decreased susceptibility to fungal infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235605, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0008735', 'increased susceptibility to endotoxin shock', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235606, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0012167', 'abnormal epigenetic regulation of gene expression', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235607, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0013561', 'abnormal endocrine gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235608, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0021016', 'decreased tau protein phosphorylation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235609, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0005363', 'decreased susceptibility to prion infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235610, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0003725', 'increased autoantibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235611, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0004800', 'decreased susceptibility to experimental autoimmune encephalomyelitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235612, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0008560', 'increased tumor necrosis factor secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235613, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0001664', 'abnormal digestion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235614, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0004558', 'delayed allantois development', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235615, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0001985', 'abnormal gustatory system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235616, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0008672', 'increased interleukin-13 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235617, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0002896', 'abnormal bone mineralization', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235618, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0011716', 'abnormal interleukin-8 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235619, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0008861', 'abnormal hair shedding', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235620, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0020916', 'increased susceptibility to Herpesvirales infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235621, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0004798', 'decreased anti-double stranded DNA antibody level', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235622, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0004512', 'anosmia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235623, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0010695', 'abnormal blood pressure regulation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235624, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0002498', 'abnormal acute inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235625, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0000352', 'decreased cell proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235626, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0008272', 'abnormal endochondral bone ossification', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235627, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0001793', 'abnormal susceptibility to infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235628, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0004145', 'abnormal muscle electrophysiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235629, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0008744', 'abnormal B cell anergy', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235630, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0001908', 'abnormal somatosensory cortex physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235631, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0012186', 'abnormal muscle precursor cell physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235632, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0031223', 'increased CXCL10 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235633, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0008701', 'abnormal interleukin-5 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235634, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0020096', 'high mean heart rate adaptation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235635, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0004822', 'decreased susceptibility to experimental autoimmune uveoretinitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235636, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0014047', 'abnormal gut-associated lymphoid tissue physiology', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235637, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0030924', 'early exit from telogen phase', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235638, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0030214', 'muscle fasciculation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235639, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0009057', 'increased interleukin-21 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235640, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0001756', 'abnormal urination', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235641, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0020942', 'abnormal susceptibility to Flaviviridae infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235642, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0008693', 'increased interleukin-23a secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235643, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0010753', 'improved mucociliary clearance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235644, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0008556', 'abnormal tumor necrosis factor secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235645, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0030949', 'abnormal Golgi vesicle transport', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235646, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0002128', 'abnormal blood circulation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235647, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0000423', 'delayed hair regrowth', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235648, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0008691', 'decreased interleukin-23 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235649, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0003566', 'abnormal cell adhesion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235650, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0030951', 'abnormal endocytosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235651, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0002634', 'abnormal sensorimotor gating', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235652, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0008666', 'increased interleukin-12a secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235653, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0002869', 'increased anti-insulin autoantibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235654, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0020936', 'abnormal susceptibility to Picornaviridae infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235655, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0010697', 'abnormal systemic arterial blood pressure regulation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235656, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0000313', 'abnormal cell death', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235657, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0006114', 'cardiac murmur', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235658, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0020924', 'abnormal susceptibility to Hepadnaviridae infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235659, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0008555', 'abnormal interferon secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235660, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0012553', 'decreased serum complement activity', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235661, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0008564', 'increased interferon-beta secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235662, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0008273', 'abnormal intramembranous bone ossification', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235663, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0000230', 'abnormal systemic arterial blood pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235664, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0010508', 'abnormal heart electrocardiography waveform feature', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235665, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0002409', 'decreased susceptibility to infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235666, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0020517', 'abnormal visceral yolk sac physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235667, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0011718', 'decreased interleukin-8 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235668, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0014275', 'increased respiration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235669, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0020099', 'increased susceptibility to diet-induced aortic fatty streak lesions', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235670, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0020922', 'increased susceptibility to Parvoviridae infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235671, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0020000', 'abnormal response to antigen', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235672, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0013971', 'blood in lymph vessels', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235673, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0030987', 'spinal cord inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235674, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0020097', 'low mean heart rate adaptation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235675, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0005621', 'abnormal cell physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235676, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0002425', 'abnormal susceptibility to autoimmune disorder', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235677, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0002254', 'reproductive system inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235678, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0002531', 'abnormal type I hypersensitivity reaction', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235679, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0008686', 'abnormal interleukin-2 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235680, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0011399', 'increased endoneurial fluid pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235681, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0001629', 'abnormal heart rate', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235682, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0010680', 'abnormal skin adnexa physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235683, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0003927', 'increased cellular glucose import', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235684, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0008692', 'abnormal interleukin-23a secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235685, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0008698', 'abnormal interleukin-4 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235686, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0008688', 'decreased interleukin-2 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235687, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0002419', 'abnormal innate immunity', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235688, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0011764', 'ureteritis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235689, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0003470', 'abnormal summary potential', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235690, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0005076', 'abnormal cell differentiation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235691, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0001838', 'defective intracellular transport of class I molecules', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235692, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0001921', 'reduced fertility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235693, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0010538', 'increased level of surface class II molecules', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235694, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0002532', 'abnormal type II hypersensitivity reaction', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235695, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0008544', 'impaired olfaction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235696, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0020913', 'increased susceptibility to Riboviria infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235697, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0013559', 'abnormal exocrine gland physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235698, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0010754', 'abnormal heart left ventricle pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235699, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0002164', 'abnormal gland physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235700, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0003280', 'urinary incontinence', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235701, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0031302', 'syncope', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235702, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0010143', 'enhanced fertility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235703, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0008705', 'increased interleukin-6 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235704, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0013636', 'abnormal bone stiffness', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235705, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0001866', 'nasal inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235706, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0003091', 'abnormal cell migration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235707, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0001864', 'vascular inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235708, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0013136', 'genital discharge', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235709, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0010950', 'abnormal lung hysteresivity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235710, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0004072', 'abnormal frontal plane axis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235711, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0012202', 'abnormal endothelial cell proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235712, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0020927', 'abnormal susceptibility to Poxviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235713, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0005612', 'decreased susceptibility to type II hypersensitivity reaction', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235714, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0031090', 'ageusia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235715, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0031089', 'sneezing', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235716, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0001819', 'abnormal immune cell physiology', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235717, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0003926', 'decreased cellular glucose uptake', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235718, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0009058', 'decreased interleukin-21 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235719, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0031102', 'rhinorrhea', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235720, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0004794', 'increased anti-nuclear antigen antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235721, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0002420', 'abnormal adaptive immunity', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235722, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0001867', 'rhinitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235723, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0000738', 'impaired muscle contractility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235724, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0012111', 'failure of morula compaction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235725, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0011048', 'decreased lung tissue damping', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235726, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0013646', 'decreased energy dissipated prior to femur fracture', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235727, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0004803', 'increased susceptibility to autoimmune diabetes', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235728, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0005005', 'abnormal self tolerance', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235729, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0020921', 'abnormal susceptibility to Parvoviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235730, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0010223', 'abnormal immunoglobulin transcytosis', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235731, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0008664', 'decreased interleukin-12 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235732, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0004264', 'abnormal extraembryonic tissue physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235733, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0008652', 'decreased interleukin-1 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235734, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0008656', 'abnormal interleukin-1 beta secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235735, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0005026', 'decreased susceptibility to parasitic infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235736, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0002314', 'abnormal respiratory mechanics', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235737, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0006142', 'abnormal sinoatrial node conduction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235738, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0012567', 'increased susceptibility to experimental autoimmune orchitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235739, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0001839', 'abnormal level of surface class I molecules', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235740, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0012205', 'abnormal neuronal stem cell self-renewal', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235741, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0008559', 'abnormal interferon-gamma secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235742, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0008685', 'decreased interleukin-18 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235743, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0020187', 'abnormal susceptibility to prion infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235744, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0009062', 'impaired lectin complement pathway', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235745, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0008006', 'increased stomach pH', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235746, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0005673', 'decreased susceptibility to graft versus host disease', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235747, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0009056', 'abnormal interleukin-21 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235748, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0010539', 'decreased level of surface class II molecules', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235749, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0009785', 'abnormal susceptibility to infection induced morbidity/mortality', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235750, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0004009', 'abnormal diastolic filling velocity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235751, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0005615', 'increased susceptibility to type III hypersensitivity reaction', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235752, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0020931', 'increased susceptibility to Adenoviridae infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235753, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0031054', 'bronchiolitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235754, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0001933', 'abnormal litter size', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235755, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0008562', 'increased interferon-alpha secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235756, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0020951', 'abnormal susceptibility to Paramyxoviridae infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235757, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0008659', 'abnormal interleukin-10 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235758, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0031435', 'abnormal copulatory plug biosynthesis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235759, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0003674', 'oxidative stress', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235760, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0020918', 'abnormal susceptibility to Ortervirales infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235761, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0002635', 'reduced sensorimotor gating', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235762, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0008675', 'increased interleukin-15 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235763, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0031066', 'cytokine storm', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235764, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0008750', 'abnormal interferon level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235765, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0005672', 'increased susceptibility to graft versus host disease', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235766, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0012556', 'increased cell death', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235767, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0003880', 'abnormal central pattern generator function', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235768, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0003878', 'abnormal ear physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235769, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0012382', 'abnormal blood cell physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235770, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0009787', 'increased susceptibility to infection induced morbidity/mortality', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235771, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0031091', 'hypogeusia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235772, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0020945', 'abnormal susceptibility to Orthomyxoviridae infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235773, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0001544', 'abnormal cardiovascular system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235774, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0004210', 'abnormal bitter taste sensitivity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235775, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0005088', 'increased acute inflammation', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235776, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0003767', 'palate inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235777, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0002473', 'impaired complement classical pathway', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235778, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0031098', 'abnormal sputum production', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235779, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0020093', 'decreased susceptibility to aortic cartilaginous metaplasia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235780, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0020939', 'abnormal susceptibility to Togaviridae infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235781, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0004795', 'decreased anti-nuclear antigen antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235782, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0008655', 'decreased interleukin-1 alpha secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235783, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0008699', 'increased interleukin-4 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235784, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0000743', 'muscle spasm', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235785, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0002148', 'abnormal hypersensitivity reaction', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235786, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0020142', 'increased anti-sperm antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235787, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0020162', 'decreased susceptibility to virus induced diabetes', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235788, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0000316', 'cellular necrosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235789, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0021024', 'abnormal cerebrospinal fluid physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235790, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0031402', 'decreased muscle fatigability', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235791, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0012555', 'decreased cell death', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235792, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0001533', 'abnormal skeleton physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235793, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0008676', 'decreased interleukin-15 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235794, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0008710', 'abnormal interleukin-9 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235795, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0021014', 'abnormal tau protein phosphorylation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235796, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0004994', 'abnormal brain wave pattern', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235797, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0003865', 'lymph node inflammation', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235798, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0008654', 'increased interleukin-1 alpha secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235799, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0012554', 'increased serum complement activity', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235800, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0020933', 'abnormal susceptibility to Retroviridae infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235801, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0010377', 'abnormal gut flora balance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235802, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0030153', 'dental pulp inflammation', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235803, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0005000', 'abnormal immune tolerance', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235804, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0008663', 'increased interleukin-12 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235805, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0011047', 'increased lung tissue damping', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235806, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0000751', 'myopathy', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235807, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0020001', 'decreased response to antigen', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235808, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0008004', 'abnormal stomach pH', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235809, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0031169', 'abnormal joint physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235810, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0006001', 'abnormal intestinal transit time', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235811, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0002998', 'abnormal bone remodeling', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235812, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0008711', 'increased interleukin-9 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235813, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0013942', 'enthesitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235814, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0020185', 'abnormal susceptibility to viral infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235815, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0020412', 'abnormal amnion physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235816, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0011926', 'abnormal heart valve physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235817, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0008695', 'abnormal interleukin-3 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235818, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0008651', 'increased interleukin-1 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235819, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0008684', 'increased interleukin-18 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235820, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0005501', 'abnormal skin physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235821, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0004796', 'increased anti-histone antibody level', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235822, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0031221', 'abnormal CXCL10 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235823, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0008713', 'abnormal cytokine level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235824, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0012123', 'abnormal bronchoconstrictive response', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235825, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0020154', 'impaired humoral immune response', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235826, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0002472', 'impaired complement alternative pathway', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235827, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0021052', 'abnormal renal arterial blood pressure regulation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235828, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0003866', 'abnormal defecation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235829, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0008704', 'abnormal interleukin-6 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235830, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0011045', 'decreased lung elastance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235831, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0003762', 'abnormal immune organ physiology', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235832, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0005402', 'abnormal action potential', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235833, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0005004', 'abnormal lymphocyte anergy', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235834, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0005666', 'abnormal adipose tissue physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235835, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0008568', 'abnormal interleukin secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235836, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0012204', 'abnormal neuronal stem cell physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235837, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0010559', 'heart block', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235838, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0002322', 'abnormal respiratory transport', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235839, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0001873', 'stomach inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235840, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0009697', 'abnormal copulation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235841, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0008563', 'decreased interferon-alpha secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235842, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0006080', 'brain ischemia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235843, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0008942', 'abnormal induced cell death', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235844, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0010381', 'abnormal dosage compensation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235845, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0005043', 'defective assembly of class II molecules', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235846, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0020184', 'abnormal susceptibility to parasitic infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235847, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0010922', 'alveolitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235848, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0020915', 'abnormal susceptibility to Herpesvirales infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235849, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0004116', 'abnormal atrioventricular bundle conduction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235850, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0002161', 'abnormal fertility/fecundity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235851, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0008680', 'abnormal interleukin-17 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235852, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0001849', 'ear inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235853, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0000350', 'abnormal cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235854, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0004802', 'decreased susceptibility to systemic lupus erythematosus', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235855, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0009046', 'muscle twitch', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235856, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0008697', 'decreased interleukin-3 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235857, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0003186', 'abnormal redox activity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235858, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0003868', 'abnormal feces composition', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235859, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0002500', 'granulomatous inflammation', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235860, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0009473', 'abnormal skin exfoliation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235861, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0004799', 'increased susceptibility to experimental autoimmune encephalomyelitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235862, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0008679', 'decreased interleukin-16 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235863, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0003875', 'abnormal hair follicle regression', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235864, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0020098', 'abnormal susceptibility to diet-induced aortic fatty streak lesions', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235865, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0008653', 'abnormal interleukin-1 alpha secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235866, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0004826', 'decreased susceptibility to experimental autoimmune thyroiditis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235867, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0031088', 'coughing', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235868, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0008197', 'abnormal follicular dendritic cell physiology', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235869, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0008567', 'decreased interferon-gamma secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235870, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0020183', 'abnormal susceptibility to fungal infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235871, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0002412', 'increased susceptibility to bacterial infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235872, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0008689', 'abnormal interleukin-23 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235873, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0009786', 'decreased susceptibility to infection induced morbidity/mortality', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235874, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0006082', 'CNS inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235875, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0002933', 'joint inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235876, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0011082', 'abnormal gastrointestinal motility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235877, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0013645', 'increased energy dissipated prior to femur fracture', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235878, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0010822', 'pneumothorax', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235879, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0002272', 'abnormal nervous system electrophysiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235880, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0020932', 'decreased susceptibility to Adenoviridae infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235881, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0005025', 'abnormal response to infection', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235882, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0013640', 'increased bone stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235883, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0011021', 'abnormal circadian regulation of heart rate', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235884, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0020928', 'increased susceptibility to Poxviridae infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235885, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0005410', 'abnormal fertilization', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235886, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0008708', 'increased interleukin-7 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235887, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0013498', 'trachea inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235888, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0002870', 'decreased anti-insulin autoantibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235889, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0030130', 'gum inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235890, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0002499', 'chronic inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235891, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0008566', 'increased interferon-gamma secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235892, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0000427', 'abnormal hair cycle', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235893, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0002411', 'decreased susceptibility to bacterial infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235894, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0004752', 'decreased length of allograft survival', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235895, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0010752', 'impaired mucociliary clearance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235896, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0031240', 'abnormal CSF3 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235897, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0031128', 'cardiovascular shunt', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235898, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0001845', 'abnormal inflammatory response', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235899, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0014274', 'decreased respiration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235900, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0003621', 'dysuria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235901, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0008662', 'abnormal interleukin-12 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235902, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0001633', 'poor circulation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235903, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0008749', 'abnormal peripheral T cell anergy', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235904, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0001986', 'abnormal taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235905, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0004804', 'decreased susceptibility to autoimmune diabetes', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235906, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0008657', 'increased interleukin-1 beta secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235907, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0003889', 'enhanced sensorimotor gating', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235908, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0020039', 'increased bone ossification', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235909, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0001983', 'abnormal olfactory system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235910, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0001790', 'abnormal immune system physiology', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235911, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0001841', 'decreased level of surface class I molecules', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235912, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0020371', 'abnormal glymphatic system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235913, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0001919', 'abnormal reproductive system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235914, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0012565', 'perivasculitis', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235915, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0004510', 'myositis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235916, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0002410', 'decreased susceptibility to viral infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235917, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0001943', 'abnormal respiration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235918, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0008683', 'abnormal interleukin-18 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235919, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0020040', 'decreased bone ossification', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235920, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0008677', 'abnormal interleukin-16 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235921, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0031110', 'meningitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235922, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0030909', 'abnormal melanocyte adhesion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235923, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0001666', 'abnormal intestinal absorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235924, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0020846', 'abnormal cell motility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235925, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0008271', 'abnormal bone ossification', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235926, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0020092', 'abnormal susceptibility to aortic cartilaginous metaplasia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235927, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0003659', 'abnormal lymph circulation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235928, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0004829', 'increased anti-chromatin antibody level', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235929, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0020155', 'enhanced humoral immune response', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235930, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0008682', 'decreased interleukin-17 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235931, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0008678', 'increased interleukin-16 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235932, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0005532', 'abnormal vascular resistance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235933, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0008746', 'abnormal peripheral B cell anergy', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235934, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0005275', 'abnormal skin tensile strength', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235935, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0012573', 'decreased susceptibility to chemically induced skin inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235936, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0001542', 'abnormal bone strength', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235937, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0008681', 'increased interleukin-17 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235938, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0001846', 'increased inflammatory response', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235939, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0020920', 'decreased susceptibility to Ortervirales infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235940, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0008673', 'decreased interleukin-13 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235941, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0003077', 'abnormal cell cycle', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235942, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0020930', 'abnormal susceptibility to Adenoviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235943, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0004211', 'abnormal sour taste sensitivity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235944, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0001876', 'decreased inflammatory response', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235945, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0004142', 'abnormal muscle tone', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235946, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0005613', 'increased susceptibility to type II hypersensitivity reaction', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235947, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0011398', 'abnormal endoneurial fluid pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235948, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0001648', 'abnormal apoptosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235949, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0008706', 'decreased interleukin-6 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235950, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0030991', 'optic nerve inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235951, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0031095', 'pharyngitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235952, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0020917', 'decreased susceptibility to Herpesvirales infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235953, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0008690', 'increased interleukin-23 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235954, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0004821', 'increased susceptibility to experimental autoimmune uveoretinitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235955, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0011717', 'increased interleukin-8 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235956, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0009562', 'abnormal odor adaptation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235957, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0003260', 'vomiting', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235958, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0012572', 'increased susceptibility to chemically induced skin inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235959, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0011012', 'bronchiectasis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235960, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0004825', 'increased susceptibility to experimental autoimmune thyroiditis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235961, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0004947', 'skin inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235962, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0013639', 'decreased bone stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235963, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0003303', 'peritoneal inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235964, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0014037', 'stranguria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235965, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0001869', 'pancreas inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235966, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0008747', 'abnormal T cell anergy', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235967, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0000304', 'abnormal cardiac stroke volume', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235968, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0008859', 'abnormal hair cycle catagen phase', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235969, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0002406', 'increased susceptibility to infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235970, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0005403', 'abnormal nerve conduction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235971, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0001761', 'abnormal urination pattern', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235972, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0011925', 'abnormal heart echocardiography feature', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235973, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0008722', 'abnormal chemokine secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235974, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0011432', 'decreased urine flow rate', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235975, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0008737', 'abnormal spleen physiology', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235976, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0005616', 'decreased susceptibility to type IV hypersensitivity reaction', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235977, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0001627', 'abnormal cardiac output', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235978, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0020100', 'decreased susceptibility to diet-induced aortic fatty streak lesions', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235979, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0010994', 'aerophagia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235980, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0004762', 'increased anti-double stranded DNA antibody level', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235981, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0008734', 'decreased susceptibility to endotoxin shock', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235982, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0008775', 'abnormal heart ventricle pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235983, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0005351', 'decreased susceptibility to autoimmune disorder', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235984, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0008557', 'abnormal interferon-alpha secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235985, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0008658', 'decreased interleukin-1 beta secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235986, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0008751', 'abnormal interleukin level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235987, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0031053', 'pleuritis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235988, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0020848', 'abnormal exocytosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235989, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0001800', 'abnormal humoral immune response', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235990, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0004801', 'increased susceptibility to systemic lupus erythematosus', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235991, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0002421', 'abnormal cell-mediated immunity', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235992, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0008546', 'abnormal vesicle-mediated transport', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235993, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0020381', 'muscle gating pore current', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235994, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0004037', 'increased muscle relaxation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235995, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0001837', 'defective assembly of class I molecules', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235996, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0008668', 'abnormal interleukin-12b secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235997, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0003633', 'abnormal nervous system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(235998, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0010368', 'abnormal lymphatic system physiology', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(235999, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0001861', 'lung inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(236000, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0005042', 'abnormal level of surface class II molecules', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(236001, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0004143', 'muscle hypertonia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(236002, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0031009', 'abnormal sperm-egg fusion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(236003, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0000351', 'increased cell proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(236004, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0030990', 'nerve inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(236005, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0004771', 'increased anti-single stranded DNA antibody level', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(236006, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0005670', 'abnormal white adipose tissue physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(236007, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0021015', 'increased tau protein phosphorylation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(236008, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0005596', 'increased susceptibility to type I hypersensitivity reaction', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(236009, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0002139', 'abnormal hepatobiliary system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(236010, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0020386', 'adipose tissue inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(236011, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0001984', 'abnormal olfaction', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(236012, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0008661', 'decreased interleukin-10 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(236013, 'HP:0034146', 'Anti-glycyl tRNA-synthetase antibody positivity', 'MP:0003278', 'esophageal inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(236014, 'HP:0008245', 'Pituitary hypothyroidism', 'MP:0003348', 'hypopituitarism', 0.40217391304347827, 14.491670050491338, 2.41416065139441, 'UPHENO:0077890', 'decreased secretion in pituitary gland'),
(236015, 'HP:0031329', 'Interstitial cardiac fibrosis', 'MP:0020323', 'abnormal heart apex size', 0.42105263157894735, 8.197756331773574, 1.8578715985062695, 'UPHENO:0015324', 'abnormal anatomical entity morphology in the heart'),
(236016, 'HP:0031329', 'Interstitial cardiac fibrosis', 'MP:0002190', 'disorganized myocardium', 0.4090909090909091, 9.93472192593978, 2.0159872083542822, 'UPHENO:0076781', 'abnormal myocardium morphology'),
(236017, 'HP:0031329', 'Interstitial cardiac fibrosis', 'MP:0005406', 'abnormal heart size', 0.4166666666666667, 7.506484928906078, 1.768531044033682, 'UPHENO:0076810', 'abnormal heart morphology'),
(236018, 'HP:0031329', 'Interstitial cardiac fibrosis', 'MP:0003141', 'cardiac fibrosis', 0.45714285714285713, 11.78271883249473, 2.320858839308757, 'UPHENO:0076294', 'anatomical entity fibrosis'),
(236019, 'HP:0031329', 'Interstitial cardiac fibrosis', 'MP:0020135', 'abnormal heart ventricle wall thickness', 0.41025641025641024, 8.197756331773574, 1.833898057371288, 'UPHENO:0015324', 'abnormal anatomical entity morphology in the heart'),
(236020, 'HP:0031329', 'Interstitial cardiac fibrosis', 'MP:0005608', 'cardiac interstitial fibrosis', 0.4444444444444444, 11.78271883249473, 2.288397676443763, 'UPHENO:0076294', 'anatomical entity fibrosis'),
(236021, 'HP:0005301', 'Persistent left superior vena cava', 'MP:0006137', 'venoocclusion', 0.40425531914893614, 9.288227922896251, 1.9377346421268533, 'UPHENO:0019766', 'abnormal vein morphology'),
(236022, 'HP:0005301', 'Persistent left superior vena cava', 'MP:0006064', 'abnormal superior vena cava morphology', 0.4090909090909091, 14.384754846574829, 2.4258343795970814, 'UPHENO:0087095', 'abnormal anterior vena cava morphology'),
(236023, 'HP:0100576', 'Amaurosis fugax', 'MP:0006147', 'monocular blindness', 0.425, 8.795504987450572, 1.9334139804155999, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(236024, 'HP:0100576', 'Amaurosis fugax', 'MP:0002090', 'abnormal vision', 0.4722222222222222, 8.795504987450572, 2.0379972793751584, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(236025, 'HP:0100576', 'Amaurosis fugax', 'MP:0004022', 'abnormal cone electrophysiology', 0.4594594594594595, 8.795504987450572, 2.0102681331620964, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(236026, 'HP:0100576', 'Amaurosis fugax', 'MP:0012030', 'abnormal a-wave amplitude', 0.4473684210526316, 8.795504987450572, 1.9836408895251956, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(236027, 'HP:0100576', 'Amaurosis fugax', 'MP:0005257', 'abnormal intraocular pressure', 0.4594594594594595, 8.795504987450572, 2.0102681331620964, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(236028, 'HP:0100576', 'Amaurosis fugax', 'MP:0012029', 'abnormal electroretinogram waveform feature', 0.4722222222222222, 8.795504987450572, 2.0379972793751584, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(236029, 'HP:0100576', 'Amaurosis fugax', 'MP:0006148', 'binocular blindness', 0.425, 8.795504987450572, 1.9334139804155999, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(236030, 'HP:0100576', 'Amaurosis fugax', 'MP:0020962', 'increased c-wave amplitude', 0.4358974358974359, 8.795504987450572, 1.9580444508368071, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(236031, 'HP:0100576', 'Amaurosis fugax', 'MP:0012031', 'abnormal b-wave amplitude', 0.4473684210526316, 8.795504987450572, 1.9836408895251956, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(236032, 'HP:0100576', 'Amaurosis fugax', 'MP:0013145', 'eye discharge', 0.4722222222222222, 8.795504987450572, 2.0379972793751584, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(236033, 'HP:0100576', 'Amaurosis fugax', 'MP:0020219', 'increased tear production', 0.4594594594594595, 8.795504987450572, 2.0102681331620964, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(236034, 'HP:0100576', 'Amaurosis fugax', 'MP:0002001', 'blindness', 0.4358974358974359, 8.795504987450572, 1.9580444508368071, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(236035, 'HP:0100576', 'Amaurosis fugax', 'MP:0014132', 'abnormal tear film physiology', 0.4722222222222222, 8.795504987450572, 2.0379972793751584, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(236036, 'HP:0100576', 'Amaurosis fugax', 'MP:0013450', 'abnormal lacrimal apparatus physiology', 0.4473684210526316, 8.795504987450572, 1.9836408895251956, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(236037, 'HP:0100576', 'Amaurosis fugax', 'MP:0012036', 'abnormal a-wave latency', 0.4473684210526316, 8.795504987450572, 1.9836408895251956, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(236038, 'HP:0100576', 'Amaurosis fugax', 'MP:0012148', 'decreased a-wave implicit time', 0.4358974358974359, 8.795504987450572, 1.9580444508368071, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(236039, 'HP:0100576', 'Amaurosis fugax', 'MP:0006149', 'decreased visual acuity', 0.4473684210526316, 8.795504987450572, 1.9836408895251956, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(236040, 'HP:0100576', 'Amaurosis fugax', 'MP:0012147', 'increased a-wave implicit time', 0.4358974358974359, 8.795504987450572, 1.9580444508368071, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(236041, 'HP:0100576', 'Amaurosis fugax', 'MP:0005260', 'ocular hypotension', 0.4473684210526316, 8.795504987450572, 1.9836408895251956, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(236042, 'HP:0100576', 'Amaurosis fugax', 'MP:0001337', 'dry eyes', 0.4722222222222222, 8.795504987450572, 2.0379972793751584, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(236043, 'HP:0100576', 'Amaurosis fugax', 'MP:0005258', 'ocular hypertension', 0.4473684210526316, 8.795504987450572, 1.9836408895251956, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(236044, 'HP:0100576', 'Amaurosis fugax', 'MP:0012032', 'abnormal ERG latency', 0.4594594594594595, 8.795504987450572, 2.0102681331620964, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(236045, 'HP:0100576', 'Amaurosis fugax', 'MP:0012039', 'abnormal b-wave implicit time', 0.4473684210526316, 8.795504987450572, 1.9836408895251956, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(236046, 'HP:0100576', 'Amaurosis fugax', 'MP:0006072', 'abnormal retina apoptosis', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(236047, 'HP:0100576', 'Amaurosis fugax', 'MP:0001389', 'abnormal eye movement', 0.425, 8.795504987450572, 1.9334139804155999, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(236048, 'HP:0100576', 'Amaurosis fugax', 'MP:0031497', 'increased visual acuity', 0.4473684210526316, 8.795504987450572, 1.9836408895251956, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(236049, 'HP:0100576', 'Amaurosis fugax', 'MP:0008795', 'abnormal lens fiber apoptosis', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(236050, 'HP:0100576', 'Amaurosis fugax', 'MP:0012034', 'abnormal a-wave shape', 0.4594594594594595, 8.795504987450572, 2.0102681331620964, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(236051, 'HP:0100576', 'Amaurosis fugax', 'MP:0012154', 'decreased b-wave latency', 0.4358974358974359, 8.795504987450572, 1.9580444508368071, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(236052, 'HP:0100576', 'Amaurosis fugax', 'MP:0004021', 'abnormal rod electrophysiology', 0.4594594594594595, 8.795504987450572, 2.0102681331620964, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(236053, 'HP:0100576', 'Amaurosis fugax', 'MP:0011832', 'abnormal visual acuity', 0.4594594594594595, 8.795504987450572, 2.0102681331620964, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(236054, 'HP:0100576', 'Amaurosis fugax', 'MP:0020218', 'abnormal tear production', 0.4722222222222222, 8.795504987450572, 2.0379972793751584, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(236055, 'HP:0100576', 'Amaurosis fugax', 'MP:0006152', 'tunnel vision', 0.4594594594594595, 8.795504987450572, 2.0102681331620964, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(236056, 'HP:0100576', 'Amaurosis fugax', 'MP:0020861', 'abnormal corneal wound healing', 0.43902439024390244, 8.795504987450572, 1.9650550155155173, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(236057, 'HP:0100576', 'Amaurosis fugax', 'MP:0001851', 'eye inflammation', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(236058, 'HP:0100576', 'Amaurosis fugax', 'MP:0012145', 'increased a-wave amplitude', 0.4358974358974359, 8.795504987450572, 1.9580444508368071, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(236059, 'HP:0100576', 'Amaurosis fugax', 'MP:0012048', 'abnormal response to retina ischemic injury', 0.4473684210526316, 8.795504987450572, 1.9836408895251956, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(236060, 'HP:0100576', 'Amaurosis fugax', 'MP:0012050', 'decreased susceptilbility to retina ischemic injury', 0.425, 8.795504987450572, 1.9334139804155999, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(236061, 'HP:0100576', 'Amaurosis fugax', 'MP:0012150', 'increased b-wave implicit time', 0.4358974358974359, 8.795504987450572, 1.9580444508368071, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(236062, 'HP:0100576', 'Amaurosis fugax', 'MP:0011831', 'abnormal visual contrast sensitivity', 0.4594594594594595, 8.795504987450572, 2.0102681331620964, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(236063, 'HP:0100576', 'Amaurosis fugax', 'MP:0012143', 'decreased a-wave amplitude', 0.4358974358974359, 8.795504987450572, 1.9580444508368071, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(236064, 'HP:0100576', 'Amaurosis fugax', 'MP:0020980', 'increased FO-wave implicit time', 0.4358974358974359, 8.795504987450572, 1.9580444508368071, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(236065, 'HP:0100576', 'Amaurosis fugax', 'MP:0012153', 'increased b-wave latency', 0.4358974358974359, 8.795504987450572, 1.9580444508368071, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(236066, 'HP:0100576', 'Amaurosis fugax', 'MP:0010749', 'absent visual evoked potential', 0.4473684210526316, 8.795504987450572, 1.9836408895251956, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(236067, 'HP:0100576', 'Amaurosis fugax', 'MP:0014179', 'abnormal blood-retina barrier function', 0.425, 8.795504987450572, 1.9334139804155999, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(236068, 'HP:0100576', 'Amaurosis fugax', 'MP:0012037', 'abnormal b-wave latency', 0.4473684210526316, 8.795504987450572, 1.9836408895251956, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(236069, 'HP:0100576', 'Amaurosis fugax', 'MP:0012144', 'decreased b-wave amplitude', 0.4358974358974359, 8.795504987450572, 1.9580444508368071, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(236070, 'HP:0100576', 'Amaurosis fugax', 'MP:0020860', 'abnormal cornea physiology', 0.4864864864864865, 8.795504987450572, 2.0685488435662327, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(236071, 'HP:0100576', 'Amaurosis fugax', 'MP:0012035', 'abnormal b-wave shape', 0.4594594594594595, 8.795504987450572, 2.0102681331620964, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(236072, 'HP:0100576', 'Amaurosis fugax', 'MP:0012152', 'decreased a-wave latency', 0.4358974358974359, 8.795504987450572, 1.9580444508368071, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(236073, 'HP:0100576', 'Amaurosis fugax', 'MP:0020974', 'abnormal FO-wave shape', 0.4594594594594595, 8.795504987450572, 2.0102681331620964, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(236074, 'HP:0100576', 'Amaurosis fugax', 'MP:0012038', 'abnormal a-wave implicit time', 0.4473684210526316, 8.795504987450572, 1.9836408895251956, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(236075, 'HP:0100576', 'Amaurosis fugax', 'MP:0020220', 'decreased tear production', 0.4594594594594595, 8.795504987450572, 2.0102681331620964, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(236076, 'HP:0100576', 'Amaurosis fugax', 'MP:0008793', 'abnormal lens epithelium apoptosis', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(236077, 'HP:0100576', 'Amaurosis fugax', 'MP:0008145', 'hemeralopia', 0.4594594594594595, 8.795504987450572, 2.0102681331620964, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(236078, 'HP:0100576', 'Amaurosis fugax', 'MP:0003096', 'increased corneal light-scattering', 0.4722222222222222, 8.795504987450572, 2.0379972793751584, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(236079, 'HP:0100576', 'Amaurosis fugax', 'MP:0011275', 'abnormal behavioral response to light', 0.4146341463414634, 8.795504987450572, 1.9096902110325777, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(236080, 'HP:0100576', 'Amaurosis fugax', 'MP:0005253', 'abnormal eye physiology', 0.4857142857142857, 8.795504987450572, 2.066906486146868, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(236081, 'HP:0100576', 'Amaurosis fugax', 'MP:0006153', 'hypermetropia', 0.4594594594594595, 8.795504987450572, 2.0102681331620964, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(236082, 'HP:0100576', 'Amaurosis fugax', 'MP:0020961', 'abnormal c-wave amplitude', 0.4473684210526316, 8.795504987450572, 1.9836408895251956, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(236083, 'HP:0100576', 'Amaurosis fugax', 'MP:0010748', 'abnormal visual evoked potential', 0.4594594594594595, 8.795504987450572, 2.0102681331620964, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(236084, 'HP:0100576', 'Amaurosis fugax', 'MP:0012149', 'decreased b-wave implicit time', 0.4358974358974359, 8.795504987450572, 1.9580444508368071, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(236085, 'HP:0100576', 'Amaurosis fugax', 'MP:0006190', 'retina ischemia', 0.4722222222222222, 8.795504987450572, 2.0379972793751584, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(236086, 'HP:0100576', 'Amaurosis fugax', 'MP:0012040', 'abnormal c-wave shape', 0.4594594594594595, 8.795504987450572, 2.0102681331620964, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(236087, 'HP:0100576', 'Amaurosis fugax', 'MP:0006251', 'eyelid apraxia', 0.4358974358974359, 8.795504987450572, 1.9580444508368071, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(236088, 'HP:0100576', 'Amaurosis fugax', 'MP:0005551', 'abnormal eye electrophysiology', 0.4722222222222222, 8.795504987450572, 2.0379972793751584, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(236089, 'HP:0100576', 'Amaurosis fugax', 'MP:0020979', 'decreased FO-wave implicit time', 0.4358974358974359, 8.795504987450572, 1.9580444508368071, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(236090, 'HP:0100576', 'Amaurosis fugax', 'MP:0006224', 'oculomotor apraxia', 0.4146341463414634, 8.795504987450572, 1.9096902110325777, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(236091, 'HP:0100576', 'Amaurosis fugax', 'MP:0020977', 'decreased FO-wave amplitude', 0.4358974358974359, 8.795504987450572, 1.9580444508368071, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(236092, 'HP:0100576', 'Amaurosis fugax', 'MP:0003100', 'myopia', 0.4594594594594595, 8.795504987450572, 2.0102681331620964, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(236093, 'HP:0100576', 'Amaurosis fugax', 'MP:0020425', 'abnormal retinal bipolar cell electrophysiology', 0.4594594594594595, 8.795504987450572, 2.0102681331620964, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(236094, 'HP:0100576', 'Amaurosis fugax', 'MP:0020976', 'increased FO-wave amplitude', 0.4358974358974359, 8.795504987450572, 1.9580444508368071, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(236095, 'HP:0100576', 'Amaurosis fugax', 'MP:0006145', 'legal blindness', 0.425, 8.795504987450572, 1.9334139804155999, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(236096, 'HP:0100576', 'Amaurosis fugax', 'MP:0020975', 'abnormal FO-wave amplitude', 0.4473684210526316, 8.795504987450572, 1.9836408895251956, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(236097, 'HP:0100576', 'Amaurosis fugax', 'MP:0008144', 'nyctalopia', 0.425, 8.795504987450572, 1.9334139804155999, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(236098, 'HP:0100576', 'Amaurosis fugax', 'MP:0006150', 'double vision', 0.4594594594594595, 8.795504987450572, 2.0102681331620964, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(236099, 'HP:0100576', 'Amaurosis fugax', 'MP:0020439', 'absent b-wave', 0.4594594594594595, 8.795504987450572, 2.0102681331620964, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(236100, 'HP:0100576', 'Amaurosis fugax', 'MP:0013468', 'chromodacryorrhea', 0.4594594594594595, 8.795504987450572, 2.0102681331620964, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(236101, 'HP:0100576', 'Amaurosis fugax', 'MP:0020958', 'abnormal c-wave implicit time', 0.4473684210526316, 8.795504987450572, 1.9836408895251956, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(236102, 'HP:0100576', 'Amaurosis fugax', 'MP:0020963', 'decreased c-wave amplitude', 0.4358974358974359, 8.795504987450572, 1.9580444508368071, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(236103, 'HP:0100576', 'Amaurosis fugax', 'MP:0020959', 'decreased c-wave implicit time', 0.4358974358974359, 8.795504987450572, 1.9580444508368071, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(236104, 'HP:0100576', 'Amaurosis fugax', 'MP:0014157', 'alacrima', 0.4594594594594595, 8.795504987450572, 2.0102681331620964, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(236105, 'HP:0100576', 'Amaurosis fugax', 'MP:0003101', 'high myopia', 0.4473684210526316, 8.795504987450572, 1.9836408895251956, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(236106, 'HP:0100576', 'Amaurosis fugax', 'MP:0012049', 'increased susceptilbility to retina ischemic injury', 0.425, 8.795504987450572, 1.9334139804155999, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(236107, 'HP:0100576', 'Amaurosis fugax', 'MP:0012146', 'increased b-wave amplitude', 0.4358974358974359, 8.795504987450572, 1.9580444508368071, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(236108, 'HP:0100576', 'Amaurosis fugax', 'MP:0012033', 'abnormal ERG implicit time', 0.4594594594594595, 8.795504987450572, 2.0102681331620964, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(236109, 'HP:0100576', 'Amaurosis fugax', 'MP:0012151', 'increased a-wave latency', 0.4358974358974359, 8.795504987450572, 1.9580444508368071, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(236110, 'HP:0100576', 'Amaurosis fugax', 'MP:0020978', 'abnormal FO-wave implicit time', 0.4473684210526316, 8.795504987450572, 1.9836408895251956, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(236111, 'HP:0100576', 'Amaurosis fugax', 'MP:0003011', 'delayed dark adaptation', 0.4722222222222222, 8.795504987450572, 2.0379972793751584, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(236112, 'HP:0100576', 'Amaurosis fugax', 'MP:0020960', 'increased c-wave implicit time', 0.4358974358974359, 8.795504987450572, 1.9580444508368071, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(236113, 'HP:0100576', 'Amaurosis fugax', 'MP:0001999', 'photosensitivity', 0.4473684210526316, 8.795504987450572, 1.9836408895251956, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(236114, 'HP:0005178', 'Complete heart block with narrow QRS complexes', 'MP:0011925', 'abnormal heart echocardiography feature', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(236115, 'HP:0005178', 'Complete heart block with narrow QRS complexes', 'MP:0031192', 'coronary artery spasm', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(236116, 'HP:0005178', 'Complete heart block with narrow QRS complexes', 'MP:0003898', 'abnormal QRS complex', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(236117, 'HP:0005178', 'Complete heart block with narrow QRS complexes', 'MP:0011021', 'abnormal circadian regulation of heart rate', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(236118, 'HP:0005178', 'Complete heart block with narrow QRS complexes', 'MP:0008777', 'increased right ventricle diastolic pressure', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(236119, 'HP:0005178', 'Complete heart block with narrow QRS complexes', 'MP:0006047', 'aortic valve regurgitation', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(236120, 'HP:0005178', 'Complete heart block with narrow QRS complexes', 'MP:0014020', 'intramural bleeding in blood vessel wall', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(236121, 'HP:0005178', 'Complete heart block with narrow QRS complexes', 'MP:0003901', 'abnormal PR interval', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(236122, 'HP:0005178', 'Complete heart block with narrow QRS complexes', 'MP:0001985', 'abnormal gustatory system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(236123, 'HP:0005178', 'Complete heart block with narrow QRS complexes', 'MP:0004009', 'abnormal diastolic filling velocity', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(236124, 'HP:0005178', 'Complete heart block with narrow QRS complexes', 'MP:0004085', 'abnormal heartbeat', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(236125, 'HP:0005178', 'Complete heart block with narrow QRS complexes', 'MP:0006046', 'atrioventricular valve regurgitation', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(236126, 'HP:0005178', 'Complete heart block with narrow QRS complexes', 'MP:0004486', 'decreased response of heart to induced stress', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(236127, 'HP:0005178', 'Complete heart block with narrow QRS complexes', 'MP:0010755', 'abnormal heart right ventricle pressure', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(236128, 'HP:0005178', 'Complete heart block with narrow QRS complexes', 'MP:0003929', 'decreased heart rate variability', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(236129, 'HP:0005178', 'Complete heart block with narrow QRS complexes', 'MP:0003899', 'abnormal QT interval', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(236130, 'HP:0005178', 'Complete heart block with narrow QRS complexes', 'MP:0004013', 'decreased pulmonary artery pressure', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(236131, 'HP:0005178', 'Complete heart block with narrow QRS complexes', 'MP:0008817', 'hematoma', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(236132, 'HP:0005178', 'Complete heart block with narrow QRS complexes', 'MP:0003900', 'shortened QT interval', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(236133, 'HP:0005178', 'Complete heart block with narrow QRS complexes', 'MP:0011938', 'prolonged PP interval', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(236134, 'HP:0005178', 'Complete heart block with narrow QRS complexes', 'MP:0006144', 'increased systemic arterial systolic blood pressure', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(236135, 'HP:0005178', 'Complete heart block with narrow QRS complexes', 'MP:0004215', 'abnormal myocardial fiber physiology', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(236136, 'HP:0005178', 'Complete heart block with narrow QRS complexes', 'MP:0003034', 'increased pulmonary vascular resistance', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(236137, 'HP:0005178', 'Complete heart block with narrow QRS complexes', 'MP:0001636', 'irregular heartbeat', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(236138, 'HP:0005178', 'Complete heart block with narrow QRS complexes', 'MP:0004217', 'salt-sensitive hypertension', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(236139, 'HP:0005178', 'Complete heart block with narrow QRS complexes', 'MP:0001596', 'hypotension', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(236140, 'HP:0005178', 'Complete heart block with narrow QRS complexes', 'MP:0003821', 'decreased left ventricle diastolic pressure', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(236141, 'HP:0005178', 'Complete heart block with narrow QRS complexes', 'MP:0004876', 'decreased mean systemic arterial blood pressure', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(236142, 'HP:0005178', 'Complete heart block with narrow QRS complexes', 'MP:0006265', 'increased pulse pressure', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(236143, 'HP:0005178', 'Complete heart block with narrow QRS complexes', 'MP:0010510', 'absent P wave', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(236144, 'HP:0005178', 'Complete heart block with narrow QRS complexes', 'MP:0003882', 'abnormal pulse pressure', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(236145, 'HP:0005178', 'Complete heart block with narrow QRS complexes', 'MP:0000304', 'abnormal cardiac stroke volume', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(236146, 'HP:0005178', 'Complete heart block with narrow QRS complexes', 'MP:0004070', 'abnormal P wave', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(236147, 'HP:0005178', 'Complete heart block with narrow QRS complexes', 'MP:0004875', 'increased mean systemic arterial blood pressure', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(236148, 'HP:0005178', 'Complete heart block with narrow QRS complexes', 'MP:0010571', 'shortened ST segment', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(236149, 'HP:0005178', 'Complete heart block with narrow QRS complexes', 'MP:0011920', 'abnormal S wave', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(236150, 'HP:0005178', 'Complete heart block with narrow QRS complexes', 'MP:0003393', 'decreased cardiac output', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(236151, 'HP:0005178', 'Complete heart block with narrow QRS complexes', 'MP:0003928', 'increased heart rate variability', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(236152, 'HP:0005178', 'Complete heart block with narrow QRS complexes', 'MP:0005330', 'cardiomyopathy', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(236153, 'HP:0005178', 'Complete heart block with narrow QRS complexes', 'MP:0020098', 'abnormal susceptibility to diet-induced aortic fatty streak lesions', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(236154, 'HP:0005178', 'Complete heart block with narrow QRS complexes', 'MP:0010759', 'decreased right ventricle systolic pressure', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(236155, 'HP:0005178', 'Complete heart block with narrow QRS complexes', 'MP:0004084', 'abnormal cardiac muscle relaxation', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(236156, 'HP:0005178', 'Complete heart block with narrow QRS complexes', 'MP:0010554', 'shortened HV interval', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(236157, 'HP:0005178', 'Complete heart block with narrow QRS complexes', 'MP:0031130', 'right-to-left shunt', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(236158, 'HP:0005178', 'Complete heart block with narrow QRS complexes', 'MP:0001914', 'hemorrhage', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(236159, 'HP:0005178', 'Complete heart block with narrow QRS complexes', 'MP:0001983', 'abnormal olfactory system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(236160, 'HP:0005178', 'Complete heart block with narrow QRS complexes', 'MP:0004264', 'abnormal extraembryonic tissue physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(236161, 'HP:0005178', 'Complete heart block with narrow QRS complexes', 'MP:0013134', 'poor circulation in autopods', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(236162, 'HP:0005178', 'Complete heart block with narrow QRS complexes', 'MP:0004010', 'increased diastolic filling velocity', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(236163, 'HP:0005178', 'Complete heart block with narrow QRS complexes', 'MP:0003897', 'abnormal ST segment', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(236164, 'HP:0005178', 'Complete heart block with narrow QRS complexes', 'MP:0006138', 'congestive heart failure', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(236165, 'HP:0005178', 'Complete heart block with narrow QRS complexes', 'MP:0010512', 'absent PR interval', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(236166, 'HP:0005178', 'Complete heart block with narrow QRS complexes', 'MP:0003394', 'increased cardiac output', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(236167, 'HP:0005178', 'Complete heart block with narrow QRS complexes', 'MP:0011929', 'abnormal aortic valve flow', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(236168, 'HP:0005178', 'Complete heart block with narrow QRS complexes', 'MP:0006266', 'decreased pulse pressure', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(236169, 'HP:0005178', 'Complete heart block with narrow QRS complexes', 'MP:0020096', 'high mean heart rate adaptation', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(236170, 'HP:0005178', 'Complete heart block with narrow QRS complexes', 'MP:0008950', 'ventricular tachycardia', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(236171, 'HP:0005178', 'Complete heart block with narrow QRS complexes', 'MP:0003041', 'increased time of onset of induced ischemic contracture', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(236172, 'HP:0005178', 'Complete heart block with narrow QRS complexes', 'MP:0003819', 'increased left ventricle diastolic pressure', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(236173, 'HP:0005178', 'Complete heart block with narrow QRS complexes', 'MP:0011919', 'abnormal R wave', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(236174, 'HP:0005178', 'Complete heart block with narrow QRS complexes', 'MP:0010552', 'abnormal HV interval', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(236175, 'HP:0005178', 'Complete heart block with narrow QRS complexes', 'MP:0006114', 'cardiac murmur', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(236176, 'HP:0005178', 'Complete heart block with narrow QRS complexes', 'MP:0009698', 'heart hemorrhage', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(236177, 'HP:0005178', 'Complete heart block with narrow QRS complexes', 'MP:0006048', 'pulmonary valve regurgitation', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(236178, 'HP:0005178', 'Complete heart block with narrow QRS complexes', 'MP:0006142', 'abnormal sinoatrial node conduction', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(236179, 'HP:0005178', 'Complete heart block with narrow QRS complexes', 'MP:0011936', 'abnormal PP interval', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(236180, 'HP:0005178', 'Complete heart block with narrow QRS complexes', 'MP:0020092', 'abnormal susceptibility to aortic cartilaginous metaplasia', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(236181, 'HP:0005178', 'Complete heart block with narrow QRS complexes', 'MP:0004011', 'decreased diastolic filling velocity', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(236182, 'HP:0005178', 'Complete heart block with narrow QRS complexes', 'MP:0011937', 'shortened PP interval', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(236183, 'HP:0005178', 'Complete heart block with narrow QRS complexes', 'MP:0002164', 'abnormal gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(236184, 'HP:0005178', 'Complete heart block with narrow QRS complexes', 'MP:0010631', 'increased Q wave amplitude', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(236185, 'HP:0005178', 'Complete heart block with narrow QRS complexes', 'MP:0010504', 'abnormal RR interval', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(236186, 'HP:0005178', 'Complete heart block with narrow QRS complexes', 'MP:0010508', 'abnormal heart electrocardiography waveform feature', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(236187, 'HP:0005178', 'Complete heart block with narrow QRS complexes', 'MP:0020097', 'low mean heart rate adaptation', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(236188, 'HP:0005178', 'Complete heart block with narrow QRS complexes', 'MP:0004072', 'abnormal frontal plane axis', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(236189, 'HP:0005178', 'Complete heart block with narrow QRS complexes', 'MP:0000343', 'abnormal response to cardiac infarction', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(236190, 'HP:0005178', 'Complete heart block with narrow QRS complexes', 'MP:0001544', 'abnormal cardiovascular system physiology', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(236191, 'HP:0005178', 'Complete heart block with narrow QRS complexes', 'MP:0031302', 'syncope', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(236192, 'HP:0005178', 'Complete heart block with narrow QRS complexes', 'MP:0006263', 'decreased systemic arterial diastolic blood pressure', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(236193, 'HP:0005178', 'Complete heart block with narrow QRS complexes', 'MP:0000233', 'abnormal blood flow velocity', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(236194, 'HP:0005178', 'Complete heart block with narrow QRS complexes', 'MP:0011918', 'abnormal PQ interval', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(236195, 'HP:0005178', 'Complete heart block with narrow QRS complexes', 'MP:0031215', 'abnormal response to myocardial ischemic injury', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(236196, 'HP:0005178', 'Complete heart block with narrow QRS complexes', 'MP:0010520', 'sinoatrial block', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(236197, 'HP:0005178', 'Complete heart block with narrow QRS complexes', 'MP:0009732', 'ventricular premature beat', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(236198, 'HP:0005178', 'Complete heart block with narrow QRS complexes', 'MP:0003137', 'abnormal impulse conducting system conduction', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(236199, 'HP:0005178', 'Complete heart block with narrow QRS complexes', 'MP:0010637', 'sinus bradycardia', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(236200, 'HP:0005178', 'Complete heart block with narrow QRS complexes', 'MP:0011930', 'abnormal tricuspid valve flow', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(236201, 'HP:0005178', 'Complete heart block with narrow QRS complexes', 'MP:0011952', 'decreased cardiac stroke volume', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(236202, 'HP:0005178', 'Complete heart block with narrow QRS complexes', 'MP:0010634', 'increased QRS amplitude', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(236203, 'HP:0005178', 'Complete heart block with narrow QRS complexes', 'MP:0010695', 'abnormal blood pressure regulation', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(236204, 'HP:0005178', 'Complete heart block with narrow QRS complexes', 'MP:0005333', 'decreased heart rate', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(236205, 'HP:0005178', 'Complete heart block with narrow QRS complexes', 'MP:0010393', 'shortened QRS complex duration', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(236206, 'HP:0005178', 'Complete heart block with narrow QRS complexes', 'MP:0011928', 'abnormal mitral valve flow', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(236207, 'HP:0005178', 'Complete heart block with narrow QRS complexes', 'MP:0010511', 'shortened PR interval', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(236208, 'HP:0005178', 'Complete heart block with narrow QRS complexes', 'MP:0010757', 'decreased right ventricle diastolic pressure', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(236209, 'HP:0005178', 'Complete heart block with narrow QRS complexes', 'MP:0003824', 'decreased left ventricle developed pressure', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(236210, 'HP:0005178', 'Complete heart block with narrow QRS complexes', 'MP:0002128', 'abnormal blood circulation', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(236211, 'HP:0005178', 'Complete heart block with narrow QRS complexes', 'MP:0009384', 'cardiac valve regurgitation', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(236212, 'HP:0005178', 'Complete heart block with narrow QRS complexes', 'MP:0006143', 'increased systemic arterial diastolic blood pressure', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(236213, 'HP:0005178', 'Complete heart block with narrow QRS complexes', 'MP:0004012', 'increased pulmonary artery pressure', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(236214, 'HP:0005178', 'Complete heart block with narrow QRS complexes', 'MP:0031216', 'decreased susceptibility to myocardial ischemic injury', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(236215, 'HP:0005178', 'Complete heart block with narrow QRS complexes', 'MP:0010514', 'fragmented QRS complex', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(236216, 'HP:0005178', 'Complete heart block with narrow QRS complexes', 'MP:0031217', 'increased susceptibility to myocardial ischemic injury', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(236217, 'HP:0005178', 'Complete heart block with narrow QRS complexes', 'MP:0008775', 'abnormal heart ventricle pressure', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(236218, 'HP:0005178', 'Complete heart block with narrow QRS complexes', 'MP:0008932', 'abnormal embryonic tissue physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(236219, 'HP:0005178', 'Complete heart block with narrow QRS complexes', 'MP:0011951', 'increased cardiac stroke volume', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(236220, 'HP:0005178', 'Complete heart block with narrow QRS complexes', 'MP:0006264', 'decreased systemic arterial systolic blood pressure', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(236221, 'HP:0005178', 'Complete heart block with narrow QRS complexes', 'MP:0020093', 'decreased susceptibility to aortic cartilaginous metaplasia', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(236222, 'HP:0005178', 'Complete heart block with narrow QRS complexes', 'MP:0000231', 'hypertension', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(236223, 'HP:0005178', 'Complete heart block with narrow QRS complexes', 'MP:0010559', 'heart block', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(236224, 'HP:0005178', 'Complete heart block with narrow QRS complexes', 'MP:0010560', 'intraventricular block', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(236225, 'HP:0005178', 'Complete heart block with narrow QRS complexes', 'MP:0004485', 'increased response of heart to induced stress', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(236226, 'HP:0005178', 'Complete heart block with narrow QRS complexes', 'MP:0003042', 'decreased time of onset of induced ischemic contracture', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(236227, 'HP:0005178', 'Complete heart block with narrow QRS complexes', 'MP:0002952', 'ventricular cardiomyopathy', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(236228, 'HP:0005178', 'Complete heart block with narrow QRS complexes', 'MP:0005532', 'abnormal vascular resistance', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(236229, 'HP:0005178', 'Complete heart block with narrow QRS complexes', 'MP:0010553', 'prolonged HV interval', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(236230, 'HP:0005178', 'Complete heart block with narrow QRS complexes', 'MP:0004156', 'abnormal QT variability', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(236231, 'HP:0005178', 'Complete heart block with narrow QRS complexes', 'MP:0008776', 'increased right ventricle peak pressure', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(236232, 'HP:0005178', 'Complete heart block with narrow QRS complexes', 'MP:0012028', 'abnormal visceral endoderm physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(236233, 'HP:0005178', 'Complete heart block with narrow QRS complexes', 'MP:0006049', 'semilunar valve regurgitation', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(236234, 'HP:0005178', 'Complete heart block with narrow QRS complexes', 'MP:0004484', 'abnormal response of heart to induced stress', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(236235, 'HP:0005178', 'Complete heart block with narrow QRS complexes', 'MP:0002842', 'increased systemic arterial blood pressure', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(236236, 'HP:0005178', 'Complete heart block with narrow QRS complexes', 'MP:0010570', 'prolonged ST segment', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(236237, 'HP:0005178', 'Complete heart block with narrow QRS complexes', 'MP:0001598', 'abnormal blood viscosity', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(236238, 'HP:0005178', 'Complete heart block with narrow QRS complexes', 'MP:0003820', 'increased left ventricle systolic pressure', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(236239, 'HP:0005178', 'Complete heart block with narrow QRS complexes', 'MP:0010505', 'abnormal T wave', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(236240, 'HP:0005178', 'Complete heart block with narrow QRS complexes', 'MP:0003035', 'decreased pulmonary vascular resistance', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(236241, 'HP:0005178', 'Complete heart block with narrow QRS complexes', 'MP:0000249', 'abnormal blood vessel physiology', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(236242, 'HP:0005178', 'Complete heart block with narrow QRS complexes', 'MP:0004122', 'abnormal sinus arrhythmia', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(236243, 'HP:0005178', 'Complete heart block with narrow QRS complexes', 'MP:0010515', 'abnormal Q wave', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(236244, 'HP:0005178', 'Complete heart block with narrow QRS complexes', 'MP:0003039', 'increased time of peak ischemic contracture', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(236245, 'HP:0005178', 'Complete heart block with narrow QRS complexes', 'MP:0020095', 'abnormal mean heart rate adaptation', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(236246, 'HP:0005178', 'Complete heart block with narrow QRS complexes', 'MP:0010636', 'bundle branch block', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(236247, 'HP:0005178', 'Complete heart block with narrow QRS complexes', 'MP:0012045', 'increased susceptibility to hypertension', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(236248, 'HP:0005178', 'Complete heart block with narrow QRS complexes', 'MP:0020100', 'decreased susceptibility to diet-induced aortic fatty streak lesions', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(236249, 'HP:0005178', 'Complete heart block with narrow QRS complexes', 'MP:0021052', 'abnormal renal arterial blood pressure regulation', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(236250, 'HP:0005178', 'Complete heart block with narrow QRS complexes', 'MP:0004877', 'abnormal systemic vascular resistance', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(236251, 'HP:0005178', 'Complete heart block with narrow QRS complexes', 'MP:0011953', 'prolonged PQ interval', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(236252, 'HP:0005178', 'Complete heart block with narrow QRS complexes', 'MP:0010680', 'abnormal skin adnexa physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(236253, 'HP:0005178', 'Complete heart block with narrow QRS complexes', 'MP:0031170', 'abnormal vasculature physiology', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(236254, 'HP:0005178', 'Complete heart block with narrow QRS complexes', 'MP:0010697', 'abnormal systemic arterial blood pressure regulation', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(236255, 'HP:0005178', 'Complete heart block with narrow QRS complexes', 'MP:0003233', 'prolonged QT interval', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(236256, 'HP:0005178', 'Complete heart block with narrow QRS complexes', 'MP:0010758', 'increased right ventricle systolic pressure', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(236257, 'HP:0005178', 'Complete heart block with narrow QRS complexes', 'MP:0003547', 'abnormal pulmonary pressure', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(236258, 'HP:0005178', 'Complete heart block with narrow QRS complexes', 'MP:0010394', 'decreased QRS amplitude', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(236259, 'HP:0005178', 'Complete heart block with narrow QRS complexes', 'MP:0010509', 'decreased P wave amplitude', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(236260, 'HP:0005178', 'Complete heart block with narrow QRS complexes', 'MP:0006141', 'abnormal atrioventricular node conduction', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(236261, 'HP:0005178', 'Complete heart block with narrow QRS complexes', 'MP:0004216', 'salt-resistant hypertension', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(236262, 'HP:0005178', 'Complete heart block with narrow QRS complexes', 'MP:0012046', 'decreased susceptibility to hypertension', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(236263, 'HP:0005178', 'Complete heart block with narrow QRS complexes', 'MP:0011926', 'abnormal heart valve physiology', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(236264, 'HP:0005178', 'Complete heart block with narrow QRS complexes', 'MP:0002843', 'decreased systemic arterial blood pressure', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(236265, 'HP:0005178', 'Complete heart block with narrow QRS complexes', 'MP:0031129', 'left-to-right shunt', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(236266, 'HP:0005178', 'Complete heart block with narrow QRS complexes', 'MP:0031128', 'cardiovascular shunt', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(236267, 'HP:0005178', 'Complete heart block with narrow QRS complexes', 'MP:0001627', 'abnormal cardiac output', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(236268, 'HP:0005178', 'Complete heart block with narrow QRS complexes', 'MP:0010756', 'decreased right ventricle peak pressure', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(236269, 'HP:0005178', 'Complete heart block with narrow QRS complexes', 'MP:0010754', 'abnormal heart left ventricle pressure', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(236270, 'HP:0005178', 'Complete heart block with narrow QRS complexes', 'MP:0011931', 'abnormal pulmonary valve flow', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(236271, 'HP:0005178', 'Complete heart block with narrow QRS complexes', 'MP:0001629', 'abnormal heart rate', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(236272, 'HP:0005178', 'Complete heart block with narrow QRS complexes', 'MP:0001634', 'internal hemorrhage', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(236273, 'HP:0005178', 'Complete heart block with narrow QRS complexes', 'MP:0003040', 'decreased time of peak ischemic contracture', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(236274, 'HP:0005178', 'Complete heart block with narrow QRS complexes', 'MP:0010519', 'atrioventricular block', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(236275, 'HP:0005178', 'Complete heart block with narrow QRS complexes', 'MP:0003822', 'decreased left ventricle systolic pressure', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(236276, 'HP:0005178', 'Complete heart block with narrow QRS complexes', 'MP:0013135', 'poor circulation in tail', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(236277, 'HP:0005178', 'Complete heart block with narrow QRS complexes', 'MP:0020099', 'increased susceptibility to diet-induced aortic fatty streak lesions', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(236278, 'HP:0005178', 'Complete heart block with narrow QRS complexes', 'MP:0002626', 'increased heart rate', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(236279, 'HP:0005178', 'Complete heart block with narrow QRS complexes', 'MP:0020094', 'increased susceptibility to aortic cartilaginous metaplasia', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(236280, 'HP:0005178', 'Complete heart block with narrow QRS complexes', 'MP:0003033', 'abnormal pulmonary vascular resistance', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(236281, 'HP:0005178', 'Complete heart block with narrow QRS complexes', 'MP:0010513', 'abnormal ventricular activation time', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(236282, 'HP:0005178', 'Complete heart block with narrow QRS complexes', 'MP:0011927', 'abnormal cardiac valve flow', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(236283, 'HP:0005178', 'Complete heart block with narrow QRS complexes', 'MP:0003823', 'increased left ventricle developed pressure', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(236284, 'HP:0005178', 'Complete heart block with narrow QRS complexes', 'MP:0006044', 'tricuspid valve regurgitation', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(236285, 'HP:0005178', 'Complete heart block with narrow QRS complexes', 'MP:0004116', 'abnormal atrioventricular bundle conduction', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(236286, 'HP:0005178', 'Complete heart block with narrow QRS complexes', 'MP:0004878', 'increased systemic vascular resistance', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(236287, 'HP:0005178', 'Complete heart block with narrow QRS complexes', 'MP:0000230', 'abnormal systemic arterial blood pressure', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(236288, 'HP:0005178', 'Complete heart block with narrow QRS complexes', 'MP:0006045', 'mitral valve regurgitation', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(236289, 'HP:0005178', 'Complete heart block with narrow QRS complexes', 'MP:0009275', 'bruising', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(236290, 'HP:0005178', 'Complete heart block with narrow QRS complexes', 'MP:0010516', 'absent Q wave', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(236291, 'HP:0005178', 'Complete heart block with narrow QRS complexes', 'MP:0011954', 'shortened PQ interval', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(236292, 'HP:0005178', 'Complete heart block with narrow QRS complexes', 'MP:0004879', 'decreased systemic vascular resistance', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(236293, 'HP:0005178', 'Complete heart block with narrow QRS complexes', 'MP:0001633', 'poor circulation', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(236294, 'HP:0005178', 'Complete heart block with narrow QRS complexes', 'MP:0005435', 'hemoperitoneum', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(236295, 'HP:0000863', 'Central diabetes insipidus', 'MP:0003632', 'abnormal nervous system morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(236296, 'HP:0000863', 'Central diabetes insipidus', 'MP:0003115', 'abnormal respiratory system development', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(236297, 'HP:0000863', 'Central diabetes insipidus', 'MP:0000266', 'abnormal heart morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(236298, 'HP:0000863', 'Central diabetes insipidus', 'MP:0002163', 'abnormal gland morphology', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(236299, 'HP:0000863', 'Central diabetes insipidus', 'MP:0013123', 'head/neck swellings', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(236300, 'HP:0000863', 'Central diabetes insipidus', 'MP:0003936', 'abnormal reproductive system development', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(236301, 'HP:0000863', 'Central diabetes insipidus', 'MP:0002127', 'abnormal cardiovascular system morphology', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(236302, 'HP:0000863', 'Central diabetes insipidus', 'MP:0002109', 'abnormal limb morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(236303, 'HP:0000863', 'Central diabetes insipidus', 'MP:0011200', 'abnormal extraembryonic coelom morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(236304, 'HP:0000863', 'Central diabetes insipidus', 'MP:0003795', 'abnormal bone structure', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(236305, 'HP:0000863', 'Central diabetes insipidus', 'MP:0002164', 'abnormal gland physiology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(236306, 'HP:0000863', 'Central diabetes insipidus', 'MP:0002085', 'abnormal embryonic tissue morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(236307, 'HP:0000863', 'Central diabetes insipidus', 'MP:0002132', 'abnormal respiratory system morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(236308, 'HP:0000863', 'Central diabetes insipidus', 'MP:0003861', 'abnormal nervous system development', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(236309, 'HP:0000863', 'Central diabetes insipidus', 'MP:0013119', 'abdomen swellings', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(236310, 'HP:0000863', 'Central diabetes insipidus', 'MP:0002925', 'abnormal cardiovascular development', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(236311, 'HP:0000863', 'Central diabetes insipidus', 'MP:0002210', 'abnormal sex determination', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(236312, 'HP:0000863', 'Central diabetes insipidus', 'MP:0031277', 'pectus carinatum', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(236313, 'HP:0000863', 'Central diabetes insipidus', 'MP:0011174', 'lipodystrophy', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(236314, 'HP:0000863', 'Central diabetes insipidus', 'MP:0000428', 'abnormal craniofacial morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(236315, 'HP:0000863', 'Central diabetes insipidus', 'MP:0002160', 'abnormal reproductive system morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(236316, 'HP:0000863', 'Central diabetes insipidus', 'MP:0013121', 'testicular swellings', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(236317, 'HP:0000863', 'Central diabetes insipidus', 'MP:0013120', 'urogenital swellings', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(236318, 'HP:0000863', 'Central diabetes insipidus', 'MP:0013177', 'abnormal tail tip morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(236319, 'HP:0000863', 'Central diabetes insipidus', 'MP:0010233', 'hairless tail', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(236320, 'HP:0000863', 'Central diabetes insipidus', 'MP:0010478', 'intracranial aneurysm', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(236321, 'HP:0000863', 'Central diabetes insipidus', 'MP:0014062', 'nervous system inclusion bodies', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(236322, 'HP:0000863', 'Central diabetes insipidus', 'MP:0005360', 'urolithiasis', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(236323, 'HP:0000863', 'Central diabetes insipidus', 'MP:0005500', 'abnormal gustatory system morphology', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(236324, 'HP:0000863', 'Central diabetes insipidus', 'MP:0013118', 'swellings', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(236325, 'HP:0000863', 'Central diabetes insipidus', 'MP:0008923', 'thoracoschisis', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(236326, 'HP:0000863', 'Central diabetes insipidus', 'MP:0004264', 'abnormal extraembryonic tissue physiology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(236327, 'HP:0000863', 'Central diabetes insipidus', 'MP:0006279', 'abnormal limb development', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(236328, 'HP:0000863', 'Central diabetes insipidus', 'MP:0002108', 'abnormal muscle morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(236329, 'HP:0000863', 'Central diabetes insipidus', 'MP:0003942', 'abnormal urinary system development', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(236330, 'HP:0000863', 'Central diabetes insipidus', 'MP:0001985', 'abnormal gustatory system physiology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(236331, 'HP:0000863', 'Central diabetes insipidus', 'MP:0010126', 'abnormal distal visceral endoderm morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(236332, 'HP:0000863', 'Central diabetes insipidus', 'MP:0030572', 'abnormal pilosebaceous unit morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(236333, 'HP:0000863', 'Central diabetes insipidus', 'MP:0001929', 'abnormal gametogenesis', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(236334, 'HP:0000863', 'Central diabetes insipidus', 'MP:0030222', 'hyperostosis', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(236335, 'HP:0000863', 'Central diabetes insipidus', 'MP:0013332', 'peliosis', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(236336, 'HP:0000863', 'Central diabetes insipidus', 'MP:0013133', 'pale limbs', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(236337, 'HP:0000863', 'Central diabetes insipidus', 'MP:0002086', 'abnormal extraembryonic tissue morphology', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(236338, 'HP:0000863', 'Central diabetes insipidus', 'MP:0000733', 'abnormal muscle development', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(236339, 'HP:0000863', 'Central diabetes insipidus', 'MP:0031272', 'abnormal susceptibility to induced aneurysm formation', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(236340, 'HP:0000863', 'Central diabetes insipidus', 'MP:0001726', 'abnormal allantois morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(236341, 'HP:0000863', 'Central diabetes insipidus', 'MP:0000752', 'dystrophic muscle', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(236342, 'HP:0000863', 'Central diabetes insipidus', 'MP:0013283', 'failure of ventral body wall closure', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(236343, 'HP:0000863', 'Central diabetes insipidus', 'MP:0020981', 'abnormal immune system development', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(236344, 'HP:0000863', 'Central diabetes insipidus', 'MP:0011167', 'abnormal adipose tissue development', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(236345, 'HP:0000863', 'Central diabetes insipidus', 'MP:0013124', 'mouth swellings', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(236346, 'HP:0000863', 'Central diabetes insipidus', 'MP:0013560', 'abnormal endocrine gland morphology', 0.43478260869565216, 6.358033815197547, 1.6626372209074232, 'UPHENO:0003116', 'abnormal endocrine system'),
(236347, 'HP:0000863', 'Central diabetes insipidus', 'MP:0005499', 'abnormal olfactory system morphology', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(236348, 'HP:0000863', 'Central diabetes insipidus', 'MP:0012260', 'encephalomeningocele', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(236349, 'HP:0000863', 'Central diabetes insipidus', 'MP:0020982', 'abnormal skin adnexa development', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(236350, 'HP:0000863', 'Central diabetes insipidus', 'MP:0031377', 'ambiguous external genitalia', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(236351, 'HP:0000863', 'Central diabetes insipidus', 'MP:0010736', 'abnormal extraembryonic ectoderm morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(236352, 'HP:0000863', 'Central diabetes insipidus', 'MP:0003890', 'abnormal embryonic-extraembryonic boundary morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(236353, 'HP:0000863', 'Central diabetes insipidus', 'MP:0000685', 'abnormal immune system morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(236354, 'HP:0000863', 'Central diabetes insipidus', 'MP:0003119', 'abnormal digestive system development', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(236355, 'HP:0000863', 'Central diabetes insipidus', 'MP:0005029', 'abnormal amnion morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(236356, 'HP:0000863', 'Central diabetes insipidus', 'MP:0002113', 'abnormal skeleton development', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(236357, 'HP:0000863', 'Central diabetes insipidus', 'MP:0008932', 'abnormal embryonic tissue physiology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(236358, 'HP:0000863', 'Central diabetes insipidus', 'MP:0002111', 'abnormal tail morphology', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(236359, 'HP:0000863', 'Central diabetes insipidus', 'MP:0031274', 'increased susceptibility to induced aneurysm formation', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(236360, 'HP:0000863', 'Central diabetes insipidus', 'MP:0005457', 'abnormal percent body fat/body weight', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(236361, 'HP:0000863', 'Central diabetes insipidus', 'MP:0000462', 'abnormal digestive system morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(236362, 'HP:0000863', 'Central diabetes insipidus', 'MP:0002396', 'abnormal hematopoietic system morphology/development', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(236363, 'HP:0000863', 'Central diabetes insipidus', 'MP:0002836', 'abnormal chorion morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(236364, 'HP:0000863', 'Central diabetes insipidus', 'MP:0014134', 'abnormal embryo morphology', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(236365, 'HP:0000863', 'Central diabetes insipidus', 'MP:0006281', 'abnormal tail development', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(236366, 'HP:0000863', 'Central diabetes insipidus', 'MP:0008533', 'abnormal anterior visceral endoderm morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(236367, 'HP:0000863', 'Central diabetes insipidus', 'MP:0013113', 'greasy tail', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(236368, 'HP:0000863', 'Central diabetes insipidus', 'MP:0001718', 'abnormal visceral yolk sac morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(236369, 'HP:0000863', 'Central diabetes insipidus', 'MP:0005508', 'abnormal skeleton morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(236370, 'HP:0000863', 'Central diabetes insipidus', 'MP:0004134', 'abnormal chest morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(236371, 'HP:0000863', 'Central diabetes insipidus', 'MP:0013558', 'abnormal exocrine gland morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(236372, 'HP:0000863', 'Central diabetes insipidus', 'MP:0012514', 'pectus excavatum', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(236373, 'HP:0000863', 'Central diabetes insipidus', 'MP:0011203', 'abnormal parietal yolk sac morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(236374, 'HP:0000863', 'Central diabetes insipidus', 'MP:0031273', 'decreased susceptibility to induced aneurysm formation', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(236375, 'HP:0000863', 'Central diabetes insipidus', 'MP:0010680', 'abnormal skin adnexa physiology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(236376, 'HP:0000863', 'Central diabetes insipidus', 'MP:0003279', 'aneurysm', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(236377, 'HP:0000863', 'Central diabetes insipidus', 'MP:0011199', 'abnormal amniotic cavity morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(236378, 'HP:0000863', 'Central diabetes insipidus', 'MP:0012500', 'abnormal angioblastic cord morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(236379, 'HP:0000863', 'Central diabetes insipidus', 'MP:0013126', 'teat swellings', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(236380, 'HP:0000863', 'Central diabetes insipidus', 'MP:0013125', 'thorax swellings', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(236381, 'HP:0000863', 'Central diabetes insipidus', 'MP:0013561', 'abnormal endocrine gland physiology', 0.4166666666666667, 6.358033815197547, 1.6276304114670233, 'UPHENO:0003116', 'abnormal endocrine system'),
(236382, 'HP:0000863', 'Central diabetes insipidus', 'MP:0031310', 'abnormal cyst', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(236383, 'HP:0000863', 'Central diabetes insipidus', 'MP:0000003', 'abnormal adipose tissue morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(236384, 'HP:0000863', 'Central diabetes insipidus', 'MP:0011186', 'abnormal visceral endoderm morphology', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(236385, 'HP:0000863', 'Central diabetes insipidus', 'MP:0003384', 'abnormal ventral body wall morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(236386, 'HP:0000863', 'Central diabetes insipidus', 'MP:0003300', 'gastrointestinal ulcer', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(236387, 'HP:0000863', 'Central diabetes insipidus', 'MP:0001983', 'abnormal olfactory system physiology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(236388, 'HP:0000863', 'Central diabetes insipidus', 'MP:0003385', 'abnormal body wall morphology', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(236389, 'HP:0000863', 'Central diabetes insipidus', 'MP:0020973', 'abnormal gland development', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(236390, 'HP:0000863', 'Central diabetes insipidus', 'MP:0010678', 'abnormal skin adnexa morphology', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(236391, 'HP:0000863', 'Central diabetes insipidus', 'MP:0014137', 'abnormal preimplantation embryo morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(236392, 'HP:0000863', 'Central diabetes insipidus', 'MP:0031099', 'abnormal sputum morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(236393, 'HP:0000863', 'Central diabetes insipidus', 'MP:0014136', 'abnormal extraembryonic endoderm morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(236394, 'HP:0000863', 'Central diabetes insipidus', 'MP:0013122', 'tail swellings', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(236395, 'HP:0000863', 'Central diabetes insipidus', 'MP:0012028', 'abnormal visceral endoderm physiology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(236396, 'HP:0000863', 'Central diabetes insipidus', 'MP:0010352', 'gastrointestinal tract polyps', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(236397, 'HP:0000863', 'Central diabetes insipidus', 'MP:0003935', 'abnormal craniofacial development', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(236398, 'HP:0000863', 'Central diabetes insipidus', 'MP:0000516', 'abnormal renal/urinary system morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(236399, 'HP:0034647', 'Synovial granuloma', 'MP:0003795', 'abnormal bone structure', 0.4444444444444444, 4.825104621810128, 1.4644080520902374, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(236400, 'HP:0034647', 'Synovial granuloma', 'MP:0030878', 'abnormal fibrous joint morphology', 0.4482758620689655, 8.414032639097075, 1.9421142434902365, 'UPHENO:0076767', 'abnormal skeletal joint morphology'),
(236401, 'HP:0034647', 'Synovial granuloma', 'MP:0002114', 'abnormal axial skeleton morphology', 0.42857142857142855, 4.825104621810128, 1.4380201600727889, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(236402, 'HP:0034647', 'Synovial granuloma', 'MP:0030222', 'hyperostosis', 0.4444444444444444, 4.825104621810128, 1.4644080520902374, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(236403, 'HP:0034647', 'Synovial granuloma', 'MP:0012071', 'increased susceptibility to osteoporosis', 0.41379310344827586, 4.825104621810128, 1.4130092058870078, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(236404, 'HP:0034647', 'Synovial granuloma', 'MP:0005504', 'abnormal ligament morphology', 0.42857142857142855, 4.825104621810128, 1.4380201600727889, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(236405, 'HP:0034647', 'Synovial granuloma', 'MP:0031348', 'bone fibrous dysplasia', 0.42857142857142855, 4.825104621810128, 1.4380201600727889, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(236406, 'HP:0034647', 'Synovial granuloma', 'MP:0002937', 'synovial hyperemia', 0.4827586206896552, 10.577399924517223, 2.2597192299139284, 'UPHENO:0087892', 'abnormal synovial joint morphology'),
(236407, 'HP:0034647', 'Synovial granuloma', 'MP:0010874', 'abnormal bone volume', 0.42857142857142855, 4.825104621810128, 1.4380201600727889, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(236408, 'HP:0034647', 'Synovial granuloma', 'MP:0030804', 'abnormal synovial joint morphology', 0.5, 10.577399924517223, 2.299717365734018, 'UPHENO:0087892', 'abnormal synovial joint morphology'),
(236409, 'HP:0034647', 'Synovial granuloma', 'MP:0030484', 'abnormal osteocyte lacuna morphology', 0.41379310344827586, 4.825104621810128, 1.4130092058870078, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(236410, 'HP:0034647', 'Synovial granuloma', 'MP:0031350', 'polyostotic fibrous dysplasia', 0.41379310344827586, 4.825104621810128, 1.4130092058870078, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(236411, 'HP:0034647', 'Synovial granuloma', 'MP:0030820', 'abnormal pectoral girdle joint morphology', 0.42424242424242425, 10.577399924517223, 2.118344114198357, 'UPHENO:0087892', 'abnormal synovial joint morphology'),
(236412, 'HP:0034647', 'Synovial granuloma', 'MP:0012070', 'abnormal susceptibility to osteoporosis', 0.42857142857142855, 4.825104621810128, 1.4380201600727889, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(236413, 'HP:0034647', 'Synovial granuloma', 'MP:0010123', 'increased bone mineral content', 0.41379310344827586, 4.825104621810128, 1.4130092058870078, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(236414, 'HP:0034647', 'Synovial granuloma', 'MP:0030818', 'abnormal girdle joint morphology', 0.4482758620689655, 8.414032639097075, 1.9421142434902365, 'UPHENO:0076767', 'abnormal skeletal joint morphology'),
(236415, 'HP:0034647', 'Synovial granuloma', 'MP:0005508', 'abnormal skeleton morphology', 0.46153846153846156, 4.825104621810128, 1.492304045398379, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(236416, 'HP:0034647', 'Synovial granuloma', 'MP:0030865', 'abnormal synovial joint cavity morphology', 0.5172413793103449, 15.607147267911275, 2.8412431046909923, 'UPHENO:0087322', 'abnormal synovial cavity of joint morphology'),
(236417, 'HP:0034647', 'Synovial granuloma', 'MP:0030875', 'abnormal cartilaginous joint morphology', 0.4482758620689655, 8.414032639097075, 1.9421142434902365, 'UPHENO:0076767', 'abnormal skeletal joint morphology'),
(236418, 'HP:0034647', 'Synovial granuloma', 'MP:0030866', 'abnormal synovial joint membrane morphology', 0.4666666666666667, 10.577399924517223, 2.2217380504403987, 'UPHENO:0087892', 'abnormal synovial joint morphology'),
(236419, 'HP:0034647', 'Synovial granuloma', 'MP:0000997', 'abnormal synovial joint capsule morphology', 0.4666666666666667, 10.577399924517223, 2.2217380504403987, 'UPHENO:0087892', 'abnormal synovial joint morphology'),
(236420, 'HP:0034647', 'Synovial granuloma', 'MP:0013304', 'osteophytes', 0.42857142857142855, 4.825104621810128, 1.4380201600727889, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(236421, 'HP:0034647', 'Synovial granuloma', 'MP:0002113', 'abnormal skeleton development', 0.4444444444444444, 4.825104621810128, 1.4644080520902374, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(236422, 'HP:0034647', 'Synovial granuloma', 'MP:0010122', 'abnormal bone mineral content', 0.42857142857142855, 4.825104621810128, 1.4380201600727889, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(236423, 'HP:0034647', 'Synovial granuloma', 'MP:0031349', 'monostotic fibrous dysplasia', 0.41379310344827586, 4.825104621810128, 1.4130092058870078, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(236424, 'HP:0034647', 'Synovial granuloma', 'MP:0010971', 'abnormal periosteum morphology', 0.41379310344827586, 4.825104621810128, 1.4130092058870078, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(236425, 'HP:0034647', 'Synovial granuloma', 'MP:0002932', 'abnormal joint morphology', 0.48148148148148145, 8.414032639097075, 2.01275952371514, 'UPHENO:0076767', 'abnormal skeletal joint morphology'),
(236426, 'HP:0034647', 'Synovial granuloma', 'MP:0010124', 'decreased bone mineral content', 0.41379310344827586, 4.825104621810128, 1.4130092058870078, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(236427, 'HP:0034647', 'Synovial granuloma', 'MP:0030485', 'abnormal osteocyte lacunocanalicular system morphology', 0.42857142857142855, 4.825104621810128, 1.4380201600727889, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(236428, 'HP:0034647', 'Synovial granuloma', 'MP:0009250', 'abnormal appendicular skeleton morphology', 0.42857142857142855, 4.825104621810128, 1.4380201600727889, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(236429, 'HP:0034647', 'Synovial granuloma', 'MP:0000163', 'abnormal cartilage morphology', 0.41379310344827586, 4.825104621810128, 1.4130092058870078, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(236430, 'HP:0034647', 'Synovial granuloma', 'MP:0011642', 'abnormal bone collagen fibril morphology', 0.41379310344827586, 4.825104621810128, 1.4130092058870078, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(236431, 'HP:0034647', 'Synovial granuloma', 'MP:0013941', 'abnormal enthesis morphology', 0.41379310344827586, 4.825104621810128, 1.4130092058870078, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(236432, 'HP:0034647', 'Synovial granuloma', 'MP:0030486', 'abnormal osteocyte canaliculus morphology', 0.41379310344827586, 4.825104621810128, 1.4130092058870078, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(236433, 'HP:0034647', 'Synovial granuloma', 'MP:0000566', 'synostosis', 0.42857142857142855, 4.825104621810128, 1.4380201600727889, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(236434, 'HP:0034647', 'Synovial granuloma', 'MP:0005422', 'osteosclerosis', 0.42857142857142855, 4.825104621810128, 1.4380201600727889, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(236435, 'HP:0034647', 'Synovial granuloma', 'MP:0012072', 'decreased susceptibility to osteoporosis', 0.41379310344827586, 4.825104621810128, 1.4130092058870078, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(236436, 'HP:0034647', 'Synovial granuloma', 'MP:0030819', 'abnormal pelvic girdle joint morphology', 0.4375, 10.577399924517223, 2.1511886172477497, 'UPHENO:0087892', 'abnormal synovial joint morphology'),
(236437, 'HP:0034647', 'Synovial granuloma', 'MP:0009877', 'exostosis', 0.42857142857142855, 4.825104621810128, 1.4380201600727889, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(236438, 'HP:0011452', 'Functional abnormality of the middle ear', 'MP:0011967', 'increased or absent threshold for auditory brainstem response', 0.40540540540540543, 7.171824267787784, 1.7051382128082262, 'UPHENO:0002903', 'abnormal ear'),
(236439, 'HP:0011452', 'Functional abnormality of the middle ear', 'MP:0004812', 'abnormal linear vestibular evoked potential', 0.4166666666666667, 7.171824267787784, 1.7286584716415916, 'UPHENO:0002903', 'abnormal ear'),
(236440, 'HP:0011452', 'Functional abnormality of the middle ear', 'MP:0003938', 'abnormal ear development', 0.43243243243243246, 7.8051695233081215, 1.837174037077495, 'UPHENO:0076730', 'abnormal ear morphology'),
(236441, 'HP:0011452', 'Functional abnormality of the middle ear', 'MP:0006334', 'abnormal susceptibility to hearing loss', 0.42857142857142855, 7.171824267787784, 1.753179674736463, 'UPHENO:0002903', 'abnormal ear'),
(236442, 'HP:0011452', 'Functional abnormality of the middle ear', 'MP:0000035', 'abnormal membranous labyrinth morphology', 0.4146341463414634, 7.8051695233081215, 1.7989690943279903, 'UPHENO:0076730', 'abnormal ear morphology'),
(236443, 'HP:0011452', 'Functional abnormality of the middle ear', 'MP:0004814', 'reduced linear vestibular evoked potential', 0.40540540540540543, 7.171824267787784, 1.7051382128082262, 'UPHENO:0002903', 'abnormal ear'),
(236444, 'HP:0011452', 'Functional abnormality of the middle ear', 'MP:0004737', 'absent distortion product otoacoustic emissions', 0.40540540540540543, 7.171824267787784, 1.7051382128082262, 'UPHENO:0002903', 'abnormal ear'),
(236445, 'HP:0011452', 'Functional abnormality of the middle ear', 'MP:0030413', 'tympanic membrane retraction', 0.40476190476190477, 9.948935785159481, 2.006726239115597, 'UPHENO:0003017', 'abnormal middle ear'),
(236446, 'HP:0011452', 'Functional abnormality of the middle ear', 'MP:0030154', 'abnormal tympanic cavity morphology', 0.425, 9.948935785159481, 2.056282497297679, 'UPHENO:0003017', 'abnormal middle ear'),
